Advertisement

Forensische Toxikologie

  • R. K. Müller
  • R. Aderjan
  • B. Ahrens
  • W. Bernhard
  • H.-K. Bothe
  • U. Demme
  • G. Drasch
  • W. Engewald
  • R. Giebelmann
  • J. Grosse
  • G. Kauert
  • H. Kijewski
  • C. Köppel
  • T. Krämer
  • H. H. Maurer
  • D. Mebs
  • L. von Meyer
  • M. R. Möller
  • M. Otto
  • F. T. Peters
  • F. Pragst
  • H. Sachs
  • R. Salzer
  • A. Schmoldt
  • H. Schütz
  • J. Teske
  • D. Thieme
  • D. Tiess
  • H. Trauer
  • A. Wahl
  • G. Werner
  • J. Wichitill
  • A. Zschunke
Chapter

Zusammenfassung

Die Toxikologie ist die Wissenschaft von den Giften: Stoffen mit potenziell schädlichen (toxischen) Wirkungen auf lebende Organismen.

Literatur

  1. 1.
    Bankl H (1990) Viele Wege führten in die Ewigkeit. Maudrich, Wien, S 191Google Scholar
  2. 2.
    Bibra E von (1855) Die Narkotischen Genussmittel und der Mensch. Schmid, NürnbergGoogle Scholar
  3. 3.
    Farmilo CG, Genest K (1960) Alkaloids and related bases: Identification. In: Stewart CP, Stolman A (eds) Toxicology — mechanismus and analytical methods, vol I. 1960, New YorkGoogle Scholar
  4. 4.
    Geldmacher, Mallinckrodt M (1975) Forensische Toxikologie. In: Mueller B (Hrsg) Gerichtliche Medizin, Bd II. Springer, Berlin Heidelberg New York Tokio, S 692–988Google Scholar
  5. 5.
    Giebelmann R (1997) Zeitzeugen zur Entwicklung der Toxikologie. Shaker, AachenGoogle Scholar
  6. 6.
    Hohnstedt B, Liljestrand G (1981) Readings in pharmacology. Raven, New YorkGoogle Scholar
  7. 7.
    Issekutz B (1971) Die Geschichte der Arzneimittelforschung. Akademia Kiado, BudapestGoogle Scholar
  8. 8.
    Kobert R (1902) Lehrbuch der Intoxikationen, 1. Aufl. Enke, StuttgartGoogle Scholar
  9. 9.
    Lewin L (1920) Die Gifte in der Weltgeschichte. Springer, BerlinGoogle Scholar
  10. 10.
    Lewin L (1920) Die Kohlenmonoxydvergiftung. Springer, BerlinGoogle Scholar
  11. 11.
    Lewin L (11897, 51962) Gifte und Vergiftungen. Lehrbuch der Toxikologie, 5. Aufl. Haug, MünchenGoogle Scholar
  12. 12.
    Lohs K, Müller RK (1978) Symposium zur Geschichte der Toxikologie (Vorträge). Akademie der Wissenschaften zu Berlin und Gerichtliche Medizin der Universität LeipzigGoogle Scholar
  13. 13.
    Martinetz D, Löhs K (1985) Gift. Edition Leipzig, LeipzigGoogle Scholar
  14. 14.
    Müller RK (1967) Über den Kreis der organischen Verbindungen von toxikologisch-chemischer Relevanz. In: Vamosi M (Hrsg) Aktuelle Fragen der Gerichtlichen Medizin II. Wissenschaftl. Beiträge der Martin-Luther-Universität, Halle-Wittenberg, S 118–171Google Scholar
  15. 15.
    Müller RK, Löhs K (1981) Beiträge zur Geschichte der Toxikologie. Abteilung Toxikologische Chemie des Instituts für Gerichtliche Medizin der Universität Leipzig und Akademie der Wissenschaften zu BerlinGoogle Scholar
  16. 16.
    Müller RK (1986) (Hrsg) Dokumente zur Entwicklung der Toxikologie im 19. Jahrhundert. Geest & Portig, LeipzigGoogle Scholar
  17. 17.
    Mueller RK (1995) Historical data on the development of toxicology, toxicological analysis and related disciplines. Chapter 8 in „Toxicological analysis“. Molinapress Leipzig, S 685–691Google Scholar
  18. 18.
    Müller RK (1995) Toxikologische Aspekte bei Georgius Agricola. In: Naumann F (Hrsg) Tagungsband der Wissenschaftlichen Konferenz aus Anlass des 500. Geburtstages von Georgius Agricola. Birkhäuser, BaselGoogle Scholar
  19. 19.
    Müller RK, Prokop O (1987) Geschichte der Genussgifte. In: Schmähl D, Amberger-Lahrmann M (Hrsg) Gifte — Geschichte der Toxikologie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  20. 20.
    Paracelsus von Hohenheim Th B (1926) Aus „Die sieben Verteidigungsreden“ (Defensiones), die dritte Verteidigung „Wegen der Verschreibung der neuen Rezepte“. In: „Das erste Buch, die Verantwortung wegen einiger Verunglimpfungen durch seine Missgönner“ aus „Drei Bücher des Hochgelehrten Herrn Theophrastus von Hohenheim, Doktors beider Arzneien“. In: Aschner B (Hrsg) Sämtliche Werke, Übersetzung nach der 10-bändigen Huserschen Gesamtausgabe, Bd 1, Teil II. Fischer, Jena, S 477Google Scholar
  21. 21.
    Remane H et al. (1986) Geschichte der Chemie. Deutscher Verlag der Wissenschaften, BerlinGoogle Scholar
  22. 22.
    Reuter F (1938) Methoden der forensischen Beurteilung von Vergiftungen. In: Abderhalden E (Hrsg) Handbuch der Biologischen Arbeitsmethoden. Urban & Schwarzenberg, BerlinGoogle Scholar
  23. 23.
    Schmähl D, Amberger-Lahrmann M (1987) Gifte — Geschichte der Toxikologie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  24. 24.
    Szabadvary F (1966) Geschichte der analytischen Chemie (dt. Ubers. G. Herstein). Akademia Kiado, BudapestGoogle Scholar
  25. 25.
    Thorwald J (1965) Das Jahrhundert der Detektive. Droemer, ZürichGoogle Scholar
  26. 26.
    Valevnntin H (1950) Geschichte der Pharmazie und Chemie in Form von Zeittafeln. Wissenschaftl. Verlagsgesellschaft, StuttgartGoogle Scholar
  27. 27.
    Waiden P (1944) Drei Jahrtausende Chemie. Wilhelm Limpert, BerlinGoogle Scholar
  28. 28.
    Weinig E (1967) Vergiftungen — allgemeine gerichtliche Vergiftungslehre. In: Ponsold A (Hrsg) Lehrbuch der gerichtlichen Medizin. Thieme, StuttgartGoogle Scholar
  29. 1.
    Augustin C, Schmoldt A, Glatt HR, Scidel A (1991) Various UDP-Glucuronosyltransferases involved in regiospecific conjugations of Hydroxy-PAH. In: Proc 13th Int Symp Polynucl Arom Hydrocarb, Bordeaux, pp 687–694Google Scholar
  30. 2.
    Baker DH, Wilson RE (1963) The lethality of bork acid in the treatment of burns. JAMA 186: 1169–1170PubMedGoogle Scholar
  31. 3.
    Büch HP, Büch U (1996) Narkotika: Narkose. In: Forth W, Henschler D, Rummel W, Starke K (Hrsg) Allgemeine und spezielle Pharmakologie und Toxikologie, 7. Aufl. Spektrum Akademischer Verlag, HeidelbergGoogle Scholar
  32. 4.
    Cholerton S, Daly AK, Idle JR (1992) The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 13: 435Google Scholar
  33. 5.
    Coffman BL, Rios GR, King CD, Tephly TR (1997) Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 25/1: 1–4PubMedGoogle Scholar
  34. 6.
    Dost FH (1968) Grundlagen der Pharmakokinetik, 2. Aufl. Thieme, StuttgartGoogle Scholar
  35. 7.
    Ehling TE, Thompson DC, Foureman GL, Curtis JF, Hughes MF (1990) Prostaglandin H synthase and xenobiotic oxidation. Annu Rev Pharmacol Toxicol 30: 1–45Google Scholar
  36. 8.
    Frohne D, Schmoldt A, Pfänder HJ (1984) Die Paternostererbse — Keineswegs harmlos. Dtsch Apoth Z 124/43: 2109–2113Google Scholar
  37. 9.
    Gladtke E, Hattingberg HM von (1973) Pharmakokinetik. Eine Einführung. Springer, Berlin Heidelberg New YorkGoogle Scholar
  38. 10.
    Iwersen S, Schmoldt A (1998) A specific hydroxysteroid UGT is responsible for the conjugation of aliphatic alcohols in rats: an estimation of the importance of glucuronidation vs. oxidation. Alcohol 15/3: 185–192PubMedGoogle Scholar
  39. 11.
    Klotz U (1984) Klinische Pharmakokinetik, 2. Aufl. Fischer, StuttgartGoogle Scholar
  40. 12.
    Merk H (1994) Haut. In: Marquardt H, Schäfer SG (Hrsg) Lehrbuch der Toxikologie, Wissenschaftsverlag, MannheimGoogle Scholar
  41. 13.
    Meyerinck L von, Coffman BL, Green MD, Kirkpatrick RB, Schmoldt A, Tephly TR (1985) Separation, purification and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity. Drug Metab Dispos 13/6: 700–704Google Scholar
  42. 14.
    Muhle H (1994) Respirationstrakt. In: Marquardt H, Schäfer SG (Hrsg) Lehrbuch der Toxikologie, Bd I. Wissenschaftsverlag, MannheimGoogle Scholar
  43. 15.
    Oesch F (1994) Fremdstoffmetabolismus. In: Marquardt H, Schäfer SG (Hrsg) Lehrbuch der Toxikologie, Bd I. Wissenschaftsverlag, MannheimGoogle Scholar
  44. 16.
    Oesch F, Drehmer JS, Friedberg T, Glatt HR, Oesch-Barthlomowicz B, Platt K, Steinberg P, Utesch D, Thomas H (1990) Toxicological implication of enzymatic control of reactive metabolites. Hum Exp Toxicol 9: 171–177 (p 93 ff.)PubMedGoogle Scholar
  45. 17.
    Schenkman JB, Greim H (1993) Cytochrome P450. In: Born GVR, Cuatrecasas P, Herken H (eds) Handbook of experimental pharmacology, vol 105. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  46. 18.
    Schmoldt A (1978) Increased digitoxin cleavage by liver microsomes of spironolactone-pretreated rats. Naunyn-Schmiedeberg’s Arch Pharmacol 305: 261–263Google Scholar
  47. 19.
    Schmoldt A, Rohloff C (1978) Dehydro-digitoxosides of digitoxigenin: Formation and importance for the digitoxin metabolism in the rat. Naunyn-Schmiedeberg’s Arch Pharmacol 305: 167–172Google Scholar
  48. 20.
    Schmoldt A, Meyerinck L von, Drohn W, Blömer I (1986) Enzymatic basis for digitoxin metabolism and possible drug interactions in man. In: Erdmann E, Greef K, Skou JC (eds) Cardiac glycosides 1785–1985. Steinkopff, DarmstadtGoogle Scholar
  49. 21.
    Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, Raftogianis RB (1997) Sulfotransferase molecular biology: cDNAs and genes. Faseb J 11: 3–14PubMedGoogle Scholar
  50. 22.
    Ziegler DM (1990) Flavin-containing monoxygenases: enzymes adapted for multisubstrate specifity. Trends in Pharmacol Sciences 11: 321–324Google Scholar

Weiterfüfrende Literatur

  1. 1.
    Ellenhorn MJ (1997) Ellenhorn’s medical toxicology: Diagnosis and treatment of human poisoning, 2nd edn. Williams & Wilkins, BaltimoreGoogle Scholar
  2. 2.
    Estler CJ (1997) Arzneimittel im Alter, 2. Aufl. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  3. 3.
    Ferner RE (1996) Forensic pharmacology, medicines, mayhem, and malpractice. Oxford University Press, OxfordGoogle Scholar
  4. 4.
    Forth W, Henschler E, Rummel W, Starke K (1996) (Hrsg) Allgemeine und spezielle Pharmakologie und Toxikologie, 7. Aufl. Spektrum Akademischer Verlag, HeidelbergGoogle Scholar
  5. 5.
    Hardmann JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (1996) The pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New YorkGoogle Scholar
  6. 6.
    Jaehde U, Radziwill R, Mühlebach S, Schunack W (1998) (Hrsg) Lehrbuch der Klinischen Pharmazie. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  7. 7.
    Mutschier E, Schäfer-Korting M (1996) Arzneimittelwirkungen, 7._Aufl. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  8. 8.
    Platt D, Mutschier E (1999) (Hrsg) Pharmakotherapie im Alter. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  9. 9.
    Rang HP, Dal MM, Ritter JM (1995) Pharmacology, 3rd edn. Churchill Livingstone, EdinburghGoogle Scholar
  1. 1.
    Albrecht K (1997) Intensivtherapie aktueller Vergiftungen, 1. Aufl. Ullstein Mosby, BerlinGoogle Scholar
  2. 2.
    Baselt RC, Cravey RH (1995) Disposition of toxic drugs and chemicals in man, 4th edn. Chemical Toxicology Institute, ßFoster City/CAGoogle Scholar
  3. 3.
    Dollery C (ed) (1991) Therapeutic drugs, 1st edn. Churchill Livingstone, EdinburghGoogle Scholar
  4. 4.
    Gelmann CR, Rumack BH, Hutchinson TA (eds) (1998) Drugdex System, vol 98. Micromedex, Englewood/COGoogle Scholar
  5. 5.
    Ludewig R (Hrsg) (1999) Akute Vergiftungen, 9. Aufl. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  6. 6.
    Meyer FP (1994) Indicative therapeutic and toxic drug concentrations in plasma: a tabulation. Int J Clin Pharmacol Ther 32: 71–81PubMedGoogle Scholar
  7. 6a.
    Regenthal R, Krüger M, Koppel C, Preiß R (1999) Zu Möglichkeiten und Grenzen von therapeutischen und toxikologischen Referenzwerten für Plasma-/Serum-/ Vollblutkonzentrationen von Arzneimitteln bei akuten Vergiftungen — eine Übersicht. Anästhesiol Intensivmed 3/40: 129–144Google Scholar
  8. 7.
    Repetto MR, Repetto M (1997) Habitual, toxic and lethal concentrations of 103 drugs of abuse in humans. Toxicol Clin Toxicol 35: 1–9Google Scholar
  9. 8.
    Repetto MR, Repetto M (1997) Therapeutic, toxic and lethal concentrations in human fluids of 90 drugs affecting the cardiovascular and hematopoietic Systems. J Toxicol Clin Toxicol 35: 345–351PubMedGoogle Scholar
  10. 9.
    Rumack BH, Toll LL, Gelmann CR (eds) (1998) Poisonindex System, vol 98. Micromedex, Englewood/COGoogle Scholar
  11. 10.
    Schulz M, Schmoldt A (1994) Zusammenstellung therapeutischer und toxischer Plasmakonzentrationen von Arzneistoffen. Anästhesist 43: 835–844Google Scholar
  12. 11.
    Seyffart G (1996) Giftindex, 4. Aufl. Pabst Science Publishers, LengerichGoogle Scholar
  13. 12.
    Uges DRA (1990) Orientierende Angaben zu therapeutischen und toxischen Konzentrationen von Arzneimitteln und Giften in Blut, Serum oder Urin. VCH, WeinheimGoogle Scholar
  14. 13.
    Walter H, Meyer FP (Hrsg) (1990) Klinische Pharmakologie. Verlag Gesundheit, BerlinGoogle Scholar
  15. 14.
    Weilemann LS, Reinicke HJ (1996) Notfallmanual Vergiftungen. Thieme, StuttgartGoogle Scholar
  16. 1.
    Amendt J, Krettek R, Bratzke H (1999) Praxis der forensischen Insektenkunde. Teil 1: Insektenaufsammlung am Fundort einer Leiche. Arch Kriminol 204: 106–116PubMedGoogle Scholar
  17. 2.
    Arnold W, Bohn G (1987) Skin appendages, a special aspect of forensic diagnosis and assessment. Beitr Gerichtl Med 45: 261–267PubMedGoogle Scholar
  18. 3.
    Balabanova S, Schneider E, Wepler R et al. (1992) Die Bedeutung des Pilocarpinschweißes für den Nachweis eines zurückliegenden Drogenkonsums. Beitr Gerichtl Med 50: 111–115PubMedGoogle Scholar
  19. 4.
    Baselt RC, Cravey RH (1995) Disposition of toxic drugs and chemicals in man, 4th edn. Chemical Toxicology Institute, Foster City/CAGoogle Scholar
  20. 5.
    Benecke M (1996) Zur insektenkundlichen Begutachtung in Faulleichenfällen. Arch Kriminol 198: 99–109PubMedGoogle Scholar
  21. 6.
    Benecke M (1997) Asservierung von Insekten-, Spinnen-und Krebsmaterial für die forensisch-kriminalistische Untersuchung. Arch Kriminol 199: 167–176PubMedGoogle Scholar
  22. 7.
    Besserer K (1997) Ein Giftmord mit Nitrosodimethylamin. In: Pragst F (Hrsg) Proceedings X. GTFCH-Symposium. Moderne Messverfahren im Rahmen der Toxikologisch-Forensischen Begutachtung. Helm, Heppenheim, S 141–148Google Scholar
  23. 8.
    Brinkmann B (1999) Harmonisation of medico-legal autopsy rules. Int I Legal Med 113: 1–14Google Scholar
  24. 9.
    Cirimele V, Kintz P, Mangin P (1995) Detection of amphetamines in fingernails: an alternativ to hair analysis. Arch Toxicol 70: 68–69PubMedGoogle Scholar
  25. 10.
    Daldrup Th (1992) Nachweisgrenzen und Hirntod-Diagnostik. GTFCH-Symposium 1991. Spurenanalytik im Human-und Umweltbereich. Helm, Heppenheim, S 13–23Google Scholar
  26. 11.
    Denk R, Raff I, Sachs H (1991) Qualitätssicherung bei der Untersuchung von Kopfhaaren zum Nachweis von Betäubungsmitteln. Toxichem Krimtech 58: 79–83Google Scholar
  27. 12.
    De Zeeuw RA, Al Hosani I, Al Munthiri S, Maqbool A (1995) Proceedings of the 1995 International Conference and Workshop for Hair Analysis in Forensic Toxicology. Abu Dhabi PoliceGoogle Scholar
  28. 13.
    Dirnhofer R, Wyler D (1996) The autopsy theater and the toxicology laboratory. In: Sachs H, Bernhard W, Jeger A (eds) TIAFT Proceedings of the 34th Triennial Meeting, Interlaken. Molinapress, Leipzig, S 10–15Google Scholar
  29. 14.
    Dünkelmeyer E (1986) Über seltene Arten krimineller Giftbeibringung. Arch Kriminol 178: 35–43, 95-102Google Scholar
  30. 15.
    Engelhart DA, Lavins ES, Sutheimer CA (1998) Detection of drugs of abuse in nails. J Anal Toxicol 22: 314–318PubMedGoogle Scholar
  31. 16.
    Garside D, Ropero-Miller JD, Goldberger BA et al. (1998) Identification of cocaine analytes in fingernail and toenail specimens. J Forensic Sci 43: 974–979PubMedGoogle Scholar
  32. 17.
    Goff ML, Lord WD (1994) Entomotoxicology. A new area for forensic investigation. Am J Forens Med Pathol 15: 51–57Google Scholar
  33. 18.
    Hallbach J (1997) Fehlinterpretation einer kindlichen Amitriptylinvergiftung bei Falschangabe des Ingestionszeitpunktes. Toxichem Krimtech 64: 114–115Google Scholar
  34. 19.
    Heinemeyer G, Fabian U (Hrsg) (1997) Asservierung. In: Der Vergiftungs-und Drogennotfall. Ullstein Mosby, Berlin, S 43–48Google Scholar
  35. 20.
    Hofer R (1993) Glaskörperflüssigkeit als Untersuchungsmaterial. Toxichem Krimtech 60: 116–120Google Scholar
  36. 21.
    Hofer R (1993a) Bestimmung von Morphin in Spermaflüssigkeit. Toxichem Krimtech 60: 121–122Google Scholar
  37. 22.
    Hollweg M, Wagner H-J (1996) Asservierung von Haaren zum Nachweis chronischen Drogenkonsums. Dtsch Ärztebl 93: A–836Google Scholar
  38. 23.
    Iffland R (1991) Kohlenmonoxidbestimmung im biologischen Material. In: Arnold W (Hrsg) Rechtsmedizin und forensische Toxikologie. Neue analytische Methoden. Helm, Heppenheim, S 81–88Google Scholar
  39. 24.
    Kaatsch H-J (1990) Asservate und klinische Interpretation. Rechtsprobleme im Bereich „Klinisch-toxikologische Analytik“. Toxichem Krimtech 57: 99–110Google Scholar
  40. 25.
    Kaatsch H-J (1994) Eigentumsrechte an menschlichem Material — insbesondere an Patientenuntersuchungsmaterial. Rechtsmed 4: 132–136Google Scholar
  41. 26.
    Käferstein H (1980) Zum Nachweis von schwer flüchtigen extrahierbaren Giften in faulen Leichen. Habilitationschrift, KölnGoogle Scholar
  42. 27.
    Kidwell DA, Holland JC, Athanaselis S (1998) Testing for drugs of abuse in saliva and sweat. J Chromatogr B; Biomed Sci Appl 713: 111–135PubMedGoogle Scholar
  43. 28.
    Kijewski H (Hrsg, 1997) Das Haar als Spur — Spuren in Haaren. Rechtsmedizinische Forschungsergebnisse, Bd 16. Schmidt-Römhild, LübeckGoogle Scholar
  44. 29.
    Kijewski H, Seefeld KP, Pöhlmann K (1985) Eine neue Methode zur Carboxyhämoglobinbestimmung im flüssigen und getrockneten Blut mittels Fourier-Transform-Infrarot-Spektrometrie (FTIR). Z Rechtsmed 95: 67–74PubMedGoogle Scholar
  45. 30.
    Kintz P (1997) Drug testing in sweat. In: Pragst F (Hrsg) Moderne Messverfahren im Rahmen der Toxikologisch-Forensischen Begutachtung. Helm, Heppenheim, S 104–110Google Scholar
  46. 31.
    Klug H (1982) Zum Nachweis von Arzneistoffen in formalinfixierten Organteilen. Beitr Gerichtl Med 40: 407–411PubMedGoogle Scholar
  47. 32.
    Lemos NP, Anderson RA, Robertson JR (1999) Nail analysis for drugs of abuse: Extraction and determination of Cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 23: 147–152PubMedGoogle Scholar
  48. 33.
    Lemos NP, Anderson RA, Valentini R et al. (2000) Analysis of morphine by RIA and HPLC in fingernail clippings obtained from heroin users. J Forensic Sci 45: 407–412PubMedGoogle Scholar
  49. 34.
    Levisky JA, Bowerman DL, Jenkins WW, Karch SB (2000) Drug deposition in adipose tissue and skin: evidence for an alternative source of positive sweat patch tests. Forens Sci Int 110: 35–46Google Scholar
  50. 35.
    Ludewig R (1999) (Hrsg) Akute Vergiftungen. Ratgeber zu Erkennung, Verlauf, Behandlung und Verhütung toxikologischer Notfälle, 9. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 31–40Google Scholar
  51. 36.
    Machata G (1968) Die Differenzierung der Kohlenmonoxidvergiftung. Arch Toxikol 23: 136–140PubMedGoogle Scholar
  52. 37.
    Madea B (1994) Leichenzerstückelung mit ungewöhnlicher Konservierung der Leichenteile. Arch Kriminol 193: 72–78PubMedGoogle Scholar
  53. 38.
    Madea B, Dettmeyer R (1999) Tod durch Gifteinwirkung. In: Madea B (Hrsg) Die Ärztliche Leichenschau. Rechtsgrundlagen, praktische Durchführung, Problemlosung. Springer, Berlin Heidelberg New York Tokio, S 179–182Google Scholar
  54. 39.
    Magerl, H (1998) Toxikologische Untersuchungen — eine Entscheidungshilfe zur Hirntod-Diagnostik. In: Schulz E, Magerl H (Hrsg) Rechtsmedizin. Vorträge über aktuelle Themen, H 14. Roth, Würzburg, ISSN 0935-087X, S 18–27Google Scholar
  55. 40.
    Magerl H, Hein PM, Schulz E (1995) Der Speichel als Untersuchungssubstrat. Analytische Methoden und ihre Möglichkeiten des Einsatzes. In: Krüger H-P, Kohnen R, Schöch H (Hrsg) Medikamente und Straßenverkehr. Fischer, S 157–171Google Scholar
  56. 41.
    Martz W (1997) Untersuchungen zu propagierten Methoden der Urinverfälschung vor dem Drogentest. Toxichem Krimtech 64: 88–95Google Scholar
  57. 42.
    Moore C, Negrusz A, Lewis D (1998) Determination of drugs of abuse in meconium. J Chromatogr. B; Biomed Sci Appl 713: 137–146PubMedGoogle Scholar
  58. 43.
    Morinaga M, Kashimura S, Hara K et al. (1996) The Utility of volatile hydrocarbon analysis in cases of carbon monoxide poisoning. Int J Legal Med 109: 75–79PubMedGoogle Scholar
  59. 44.
    Neoral L, Smysl B (1985) Gerichtsmedizinische Bedeutung postmortaler Alveolarluftuntersuchungen (GC, IR) der Opfer von Massenkatastrophen. In: Müller RK (Hrsg) Diagnose und Therapie von Intoxikationen. Universität Leipzig, S 37–38Google Scholar
  60. 45.
    Norris DO, Bock JH (2000) Use of fecal material to associate a suspect with a crime scene: Report of two cases. J Forens Sci 45: 184–187Google Scholar
  61. 46.
    Pink J, Tiess D (1994) About the distribution of carboxyhemoglobin in the human body post mortem. In: Müller RK (ed) Contributions to forensic toxicology. Proceedings of 3Ith TIAFT Meeting, Leipzig 1993, pp 402–407Google Scholar
  62. 47.
    Pötsch L, Skopp G (1997) Zu Möglichkeiten und Grenzen chemisch-toxikologischer Untersuchungen an nicht konventionellen Asservaten. In: Pragst F (Hrsg) Moderne Messverfahren im Rahmen der Toxikologisch-Forensischen Begutachtung. Helm, Heppenheim, S 70–88Google Scholar
  63. 48.
    Pragst F, Rothe H, Spiegel K, Sporkert F (1998) Illegal and therapeutic drug concentrations in hair segments — a timetable of drug exposure? Forensic Sci Rev 10: 81–111Google Scholar
  64. 49.
    Reichard D, Ochterbeck W (Hrsg) (1994) Abfälle aus chemischen Laboratorien und medizinischen Einrichtungen. 2. Aufl. Ecomed, Landsberg/LechGoogle Scholar
  65. 50.
    Reiter C (1984) Zum Wachstumsverhalten der Maden der blauen Schmeißfliege Calliphora vicina. Z Rechtsmed 91: 295–308PubMedGoogle Scholar
  66. 51.
    Reiter C, Hajek P (1984) Zum altersabhängigen Wandel der Darmtraktfüllung bei Schmeißfliegenmaden — eine Untersuchungsmethode im Rahmen der forensischen Todeszeitbestimmung. Z Rechtmed 92: 39–45Google Scholar
  67. 52.
    Ridder K (1990) Gefahrgut Praxis. Gefahrgutverordnung Straße (GGVS), 6. Aufl. Ecomed, Landsberg/LechGoogle Scholar
  68. 53.
    Rochholz G (1998) Kritische Untersuchungen zum Screening und zur Identifizierung toxikologisch relevanter Substanzen unter erschwerten analytischen Bedingungen. Dissertation, Universität GießenGoogle Scholar
  69. 54.
    Röhrich J, Zörntlein S, Pötsch L, Skopp G (2000) Effect of the Shampoo Ultra Clean on drug concentrations in human hair. Int J Legal Med 113: 102–106PubMedGoogle Scholar
  70. 55.
    Roth L (Hrsg) (1989 Grundwerk, Loseblatt-Ausgabe) Gefahrstoff-Entsorgung. Ecomed, Landsberg/Lech, 23. Erg. 3/99 „Bestimmungsverordnung besonders überwachungsbedorftige Abfälle“Google Scholar
  71. 56.
    Rothe M (1997) Untersuchungen zur Abscheidung und zur analytischen Bestimmung von Arzneimittelwirkstoffen und Drogen im Haar. Dissertation Humboldt-Universität, BerlinGoogle Scholar
  72. 57.
    Rudolph I, Tiefenbach B, Tiess D et al. (1996) Akute Cocain-Intoxikation mit tödlichem Ausgang. Anästhesiol Reanimat 21: 163–166Google Scholar
  73. 58.
    Sachs H (1997) Drogennachweis in Haaren. In: Kijewski (Hrsg) Das Haar als Spur — Spuren in Haaren. Schmidt-Römhild, Lübeck, S 119–133Google Scholar
  74. 59.
    Sachs, H, Kintz P (1998) Testing for drugs in hair: Critical review of Chromatographie procedures since 1992. J Chromatogr B; Biomed Sci Appl 713: 147–161PubMedGoogle Scholar
  75. 60.
    Schäfer AT (2000) Mikroskopische Untersuchung von Pulvern halluzinogener Pilze — Psilocybe sp. Arch Krimin 205: 30–36Google Scholar
  76. 61.
    Schmoldt A, Püschel K (1992) Vergiftungen. In: Berg S (Hrsg) Unerwartete Todesfälle in Klinik und Praxis. Springer, Berlin Heidelberg New York Tokio, S 113–123Google Scholar
  77. 62.
    Schramm W, Smith RH, Craig PA, Kidwell DA (1992) Drugs of abuse in Saliva: A review. J Anal Tox 16: 1–9Google Scholar
  78. 63.
    Schütz H (1999) Das Untersuchungsmaterial. In: Screening von Drogen und Arzneimitteln mit Immunoassays, 3. Aufl. Abbott, Wiesbaden, S 35–53Google Scholar
  79. 64.
    Schütz H, Weiler G (1999) Untersuchungen zum Drogennachweis. Zur Asservierung von Untersuchungsmaterial beim Verdacht der Einnahme von Drogen und Medikamenten. Kriminalistik H 11: 755–759Google Scholar
  80. 65.
    Schulz M, Schmoldt A (1991) Therapeutische und toxische Plasmakonzentrationen sowie Eliminationshalbwertszeiten gebräuchlicher Arzneistoffe. Pharm Z Wiss 136: 87–94Google Scholar
  81. 66.
    Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52: 895–911PubMedGoogle Scholar
  82. 67.
    Scibel O (1997) Exhumierung: Retrospektive Analyse von 131 Fällen (Hamburg 1971-1995). Med. Dissertation, Universität HamburgGoogle Scholar
  83. 68.
    Skopp G, Pötsch L (1997) Drogen in Schweiß und Talg — ein Aspekt der Haaranalyse. In: Pragst F (Hrsg) Moderne Messverfahren im Rahmen der Toxikologisch-Forensischen Begutachtung. Helm, Heppenheim, S 89–97Google Scholar
  84. 69.
    Skopp G, Pötsch L (1997a) A case report on drug Screening of nail clippings to detect prenatal drug exposure. Ther Drug Monit 19: 386–389PubMedGoogle Scholar
  85. 70.
    Skopp G, Pötsch L, Zimmer G, Mattern R (1997) Zur Interpretation von Drogenbefunden auf der Haut. Blutalkohol 34: 427–434Google Scholar
  86. 71.
    Skopp G, Pötsch L, Becker J et al. (1998) Zur präanalytischen Phase chemisch-toxikologischer Untersuchungen. — I. Immunchemisches Drogenscreening im Urin — Erkennbarkeit von Manipulationen und Strategien bei rechtsmedizinischer Fragestellung. Rechtsmed 8: 163–167Google Scholar
  87. 72.
    Takayasu T, Oshima T, Nishigami J (1994) Toxicological analysis for drugs and poisons using the formalin-fixed organ tissues — 1. Methamphetamine. Jpn J Leg Med 48: 33–37Google Scholar
  88. 73.
    Tiess D (1980) Zum analytischen Nachweis des „dissoziierten Hirntodes“ nach Methanoleinnahme aus toxikologischer Sicht. Kriminal Forens Wiss 42: 91–95Google Scholar
  89. 74.
    Tiess D (1985) Intoxikationen unter Beteiligung gasförmiger Kohlenwasserstoffe. Analytik und Befundbewertung. In: Müller RK (Hrsg) Diagnose und Therapie von Intoxikationen. Universität Leipzig, S 79–88Google Scholar
  90. 75.
    Tiess D (1987) Zur toxikologischen Analytik und Befundinterpretation flüchtiger Organika an formaldehydfixierten Histologieasservaten. Kriminal Forens Wiss 65/66: 137–148Google Scholar
  91. 76.
    Tiess D (1991) Gasförmige Organika im Biomaterial — Analytik und Befundbewertung. In: Arnold W (Hrsg) Rechtsmedizin und Forensische Toxikologie. Neue analytische Methoden. Helm, Heppenheim, S 25–31aGoogle Scholar
  92. 77.
    Tiess D (1992) Außergewöhnliche Befundungen bei forensisch relevanten Vergiftungen im menschlichen Umfeld (Ausgewählte Fälle, Asservierungsempfehlungen). In: Daldrup Th (Hrsg) Spurenanalytik im Human — und Umweltbereich. Helm, Heppenheim, S 121–125Google Scholar
  93. 78.
    Tiess D, Haferland W (1975) Hinweise und Vorschläge zur Asservierung und Behandlung von Gewebeteilen in Formaldehydlösung zwecks histologischer und toxikologisch-analytischer Untersuchungen. Z Ärztl Fortb 69: 207–210Google Scholar
  94. 79.
    Tiess D, Hammer U (1985) Über endogene Aceton-/Isopropanolgehalte und-Verteilungsmuster am unkonservierten und formaldehydkonservierten Leichenmaterial. Kriminal Forens Wiss 59/60: 149–151Google Scholar
  95. 80.
    Tiess D, Hammer U (1985 a) Über endogene Aceton (Propan-2-on)-und Isopropanol (Propan-2-ol)-Konzentrationen im menschlichen Körper nach ketoacidotischen Zuständen. Z Ges Hyg 31: 527–529Google Scholar
  96. 81.
    Tiess D, Mennenga H, Duty J (1990) Detection, preservation and examination of traces of unusual environment poisoning. Forensic Sci Int 46: 19–21Google Scholar
  97. 82.
    Tiess D, Osten B (1978) Empfehlungen zur Materialentnahme und-asservierung bei der Hämoperfusion für toxikologisch-analytische Bilanzuntersuchungen. Dtsch Gesundheitswesen 33: 1244–1246Google Scholar
  98. 83.
    Tiess D, Wegener R, Rudolph I et al. (1994) Cocaine and Benzoyl-ecgonine concentrations in hair, nails and tissues: A comperativ study of ante and post mortem materials in a case of an acut lethal Cocaine intoxication. In: Spiehler V (ed) Proceedings of the Joint TIAFT/SOFT Intern. Meeting, Tampa/FL, pp 343–344Google Scholar
  99. 84.
    Uges DRA, Clarmann M von, Geldmacher-von Mallinckrodt et al. (1990) Orientierende Angaben zu therapeutischen und toxischen Konzentrationen von Arzneimitteln und Giften in Blut, Serum oder Urin. Mitt. XV. Senatskomm. DFG Klin.-toxikol. Analytik. VCH-Verlagsgesellschaft, WeinheimGoogle Scholar
  100. 85.
    Wagner H-J, Möller MR (1995) Asservierung von Haaren zum Nachweis chronischen Drogenkonsums. Dtsch Ärztebl 92: A2978-2982, Ausg C 92: 1945-1947Google Scholar
  101. 86.
    Wehinger G, Battista H J (1990) Die Analyse flüchtiger organischer Substanzen in Lungengewebsproben nach Kohlenmonoxid-Einwirkung. Zbl Rechtsmed 34: 425–426Google Scholar
  102. 87.
    Winek CL (1994) Drug & chemical blood-level data. Sonderdruck: Allegheny County Department of Labaratories, Pittsburgh/PA, 15219Google Scholar
  103. 88.
    Winek CL, Esposito FM, Cinicola DP (1990) The stability of several Compounds in formalin fixed tissues and formalin-blood Solutions. Forensic Sci Int 44: 159–168PubMedGoogle Scholar
  104. 89.
    Wolf B-G, Tiess D (1994) About quantitative determination and distribution of colchicine and related alkaloids in Colchicum autumnale. In: RK Müller (ed) Contributions to forensic toxicology. Proceedings of 31th TIAFT-Meeting, Leipzig 1993, pp 506–513Google Scholar
  105. 1.
    Ahrens B, Rochholz G, Sachs HW, Schütz H (1995) Nachweis von Clozapin in Haaren nach etwa einjähriger Liegezeit im Erdgrab. Kriminalistik 196: 138–142Google Scholar
  106. 2.
    Arnold D, Naeve W, Arnold W (1985) Ergebnisse rechtsmedizinischer Untersuchung und Beurteilung von Luftfäulnisleichen. Kriminalistik 39: 298–302, 323-325Google Scholar
  107. 3.
    Bajanowski T, Köhler H, DuChesne A et al. (1998) Proof of air embolism after exhumation. Int J Leg Med 112: 2–7Google Scholar
  108. 4.
    Banaschak S, Eisenmenger W, Kuznik J, Brinkmann B (1998) Exhumierungen und kein Ende. Eine vergleichende Analyse. Arch Kriminol 202: 38–43PubMedGoogle Scholar
  109. 5.
    Berg St (1997) Archäologie und Rechtsmedizin. Arch Kriminol 200: 129–142PubMedGoogle Scholar
  110. 6.
    Brinkmann B, Madea B, Wuermeling HB (1986) Exhumierungen aus strafprozessualen Anlässen — eine vergleichende kriminologische Studie. Arch Kriminol 177: 65–75PubMedGoogle Scholar
  111. 7.
    Brinkmann B, Banaschak S, Bratzke H et al. (1997) Fehlleistungen bei der Leichenschau in der Bundesrepublik Deutschland. Ergebnisse einer multizentrischen Studie. Arch Kriminol 199: 1–12, 65-74PubMedGoogle Scholar
  112. 8.
    Daldrup Th (1996) Todesfälle in einer Wuppertaler Klinik. In: Oehmichen M) (Hrsg) Lebensverkürzung, Tötung und Serientötung — eine interdisziplinäre Analyse der „Euthanasie“. Schmidt-Römhild, LübGoogle Scholar
  113. 9.
    Dettmeyer R, Madea B (1999) Exhumierungen. Rechtsgrundlagen. In: Madea B (Hrsg) Die Ärztliche Leichenschau. Springer, Berlin Heidelberg New York Tokio, S 241–242Google Scholar
  114. 10.
    Friedrich G (1996) Die Todesfälle von Rheinfelden. In: Oehmichen M (Hrsg) Lebensverkürzung, Tötung und Serientötung — eine interdisziplinäre Analyse der „Euthanasie“. Schmidt-Römhild, Lübeck, S 159–170Google Scholar
  115. 11.
    Geerds F (1997) Über rechtliche und tatsächliche Probleme von Leichenschau und Leichenöffnung (§ 87 StPO) (I) (II). Arch Kriminol 199: 41–52, 75-87PubMedGoogle Scholar
  116. 12.
    Geldmacher-von Mallinckrodt M (1975) Exhumierung bei Vergiftungsverdacht. In: Mueller B (Hrsg) Gerichtliche Medizin, 2. Aufl., Teil 2. Springer, Berlin, Heidelberg, New York, S 716–718Google Scholar
  117. 13.
    Grellner W (1998) Toxikologische Nachweismöglichkeiten bei Fettwachsumwandlung und mehrjähriger Liegezeit. Arch Kriminol 202: 81–86PubMedGoogle Scholar
  118. 14.
    Grellner W, Glenewinkel F (1997) Exhumations: Synopsis of morphological and toxicological findings in relation to the postmortem intervall. Survey on a 20-year period and review of the literatur. Forensic Sci Int 90: 139–159PubMedGoogle Scholar
  119. 15.
    Grellner W, Madea B (1999) Anlässe, Fragestellungen und Umstände von Exhumierungen. Ergebnisse von Exhumierungen. In: Madea B (Hrsg) Die Ärztliche Leichenschau. Springer, Berlin Heidelberg New York Tokio, S 242–249Google Scholar
  120. 16.
    Iffland R, Madea B, Balling P (1988) Diagnose Kohlenmonoxidvergiftung nach Einbalsamierung und Exhumierung. Arch Kriminol 182: 101–106Google Scholar
  121. 17.
    Käferstein H (1980) Zum Nachweis von schwer flüchtigen extrahierbaren Giften in faulen Leichen. Habilitationsschrift, Universität KölnGoogle Scholar
  122. 18.
    Käferstein H, Sticht G, Madea B (1992) Toxikologische Befunde nach mehrjähriger Erdgrabzeit. Zbl Rechtsmed 38:33Google Scholar
  123. 19.
    Käferstein H, Madea B, Sticht G (1996) Todesfälle während ambulanter Altenpflege. In: Oehmichen (Hrsg) Lebensverkürzung, Tötung und Serientötung — eine interdisziplinäre Analyse der „Euthanasie“. Schmidt-Römhild, Lübeck, S 205–216Google Scholar
  124. 20.
    Kijewski H (Hrsg) (1997) Das Haar als Spur — Spuren in Haaren. Rechtsmedizinische Forschungsergebnisse, Bd 16. Schmidt-Römhild, LübeckGoogle Scholar
  125. 21.
    Klenke K (1995) Kriminologische und rechtsmedizinische Aspekte der Obduktion exhumierter Leichen. Med. Dissertation, Universität MünsterGoogle Scholar
  126. 22.
    Krügelstein FCC (Hrsg) (1841) Promptuarium Medicinae forensis, oder: Realregister über die in die gerichtliche Arznei-Wissenschaft einschlagenden Beobachtungen, Entscheidungen und Vorfälle. — Ein Hülfsbuch für gerichtliche Aerzte. Hennings u. Hopf, Erfurt, S 207–233Google Scholar
  127. 23.
    Logemann E, Werp J (1986) Forensische Toxikologie. Die forensisch-toxikologische Analyse. In: Forster B (Hrsg) Praxis der Rechtsmedizin. Thieme, Stuttgart, Beck, München, S 675–677Google Scholar
  128. 24.
    Mallach HJ (1987) Der Stellenwert der Luftembolie in der modernen Medizin. — Untersuchungen mit einer neuen Nachweistechnik. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  129. 25.
    Maples WR (1996) Knochengeflüster. Birkhäuser, BaselGoogle Scholar
  130. 26.
    Missliwetz J (1994) Die Mordserie im Krankenhaus Wien-Lainz. Arch Kriminol 194: 1–7PubMedGoogle Scholar
  131. 27.
    Missliwetz J, Bauer G, Reiter C, Vycudilik W (1996) Todesfälle in einem Wiener Krankenhaus — Problematik und Diskussion der Lainzer Verbrechen. In: Oehmichen (Hrsg) Lebensverkürzung, Tötung und Serientötung — eine interdisziplinäre Analyse der „Euthanasie“. Schmidt-Römhild, Lübeck, S 183–193Google Scholar
  132. 28.
    Mußhoff F, Alt K (1997) Toxikologie und Archäologie — Archäometrische Untersuchungen von Nachgeburtsgefäßen. In: Pragst F (Hrsg) Proceedings X. GTFCH-Symposium. Moderne Messverfahren im Rahmen der Toxikologisch-Forensischen Begutachtung. Helm, Heppenheim, S 213-217 ai]29._Pragst F, Rothe H, Spiegel K, Sporkert F (1998) Illegal and therapeutic drug concentrations in hair segments — a timetable of drug exposure? Forensic Sci Rev 10: 81–111 ai]30._Rochholz G (1998) Kritische Untersuchungen zum Screening und zur Identifizierung toxikologisch relevanter Substanzen unter erschwerten analytischen Bedingungen. Dissertation, Universität GießenGoogle Scholar
  133. 31.
    Rochholz G, Iwersen St, Schütz HW et al. (1997) Toxikologische Befunde bei einem Drogenabhängigen nach halbjähriger Liegezeit im Erdgrab. Vortrag 76. JT DGRM, Jena 16.–20.s09.Google Scholar
  134. 32.
    Rothe M (1997) Untersuchungen zur Abscheidung und zur analytischen Bestimmung von Arzneimittelwirkstoffen und Drogen im Haar. Dissertation, Humboldt-Universität BerlinGoogle Scholar
  135. 33.
    Scibel O (1997) Exhumierung: Retrospektive Analyse von 131 Fällen (Hamburg 1971-1995). Med. Dissertation, Universität HamburgGoogle Scholar
  136. 34.
    Sachs, H, Kintz P (1998) Testing for drugs in hair: Critical review of Chromatographie procedures since 1992. J Chromatogr B: Biomed Sci Appl 713: 147–161Google Scholar
  137. 35.
    Specht W, Katte W (1954) Giftverdacht? Kriminalistik, HamburgGoogle Scholar
  138. 36.
    Vock R, Wünsch P-H, Müller-Wallraf R (1989) Exhumierung — eine sinnvolle diagnostische Maßnahme. Dtsch Ärztebl 86/8: B352–B353Google Scholar
  139. 1.
    Ardrey RE, Zeeuw RA de, Finkle BS et al (1985) Gas Chromatographie retention indices of toxicologically relevant substances on SE-30 or OV-1, 2nd edn. Verlag Chemie, WeinheimGoogle Scholar
  140. 2.
    Finkle BS, Franke JP, Moffat AC et al. (1981) Gas Chromatographie retention indices. Special Issue of TIAFT BulletinGoogle Scholar
  141. 3.
    Finkle BS, Franke JP, Moffat AC et al. (1982) Gaschromatographische Retentioindices toxikologisch relevanter Verbindungen auf SE-30 oder OV-1. Mitteilung I der Kommission für klinisch-toxikologische Analytik. Verlag Chemie, WeinheimGoogle Scholar
  142. 4.
    Moffat AC, Franke JP, Stead AH et al (1987) Thin-layer Chromatographie rf values of toxicologically relevant substances on standardized Systems. VCH Publishers, WeinheimGoogle Scholar
  143. 5.
    Mueller RK (1977) Some remarks on analytical toxicology today. Proc. European Meeting of TIAFT, Leipzig, pp 11–14Google Scholar
  144. 6.
    Mueller RK (1978) Systematisation of toxicological analysis (necessities of and possibilities for the determination of a consistent data base for toxicologically relevant Compounds). 8th IAFS Meeting, Wichita/KS, May 22-26, 1978Google Scholar
  145. 7.
    Proposed Laboratory Guidelines for Toxicological Analysis. (1994) In Contributions to Forensic Toxicology. Molina Press, Leipzig, pp 537–545Google Scholar
  146. 8.
    TIAFT Committee on Systematic Toxicological Analysis and Guidelines (RA de Zeeuw, RK Mueller, BS Finkle et al.) Proposed Laboratory Guidelines for Toxicological Analysis. TIAFT Bulletin 23/1, pp 8-14; 23/2, pp 9-11; 23/4, pp 13; 24/1, pp 7-16Google Scholar
  147. 9.
    Zeeuw RA de (1978) Systematic toxicological analysis today: Current Status and future perspectives. 8th IAFS Meeting, Wichita/KS, May 22-26, 1978Google Scholar
  148. 10.
    Zeeuw RA de, Franke JP, Degel F et al. (1992) Thinlayer Chromatographie rf values of toxicologically relevant substances on standardized Systems, 2nd edn. VCH Publishers, WeinheimGoogle Scholar
  149. 11.
    Zeeuw RA de, Franke JP, Maurer HH, Pfleger K (1992) Gas Chromatographie retention indices of toxicologically relevant substances, 3rd edn. Verlag Chemie, WeinheimGoogle Scholar
  150. 12.
    Zeeuw RA de, Franke JP, Machata G et al. (1992) Gas Chromatographie retention indices of solvents and other volatile substances for use in toxicological analysis. VCH Verlagsgesellschaft, WeinheimGoogle Scholar
  151. 1.
    Allen LVI, Stiles ML (1981) Specificity of the EMIT drug abuse urine assay methods. Clin Toxicol 18: 1043PubMedGoogle Scholar
  152. 2.
    Dragendorff G (1872) Beiträge zur gerichtlichen Chemie einzelner organischer Gifte. Schmitzdorff, St PetersburgGoogle Scholar
  153. 3.
    Giebelmann R (1964) Zur Analytik von Phenoxyverbindungen. Pharmazie 19: 703PubMedGoogle Scholar
  154. 4.
    Schwerd W (1962) Der rote Blutfarbstoff. Schmidt-Röhmhild, LübeckGoogle Scholar
  155. 5.
    Stock A, Lun H (1931) Die quantitative Bestimmung kleinster Quecksilbermengen Angew Chem 44: 200–206Google Scholar
  156. 6.
    Weinig E, Neugebauer G (1952) Bestimmung von Äthanol neben Methanol in Flüssigkeiten und Organen. Dtsch Z Ges Gerichtl Med 41: 30–35Google Scholar
  157. 1.
    Stoeppler M (1991) Analytical chemistry of metals and metal compounds. In: Merian E (ed) Metals and their Compounds in the environment. VCH-Verlag, Weinheim, pp 105 ff.Google Scholar
  158. 2.
    Welz B, Sperling M (1997) Atomabsorptionsspektroskopie, 4. Aufl. Wiley-VCH Verlag, Weinheim, S 242 ff., S 658 ff.Google Scholar
  159. 1.
    Bonte W (1987) Begleitstoffe alkoholischer Getränke. Schmidt-Römhild, LübeckGoogle Scholar
  160. 2.
    Chen XH, Franke JP, Ensing K, Wijsbeek J, Zeeuw RA de (1993a) Pitfalls and Solutions in the development of a fully automated solid-phase extraction method for drug Screening purposes in plasma and whole blood. J Anal Toxicol 17: 421–426PubMedGoogle Scholar
  161. 3.
    Chen XH, Wijsbeek J, Franke JP, Zeeuw RA de (1992b) A single column procedure on Bond Elut Certify for systematic toxicological analysis od drugs in plasma and urine. J Forens Sci 37: 61–71Google Scholar
  162. 4.
    Chen XH, Franke JP, Zeeuw RA de (1992a) Isolation of acidic, neutral and basic drugs from whole blood using a Single mixed-mode solid phase extraction column. J Anal Toxicol 16: 351–355PubMedGoogle Scholar
  163. 5.
    Chen XH, Wijsbeek J, Franke JP, Zeeuw RA de. (1993b) Study of lot-to-lot reproducibilities of Bond Elut Certify and Clean Screen DAU mixed mode solid-phase extraction columns in the extraction of drugs from whole blood. J Chromatogr 617: 147–151PubMedGoogle Scholar
  164. 6.
    Demme U, Becker J, Bussemas H et al. (1999) Zur Extrahierbarkeit toxikologisch relevanter Verbindungen mit 1-Chlorbutan. In: ägst F, Aderjan R (Hrsg) GTFCH-Symposium Nachweis berauschender Mittel im Straßenverkehr. Helm, Heppenheim, S 213–218Google Scholar
  165. 7.
    Ensing K, Franke JP, Temmink A, Chen XH, Zeeuw RA de (1992) Application of Empore C-8 extraction discs for Screening urine in systematic toxicological analysis. J Forensic Sci 37: 460–466PubMedGoogle Scholar
  166. 8.
    Gibitz HJ, Schütz H (1993) Bestimmung von Ethanol im Serum. VCH, WeinheimGoogle Scholar
  167. 9.
    Hata M, Takahashi S, Matsubara K, Fukui Y (1980) The use n-butylchloride as extracting solvent in gas Chromatographie analysis for quantifitative determination of some basic drugs. Jap J Legal Med 34: 645–650Google Scholar
  168. 10.
    Huang Z, Chen XH, Wijsbeek J, Franke JP, Zeeuw RA de (1996) An enzymatic digestion and solid-phase extraction procedure for the screening for acidic, neutral and basic drugs in liver using gas chromatography for analysis. J Anal Toxicol 20: 248–254PubMedGoogle Scholar
  169. 11.
    Hübschmann HJ (1996) Probenvorbereitung durch Festphasenextraktion. In: Hübschmann HJ (Hrsg) Handbuch der GC/MS. VCH, Weinheim, S 14–26Google Scholar
  170. 12.
    Kupferschmidt R (2000) Aufarbeitung biologischer Proben mittels Festphasenextraktion. Firmenschrift Fa. Separtis, Grenzach-WyhlenGoogle Scholar
  171. 13.
    Lauermann I (1991) Isolation from protein-rich biological material. In: Müller RK (Hrsg) Toxicological analysis. Gesundheit, Berlin, pp 61–65Google Scholar
  172. 14.
    Machata G (1964) Über die gaschromatographische Blutalkoholanalyse Analyse der Dampfphase. Mikrochem Akta 2: 262–271Google Scholar
  173. 15.
    Müller RK (1991) Extraktion. In: Müller RK (Hrsg) Toxicological analysis. Gesundheit, Berlin, pp 66–90Google Scholar
  174. 16.
    Pfleger K, Maurer HH, Weber A (1992) Mass spectral and GC data of drugs, poisons, peticides, pollutants and their metabolites, vol 1. VCH, WeinheimGoogle Scholar
  175. 17.
    Scheurer J, Moore CM (1992) Solid-phase extraction of drugs from biological tissues — a review. J Anal Toxicol 16: 264–269PubMedGoogle Scholar
  176. 18.
    Simpson N, Van Hörne KC (1993) Handbook of sorbent extraction technology. Fa. Varian, Zug, SchweizGoogle Scholar
  177. 19.
    Waters Corporation (1999) Oasis sample extraction applications notebook. Fa. Waters, Milford/MS, USAGoogle Scholar
  178. 20.
    Zeeuw RA de, Wijsbeek J, Franke JP (2000) SPEC Disc solid-phase extraction for rapid broad-spectrum drug screening in urine. J Anal Toxicol 24: 97–101PubMedGoogle Scholar
  179. 21.
    Zief M (1990) An overview of solid phase extraction for sample preparation. Am Lab 22: 70–83Google Scholar
  180. 1.
    Brzezinka H, Dallakian P, Budzikiewicz H (1999) Thinlayer chromatography and mass spectrometry for Screening of biological samples for drugs and metabolites. J Planar Chromatogr 12: 96–108Google Scholar
  181. 2.
    Cserhäti T, Forgäcs E (1996) Introduction to techniques and instrumentation. In: Fried B, Sherma J (eds) Practical thin layer chromatography. A multidisciplinary approach. CRC Press, Boca Raton, USA, pp 1–18Google Scholar
  182. 3.
    Daldrup T, Mußhoff F (1995) Forensische Analytik: Drogen und Arzneimittel. In: Günzler H, Bahadir AM, Borsdorf R et al. (Hrsg) Analytiker-Taschenbuch 13. Springer, Berlin Heidelberg New York Tokio, S 202–207Google Scholar
  183. 4.
    Daldrup T (1978) Postmortaler Eiweiß-Zerfall in menschlichen Organen. Reaktionen und zeitliche Zusammenhänge. Dissertation, Mathematisch-naturwissenschaftliche Fakultät der RWTH AachenGoogle Scholar
  184. 5.
    Degel F, Paulus N (1991) Toxi-Lab Drug Compendium, International Edition, vol I. Irvine/CA 92718 USAGoogle Scholar
  185. 6.
    Zeeuw RA de, Franke JP, Degel F et al. (1992) Thinlayer Chromatographie Rf values of toxicologically relevant substances on standardized Systems. VCH, WeinheimGoogle Scholar
  186. 7.
    Zeeuw RA de, Franke JP, Wittig B et al. (1989) ToxAnalysis. VCH, WeinheimGoogle Scholar
  187. 8.
    Ebel S, Kung JS (1990) UV/VIS spectra and spectral librarys in TLC/HPTLC. J Planar Chromatogr 3: 42–46Google Scholar
  188. 9.
    Ebel S (1996) Quantitative analysis in TLC and HPTLC. J Planar Chromatogr 9: 4–15Google Scholar
  189. 10.
    Frey HP, Zieloff K (1993) Qualitative und quantitative Dünnschichtchromatographie. VCH, WeinheimGoogle Scholar
  190. 11.
    Jork H, Funk W, Fischer W, Wimmer H (1990) Dünnschichtchromatographie: Reagenzien und Nachweismethoden. VCH, WeinheimGoogle Scholar
  191. 12.
    Kaempe B (1969) Interfering Compounds and artifacts in the identification of drugs in autopsy material. In: Stolman A (ed) Progress in chemical toxicology, vol 4. Academic Press, New YorkGoogle Scholar
  192. 13.
    Machata G, Schütz H (1989) Empfehlungen zur Dünnschichtchromatographie. VCH, WeinheimGoogle Scholar
  193. 14.
    Merck E (1991) Merck tox Screening System MTSS: Thin-layer chromatography and color reactions on the plate. Fa. Merck, DarmstadtGoogle Scholar
  194. 15.
    Moffat AC, Franke JP, Stead AH et al. (1987) Thin layer Chromatographie Rf values of toxicologicallay relevant substances on standardized systems. VCH, WeinheimGoogle Scholar
  195. 16.
    Moffat AC (1986) Clarke’s isolation and identification of drugs in pharmaceuticals, body fluids and post-mortem material. The Pharmaceutical Press, LondonGoogle Scholar
  196. 17.
    Müller RK (1991) Toxicological analysis. Gesundheit, BerlinGoogle Scholar
  197. 18.
    Ojanperä I (1996) Thin-layer chromatography in forensic toxicology. In: Fried B, Sherma J (eds), Practical thin layer chromatography. A multidisciplinary approach. CRC Press, Boca Raton, pp 193–226Google Scholar
  198. 19.
    Ojanperä I, Vuori E (1994) Identification of drugs in autopsy liver samples by instrumental qualitative thinlayer chromatography. J Chromatogr A 674: 147–152PubMedGoogle Scholar
  199. 20.
    Ojanperä I, Jänchen P (1994) Drug Screening by instrumental qualitative thin-layer chromatography. LC-GC Int 7: 164–167Google Scholar
  200. 21.
    Reuter D (1998) Aufbau und Erprobung einer Bibliothek von UV-Remissionsspektren sowie ihre Anwendung in der systematischen toxikologischen Analyse. Med. Dissertation, FSU JenaGoogle Scholar
  201. 22.
    Schütz H (1986) Dünnschichtchromatographische Suchanalyse für 1,4-Benzodiazepine in Harn, Blut und Mageninhalt. VCH, WeinheimGoogle Scholar
  202. 23.
    Siek TJ, Stradling CW, McCain MW, Mehary TC (1997) Computer-aided identifications of thin-layer Chromatographie patterns in broad-spectrum drug screening. Clin Chem 43/4: 619–626PubMedGoogle Scholar
  203. 24.
    Stahl, E (1967) Dünnschicht-Chromatographie — Ein Laboratoriumshandbuch. Springer, Berlin Heidelberg New YorkGoogle Scholar
  204. 25.
    Struppe HG (1984) Das Prinzip der Chromatographie. In: Leibnitz E, Struppe HG (Hrsg) Handbuch der Gaschromatographie. Geest & Portig, Leipzig, S 10–12Google Scholar
  205. 1.
    Baars B, Schaller H (1994) Fehlersuche in der Gaschromatographie. VCH, WeinheimGoogle Scholar
  206. 2.
    Baugh PJ (1997) (Hrsg) Gaschromatographie. Eine anwenderorientierte Darstellung (Übersetzung aus dem Englischen). Vieweg, WiesbadenGoogle Scholar
  207. 3.
    David W, Kusserow B (1999) GC-Tips. Problemlösungen rund um den Gaschromatographen. Hoppenstedt, DarmstadtGoogle Scholar
  208. 4.
    Gerhards P, Bons U, Sawazki J, Szigan J, Wertmann A. (1998) GC/MS in clinical chemistry. Wiley-VCH, WeinheimGoogle Scholar
  209. 5.
    Grant DW (1995) Capillary gas chromatography. Wiley & Sons, ChichesterGoogle Scholar
  210. 6.
    Grob K. (2001) Split and splitless injection in capillary gas chromatography. Wiley-VCH, WeinheimGoogle Scholar
  211. 7.
    Hackenberg H, Beringer K (1996) Die Headspace-Gaschromatographie als Analysen-und Bestimmungsmethode. Vieweg, BraunschweigGoogle Scholar
  212. 8.
    Kolb B (1999) Gaschromatographie in Bildern. Wiley-VCH, WeinheimGoogle Scholar
  213. 9.
    Kolb B, Ettre L (1997) Static headspace-gas chromatography. Wiley-VCH, WeinheimGoogle Scholar
  214. 1.
    Achilli G, Cellerino GP, Melzid’eril GV, Tagliaro F. (1996) Determination of illicit drugs and related substances by high-performance liquid chromatography with an electrochemical coulometric-array detector. J Chromatogr A 729: 273–277PubMedGoogle Scholar
  215. 2.
    Beal JL, Tett SE (1998) Determination of pindolol enantiomers in human plasma and urine by simple liquid liquid extraction and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 715: 409–415PubMedGoogle Scholar
  216. 3.
    Beike J, Köhler H, Brinkmann B, Blaschke G (1999) Immunoaffinity extraction of morphine, morphine-3-glucuronide and morphine-6-glucuronide from blood of heroin victims for simultaneous high-performance liquid Chromatographie determination. J Chromatogr B Biomed Sci Appl 726: 111–119PubMedGoogle Scholar
  217. 4.
    Bergemann D, Geier A, von Meyer L (1999) Determination of lysergic acid diethylamide in body fluids by high-performance liquid chromatography and fluorescence detection — a more sensitive method suitable for routine use. J Forensic Sci 44: 372–374PubMedGoogle Scholar
  218. 5.
    Betto P, Meneguz A, Ricciarello G, Pichini S (1992) Simultaneous high-performance liquid chromatographie analysis of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in plasma using electrochemical detection. J Chromatogr 575:117–121PubMedGoogle Scholar
  219. 6.
    Bogusz MJ, Erkens M (1994) Reversed phase high-performance liquid chromatographic database of retention indices and UV spectra of toxicologically relevant substances and its interlaboratory use. J Chromatogr 674: 97–126.Google Scholar
  220. 7.
    Bogusz MJ, Maier RD, Erkens M, Driessen S (1997) Determination of morphine and its 3-and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography — atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 703: 115–127PubMedGoogle Scholar
  221. 8.
    Boos KS, Wilmers B, Schlimme E, Sauerbrey R (1988) On-line sample processing and analysis of diol Compounds in biological fluids. J Chromatogr 456: 93–104PubMedGoogle Scholar
  222. 9.
    Botnen IV, Notø H, Jacob J, Ovrebo S (1999) Detection of polycyclic aromatic hydrocarbon metabolites by high-pressure liquid chromatography after purification on immunoaffinity columns in urine from occupationally exposed workers. Int Arch Occup Environ Health 72: 161–168PubMedGoogle Scholar
  223. 10.
    Buchberger W (1998) Elektrochemische Analysenverfahren — Grundlagen, Instrumentation, Anwendungen. Spektrum Akademischer Verlag, Heidelberg, S. 199–298Google Scholar
  224. 11.
    Dowrie RH, Ebling WF, Mandema JW, Stanski DR (1996) High-performance liquid chromatographic assay of propofol in human and rat plasma and fourteen rat tissues using electrochemical detection. J Chromatogr B Biomed Appl 678: 279–288PubMedGoogle Scholar
  225. 12.
    Eppert GJ (1997) Flüssigchromatographie. HPLC — Theorie und Praxis. Vieweg, BraunschweigGoogle Scholar
  226. 13.
    Fisher DH, Broudy MI, Fisher LM (1996) Quantification of 9-carboxy-11-nor-delta 9-tetrahydrocannabinol in urine using brominated 9-carboxy-11-nor-delta 9-tetrahydrocannabinol as the internal Standard and high-performance liquid chromatography with electrochemical detection. Biomed Chromatogr 10: 161–166PubMedGoogle Scholar
  227. 14.
    Gaillard Y, Pèpin G (1997) Use of high-performance liquid chromatography with photodiode array detection for the creation of a 600-compound library. Application to forensic toxicology. J Chromatogr A 763: 149–163PubMedGoogle Scholar
  228. 15.
    Gottwald W (1993) RP-HPLC für Anwender. VCH, WeinheimGoogle Scholar
  229. 16.
    Harzer K (1982) Nachweis von LSD in Körperflüssigkeiten mit Hochleistungs-Flüssigchromatographie. J Chromatogr 249: 205–208PubMedGoogle Scholar
  230. 17.
    Herre S, Pragst F (1997) Shift of the high-performance liquid Chromatographie retention times of metabolites in relation to the original drug at an RP-8 column with acidic mobile phase. J Chromatogr B Biomed Sci Appl 692: 111–126PubMedGoogle Scholar
  231. 18.
    Hill DW, Kind AJ (1994) Reversed-phase solvent-gradient HPLC retention indexes of drugs. J Anal Toxicol 18: 233–242PubMedGoogle Scholar
  232. 19.
    Hoja H, Marquet P, Verneuil B et al. (1997) Applications of liquid chromatography-mass spectrometry in analytical toxicology: a review. J Anal Toxicol 2: 116–126Google Scholar
  233. 20.
    Kissinger PT (1996) Electrochemical detection in bioanalysis. J Pharm Biomed Anal 14: 871–880PubMedGoogle Scholar
  234. 21.
    Koves EM (1995) Use of high-performance liquid chromatography — diode array detection in forensic toxicology. J Chromatogr A 695: 103–119Google Scholar
  235. 22.
    Kussak A, Andersson B, Andersson K, Nilsson CA. (1998) Determination of aflatoxicol in human urine by immunoaffinity column clean-up and liquid chromatography. Chemosphere 36: 1841–1848PubMedGoogle Scholar
  236. 23.
    Lai C-K, Lee T, Au K-M, Chan AY-W (1997) Uniform solid-phase extraction procedure for toxicological drug Screening in serum and urine by HPLC with photodiode-array detection. Clin Chem 43: 312–325PubMedGoogle Scholar
  237. 24.
    Lambert WE, Van Bocxlaer JF, De Leenheer AP (1997) Potential of high-performance liquid chromatography with photodiode array detection in forensic toxicology. J Chromatogr B Biomed Sci Appl 689: 45–53PubMedGoogle Scholar
  238. 25.
    Lin LA, Tomlinson JA, Satzger RD (1997) Detection of clenbuterol in bovine retinal tissue by high-performance liquid chromatography with electrochemical detection. J Chromatogr A 762: 275–280PubMedGoogle Scholar
  239. 26.
    Lindenblatt H, Krämer E, Holzmann-Erens P et al (1998) Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction. J Chromatogr B Biomed Sci Appl 709: 255–263PubMedGoogle Scholar
  240. 27.
    Manchon M, Mialon A, Berny C, Baltassat P (1997) Value of the Remedi chromatography automate for the analytic diagnosis of drug poisoning. Ann Biol Clin 55: 223–228Google Scholar
  241. 28.
    Marquet P, Lachatre G (1999) Liquid chromatographymass spectrometry: potential in forensic and clinical toxicology. J Chromatogr B Biomed Sci Appl 733: 93–118PubMedGoogle Scholar
  242. 29.
    Maurer HH (1998) Liquid chromatography — mass spectrometry in forensic and clinical toxicology. J Chromatogr B Biomed Sci Appl 713: 3–25PubMedGoogle Scholar
  243. 30.
    Meyer VR (1999) Fallstricke und Fehlerquellen in der HPLC. Wiley-VCH, WeinheimGoogle Scholar
  244. 31.
    Ohta H, Seto Y, Tsunoda N (1997) Determination of aconitum alkaloids in blood and urine samples. I. High-performance liquid Chromatographie Separation, solid-phase extraction and mass spectrometric confirmation. J Chromatogr B Biomed Sci Appl 691: 351–356PubMedGoogle Scholar
  245. 32.
    Olah TV, McLoughlin DA, Gilbert JD (1997) The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug Screening procedure. Rapid Commun Mass Spectrom 1: 17–23Google Scholar
  246. 33.
    Pragst F, Erxleben B-T, Herre S, Aberger K (1994) HPLC in der systematischen toxikologischen Analyse. GIT Spezial Chromatographie 2/94: 92–96Google Scholar
  247. 34.
    Pragst F, Erxleben B-T, Herre S (1997) UV-Spektren toxischer Verbindungen. Photodiodenarray-UV-Spektrenbibliothek von Medikamentwirkstoffen, illegalen Drogen, Pestiziden, Umweltnoxen und anderen Giften, Handbuch und Software, Version 1/97. Institut für Rechtsmedizin der Humboldt-Universität zu Berlin. Version für Fa. Hewlett-Packard/Agilent unter Mitwirkung von M. Rothe (Peak 3/1999, S. 2-4), Version für Fa. Knauer und Fa. Kontron unter Mitwirkung von M. Herzler.Google Scholar
  248. 35.
    Röhrich J, Zörntlein S, Lötz J et al. (1998) False positive LSD testing in urine samples from intensive care. J Anal Toxicol 22: 393–395PubMedGoogle Scholar
  249. 36.
    Röhrich J, Zörntlein S, Becker J (2000) Analysis of LSD in human body fluids and hair samples applying ImmunElut columns. Forensic Sci Int 107: 181–190PubMedGoogle Scholar
  250. 37.
    Sciler N (1993) Fluorescent derivatives. In: Blau K, Halket J (eds) Handbook of derivatives for chromatography. Wiley & Sons, New York, pp 175–213Google Scholar
  251. 38.
    Selavka CM, Krull IS (1987) The forensic determination of drugs of abuse using liquid chromatography with electrochemical detection. J Liqu Chromatogr 10: 345–375Google Scholar
  252. 39.
    Spratt E, Vallaro GM (1998) LC/MS with a particle beam interface in forensic toxicology. Clin Lab Med 18: 651–663PubMedGoogle Scholar
  253. 40.
    Tatsuno M, Nishikawa M, Katagi M, Tsuchihashi H. (1996) Simultaneous determination of illicit drugs in human urine by liquid chromatography mass spectrometry. J Anal Toxicol 20: 281–286PubMedGoogle Scholar
  254. 41.
    Tracqui A, Kintz P, Ludes B, Mangin P (1997) High-performance liquid chromatography-ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma. J Chromatogr B Biomed Sci Appl 692: 101–109PubMedGoogle Scholar
  255. 42.
    Turcant A, Premel-Cabic A, Cailleux A, Allain P (1991) Toxicological Screening of drugs by microbore high performance liquid chromatography with photodiodearray detection and ultraviolet spectral library searches. Clin Chem 37: 1210–1215PubMedGoogle Scholar
  256. 43.
    Weinmann W, Svoboda M (1998) Fast Screening for drugs of abuse by solid-phase extraction combined with flow-injection ionspray-tandem mass spectrometry. J Anal Toxicol 22: 319–328PubMedGoogle Scholar
  257. 44.
    Weinmann W, Wiedemann A, Eppinger B et al. (1999) Screening for drugs in serum by electrospray ionization/ collision-induced dissociation and library searching. J Am Soc Mass Spectrom 10: 1028–1037PubMedGoogle Scholar
  258. 45.
    Yamashita GT, Rabenstein DL (1989) Determination of penicillamine, penicillamine disulfide and penicillamine-glutathione mixed disulfide by high-performance liquid chromatography with electrochemical detection. J Chromatogr 491: 341–354PubMedGoogle Scholar
  259. 1.
    Bridges JW (1969) Fluorescence analysis. In: Sunshine I (ed) Handbook of analytical toxicology. ClevelandGoogle Scholar
  260. 2.
    Bridges JW (1975) Fluorescence of drugs. In: Reid E (ed) Assay of drugs and other trace Compounds in biological fluids. Longman, LondonGoogle Scholar
  261. 3.
    Demme U (1991) Fluorometry. In: Müller RK (ed) Toxicological analysis. Verlag Gesundheit, BerlinGoogle Scholar
  262. 4.
    De Silva JA, Strojny N (1975) Spectrofluorometric determination of pharmaceuticals containing aromatic or aliphatic primary amino groups as their fluorescamine (Fluram) derivatives. Anal Chem 47: 714–718PubMedGoogle Scholar
  263. 5.
    Dibbern HW, Wirbitzki E (1978, 1981, 1983, 1991) UV und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Bd I-IV. Editio Cantor Aulendorf, RavensbergGoogle Scholar
  264. 6.
    Dünges W (1976) Fluorescence labeling of picomol amounts of acidic herbicides for toxicological analysis. Chromatographia 9: 624–626Google Scholar
  265. 7.
    Frey HP, Zieloff K (1993) Qualitative und quantitative Dünnschichtchromatographie. VCH, WeinheimGoogle Scholar
  266. 8.
    Hanisch W (1991) Entwicklung hochempfindlicher chromatographischer Methoden zum Nachweis von Tetrahydrocannabinol und Heroin bzw. deren Metaboliten. Med. Dissertation, Universität MünchenGoogle Scholar
  267. 9.
    Jork H, Funk W, Fischer W, Wimmer H (1990) Dünnschichtchromatographie: Reagenzien und Nachweismethoden. VCH, WeinheimGoogle Scholar
  268. 10.
    Kakac B, Vedeljek Z (1963) Handbuch der Kolorimetrie, Bd II, Kolorimetrie in der Pharmazie. Gustav Fischer, JenaGoogle Scholar
  269. 11.
    Mills T III, Price WN, Price T, Roberson JC (1982) Instrumental data for drug analysis, vol I+II. Elsevier, New YorkGoogle Scholar
  270. 12.
    Moffat AC (1986) Clarke’s isolation and identification of drugs in pharmaceuticals, body fluids and post-mortem material. The Pharmaceutical Press, LondonGoogle Scholar
  271. 13.
    Monforte JR, Bath J, Sunshine I (1972) Fluorometric determination of primary and secondary amines in blood and urine after thin layer chromatography. Clin Chem 18: 1325–1333Google Scholar
  272. 14.
    Müller RK (1991) Toxicological analysis. Verlag Gesundheit, BerlinGoogle Scholar
  273. 15.
    Nagel S, Schmechta H (1980) Spektrophotometrische Methode zur zuverlässigen Kohlenmonoxid-Hämoglobin-Bestimmung in Gegenwart von Hämiglobin. Z Med Lab Diagn 21: 297–301PubMedGoogle Scholar
  274. 16.
    Pütter W (1975) Quantitative Bestimmung der Hauptmetaboliten der Acetylsalicylsäure. Arzneimittel-Forsch (Drug Res) 25: 1–12Google Scholar
  275. 17.
    Schütz H, Machbert G (1988) Photometrische Bestimmung von Carboxy-Hämoglobin (CO-Hb) im Blut. VCH, WeinheimGoogle Scholar
  276. 18.
    Schwarze W, Bardella H, Micheel B (1982) Fluoreszenzmethoden — ihre Anwendung zur quantitativen Analyse organischer Substanzen, Teil 1. Pharmazie 37: 323–341Google Scholar
  277. 19.
    Schwarze W, Schwarz K (1985) Fluoreszenzmethoden — ihre Anwendung zur quantitativen Analyse organischer Substanzen, Teil 2. Pharmazie 40: 593–613PubMedGoogle Scholar
  278. 20.
    Schwerd W (1962) Der rote Blutfarbstoff und seine wichtigsten Derivate. Schmidt-Römhild, LübeckGoogle Scholar
  279. 21.
    Udenfriend S (1962) Fluorescence assay in biology and medicine, vol I+II. Academic Press, New YorkGoogle Scholar
  280. 22.
    Von Meyer L, Hanisch W (1989) Dünnschichtchromatographische Methode zur Bestimmung von THC-COOH im Urin und Morphin im Serum. Toxichem+Krimtech 56: 8–9Google Scholar
  281. 1.
    Bellamy LJ (1980) The infrared spectra of complex molecules: advances in infrared group frequencies. Chapman & Hall, LondonGoogle Scholar
  282. 2.
    Colthup NB, Daly LH, Wiberley SE (1990) Introduction to infrared and Raman spectroscopy. Academic Press, San DiegoGoogle Scholar
  283. 3.
    FDM Reference Spectra Databases: http://www.fdmspectra. com/index.html (enthält u. a. die Sammlungen: FTIR Spectra of Drugs, Canadian Forensic FTIR Spectra, FDM NIR Spectra of Food & Agricultural Materials)Google Scholar
  284. 4.
    Günzler H, Heise HM (1996) IR-Spektroskopie: eine Einführung, VCH, WeinheimGoogle Scholar
  285. 5.
    Harris DC (1997) Lehrbuch der quantitativen Analyse. Vieweg, BraunschweigGoogle Scholar
  286. 6.
    Hesse M, Meir H, Zeeh B (1995) Spektroskopische Methoden in der organischen Chemie. Thieme, StuttgartGoogle Scholar
  287. 7.
    Nakamoto K (1997) Infrared and Raman spectra of inorganic and coordination Compounds. Wiley, New YorkGoogle Scholar
  288. 8.
    Nicolet and Sigma/Aldrich spectral libraries: http://ftirsearch. com/lib_list.htm (enthält u.a. die Sammlungen: Sigma Steroids Library, Hazardous Chemicals Vapor Phase Library, Hazardous Chemicals Condensed Phase Library, Food Additives Library, Georgia State Crime Lab Drug Library, Toronto Forensic Library, Raman Forensic Library)Google Scholar
  289. 9.
    Otto M (1997) Chemometrie: Statistik und Computereinsatz in der Analytik. VCH, WeinheimGoogle Scholar
  290. 10.
    Roeges NPG (1994) A guide to the complete Interpretation of infrared spectra of organic structures. Wiley, ChichesterGoogle Scholar
  291. 11.
    Schräder B (Ed) (1995) Infrared and Raman spectroscopy: methods and applications. VCH, WeinheimGoogle Scholar
  292. 12.
    Schräder B (1989) Raman-, Infrared atlas of organic Compounds. VCH, WeinheimGoogle Scholar
  293. 13.
    Skoog DA, Leary JJ (1996) Instrumentelle Analytik: Grundlagen — Geräte — Anwendungen. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  294. 14.
    Steger WE (1992) Strukturanalytik. Deutscher Verlag für Grundstoffindustrie, LeipzigGoogle Scholar
  295. 15.
    Weidlein J, Müller U, Dehnicke K (1988) Schwingungsspektroskopie: eine Einführung. Thieme StuttgartGoogle Scholar
  296. 16.
    http://www2.ccc.uni-erlangen.de/IR/Google Scholar
  297. 1.
    Blau K, Halket JM (1994) Handbook of derivates for chromatography, 2nd edn. Wiley & Sons, ChichesterGoogle Scholar
  298. 2.
    Bogusz MJ (1999) J Chromatogr B Biomed Sci Appl 733: 65–91PubMedGoogle Scholar
  299. 3.
    Budzikiewicz H (1992) Massenspektrometrie. VCH, WeinheimGoogle Scholar
  300. 4.
    Dienes-Nagy A, Rivier L, Giroud C, Augsburger M, Mangin P (1999) J Chromatogr A 854: 109–118PubMedGoogle Scholar
  301. 5.
    Donike M (1975) Sportarzt und Sportmedizin 26: 1–6Google Scholar
  302. 6.
    Drummer OH (1998) J Chromatogr B Biomed Sci Appl 713: 201–225PubMedGoogle Scholar
  303. 7.
    Fitzgerald RL, Rivera JD, Herold DA (1999) Clin Chem 45: 1224–1234PubMedGoogle Scholar
  304. 8.
    Lehrer M (1998) Clin Lab Med 18: 631–649PubMedGoogle Scholar
  305. 9.
    Makin HLJ, Trafford DJH, Nolan J (1998) Mass spectra and GC data of Steroids, 1st edn. Wiley-VCH, WeinheimGoogle Scholar
  306. 10.
    Marquet P, Lachatre G (1999) J Chromatogr B Biomed Sci Appl 733: 93–118PubMedGoogle Scholar
  307. 11.
    Maurer HH (1998) J Chromatogr B Biomed Sci Appl 713: 3–25PubMedGoogle Scholar
  308. 12.
    McLafferty FW, Stauffer DB (1988) The Wiley/NBS registry of mass spectral data. Wiley-Interscience, New YorkGoogle Scholar
  309. 13.
    McLafferty FW, Turecek F (1993) Interpretation von Massenspektren. Spektrum Akademischer Verlag, HeidelbergGoogle Scholar
  310. 14.
    Pfleger K, Maurer H, Weber A (1992) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. 2nd edn. VCH, WeinheimGoogle Scholar
  311. 15.
    Polettini A, Groppi A, Vignali C, Montagna M (1998) J Chromatogr B Biomed Sci Appl 713: 265–279PubMedGoogle Scholar
  312. 16.
    Segura J, Ventura R, Jurado C (1998) J Chromatogr B Biomed Sci Appl 713: 61–90PubMedGoogle Scholar
  313. 17.
    Weinmann W, Svoboda M (1998) J Anal Toxikol 22: 319–328Google Scholar
  314. 18.
    Yinon J (1987) Forensic mass spectrometry. CRC, Boca Raton/FLGoogle Scholar
  315. 1.
    Bernhard W. (1993) Detection of drugs of abuse by ion mobility spectrometry, applications in forensic chemistry and toxicology. Proc. of the International Association of Forensic Sciences, DüsseldorfGoogle Scholar
  316. 2.
    Danylewich-May LL. (1991) Modifications to the ionization process to enhance the detection of explosives by ion mobility spectrometry. Proc. of the 1st International Symposium on Explosive Detection Technology, Atlantic City/NJGoogle Scholar
  317. 3.
    Fetterolf DD, Clark TD. (1993) Detection of trace explosive evidence by ion mobility spectrometry. J Forensic Sciences JFSCA 38/1: 28–39Google Scholar
  318. 4.
    Kim LH, Lawrence MJ, Martinak DE. (1993) Field detection of illicit drugs using ion mobility spectrometry. International Symposium of Forensic Sciences, TokyoGoogle Scholar
  319. 5.
    McDaniel EW. (1964) Collision phenomena in ionization gases. Wiley, New York, p 426Google Scholar
  320. 1.
    Achilli G, Cellerino GP, Melzid’eril GV, Tagliaro F. (1996) Determination of illicit drugs and related substances by high-performance liquid chromatography with an electrochemical coulometric-array detector. J Chromatogr A 729: 273–277PubMedGoogle Scholar
  321. 2.
    Buchberger W (1998) Elektrochemische Analysenverfahren — Grundlagen, Instrumentation, Anwendungen. Spektrum Akademischer Verlag, HeidelbergGoogle Scholar
  322. 3.
    Daldrup T (1989) Analytik toxischer Spurenmetalle bei akuten Vergiftungen mittels Voltametrie. In: Gibitz HJ, Geldmacher-von Malinckrodt M (Hrsg) Klinisch-toxikologische Analytik bei akuten Vergiftungen und Drogenmissbrauch. VCH, Weinheim, S 127–138Google Scholar
  323. 4.
    Daldrup T, Franke JP, Geldmacher-von Malinckrodt M (1993) Metallscreening aus Urin bei akuten Vergiftungen. Schneller Nachweis von Antimon, Arsen, Bismut, Blei, Cadmium, Cobalt, Indium, Kupfer, Nickel, Thallium, Zink und Zinn. Mitteilung XII der Senatskommission für Klinisch-toxikologische Analytik. Deutsche Forschungsgemeinschaft, VCH, Weinheim.Google Scholar
  324. 5.
    Duly EB, Luney SR, Trinick TR, Murray JM, Corner JEA (1995) Validation of an ion selective electrode System for the analysis of serum fluoride ion. J Autom Chem 17: 219–223Google Scholar
  325. 6.
    Egekeze JE, Oehme FW (1979) Direct potentiometric method for the determination of cyanide in biological materials. J Anal Toxicol 3: 119–124Google Scholar
  326. 7.
    Fuchs C, Dorn D, Fuchs CA et al. (1975) Fluoride determination in plasma by ion selective electrodes: a simplified method for the clinical laboratory. Clin Chim Acta 60: 157–167PubMedGoogle Scholar
  327. 8.
    Ikeda S, Schweiss JF, Frank PA, Homan SM (1987) In vitro Cyanide release from sodium nitroprusside. Anesthesiology 66: 381–385PubMedGoogle Scholar
  328. 9.
    Ikeda S, Frank PA, Schweiss JF, Homan SM (1988) In vitro cyanide release from sodium nitroprusside in various intravenous solutions. Anesth Analg 67: 360–362PubMedGoogle Scholar
  329. 10.
    Kamman K, Galster H (1996) Das Arbeiten mit ionenselektiven Elektroden, 3. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  330. 11.
    Kissinger PT (1996) Electrochemical detection in bioanalysis. J Pharm Biomed Anal 14: 871–880PubMedGoogle Scholar
  331. 12.
    Lagois J. (2000) Dräger Alkoholtest 7110 Evidential — das Meßgerät zur gerichtsverwertbaren Atemalkoholanalyse in Deutschland. Blutalkohol 37: 77–91Google Scholar
  332. 13.
    Lindell H, Jappinen P, Savolainen H (1988) Determination of sulfide in blood with an ion-selective electrode by pre-concentration of trapped sulfide in sodium hydroxide Solution. Analyst 113: 839–840PubMedGoogle Scholar
  333. 14.
    Neefus JD, Cholak J, Saltzmann BE (1970) The determination of fluoride in urine using a fluoride-spezific ion electrode. Am Ind Hyg Assoc J 31: 96–99PubMedGoogle Scholar
  334. 15.
    Öhme F (1986) Ionenselektive Elektroden: Grundlagen und Methoden der Direkt-Potenziometrie. Hüthig, HeidelbergGoogle Scholar
  335. 16.
    Penman AD, Brackin BT, Embrey R (1997) Outbreak of acute fluoride poisoning caused by a fluoride overfeed, Mississippi, 1993. Public Health Rep 112: 403–409PubMedCentralPubMedGoogle Scholar
  336. 17.
    Poklis A, Mackell M (1989) Disposition of fluoride in a fatal case of unexpected sodium fluoride poisoning. Forensic Sci Int 41: 55–59PubMedGoogle Scholar
  337. 18.
    Scheuerman EH (1986) Suicide by exposure to sulfuryl fluoride. J Forensic Sci 31: 1154–1158PubMedGoogle Scholar
  338. 19.
    Selavka CM, Krull IS (1987) The forensic determination of drugs of abuse using liquid chromatography with electrochemical detection. J Liqu Chromatogr 10: 345–375Google Scholar
  339. 20.
    Stein U, Steinecke H, Pragst F et al. (1999) Ionenselektive Elektroden und Mikrodestillation. Toxichem + Krimtech 66: 129–141Google Scholar
  340. 21.
    Steinecke H, Fischer W (1983) Fluoridbestimmung in menschlichen Organen und Körperflüssigkeiten mit einer ionenselektiven Elektrode. Z Med Labor-Diagn: 304–307Google Scholar
  341. 22.
    Steinecke H, Heesen U (1989) Direktpotenziometrische Bestimmung von Cyanidspiegeln nach Infusion von Nitroprussid-natrium. Anaesthesiol Reanimat 14: 333–337Google Scholar
  342. 23.
    Torra M, Rodamilans M, Corbella J (1998) Serum and urine ionic fluoride. Normal ränge in a nonexposed population. Biol Trace Elem Res 63: 67–71PubMedGoogle Scholar
  343. 24.
    Torra M, Rodamilans M, Corbella J (1998) Serum and urine fluoride concentration: relationships to age, sex and renal function in a non-fluoridated population. Sci Total Environ 220: 81–85PubMedGoogle Scholar
  344. 25.
    Ulrich P (1988) Fluoridbestimmung in der Klinischen Chemie mit der ionenselektiven Elektrode. GIT Labor-Medizin 9/88: 470–473Google Scholar
  345. 26.
    Yagi K, Ikeda S, Schweiss JF, Homan SM (1990) Measurement of blood Cyanide with a microdiffusion method and an ion-specific electrode. Anesthesiology 73: 1028–1031PubMedGoogle Scholar
  346. 1.
    Alt A, Reinhardt G (1996) Speiseöle auf Hanfbasis und ihr Einfluss auf die Ergebnisse von Urin-und Blutanalysen. Blutalkohol 33: 347–356Google Scholar
  347. 2.
    Alt A, Reinhardt G (1997) Nahrungsmittel auf Hanfbasis und deren forensische Bedeutung. Blutalkohol 34: 286–293Google Scholar
  348. 3.
    Brandenberger H, Maes R, Bäumler J et al. (1988) Empfehlungen zur klinisch-toxikologischen Analytik. Folge 1: Einsatz von immunchemischen Testen in der Suchtmittelanalytik. Mitteilung X der Senatskomission für Klinisch-toxikologische Analytik der Deutschen Forschungsgemeinschaft. VCH, WeinheimGoogle Scholar
  349. 4.
    Cone EJ, Dickerson S, Paul BD, Mitchell JM (1993) Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays. J Anal Toxicol 17: 156–164PubMedGoogle Scholar
  350. 5.
    Demedts P, Wauters A, Franck F, Neels H (1994) Evaluation of the Remedi Drug profiling System. Eur J Clin Chem Clin Biochem 32: 409–41PubMedGoogle Scholar
  351. 6.
    Drasch G, von Meyer L, Sachs H, Roider G (1998) Morphingehalt in Mohnsamen (Blaumohn). Vortrag Jahrestagung DGRM, HannoverGoogle Scholar
  352. 7.
    George S, Braithwaite RA (1996) The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs of abuse assays. J Anal Toxicol 20: 195–196PubMedGoogle Scholar
  353. 8.
    Hallbach J, Guder WG. 1991 Determination of the detection limits as cut-off for group specific immunoassay in urine. In: Kaempe B (ed) Forensic toxicology. Proceedings of the 29th International Meeting TIAFT, June 24th-27th 1991. Printing Mackeenzie, CopenhagenGoogle Scholar
  354. 9.
    Hausmann E, Kohl B, Boehmer H von, Wellhöner HH. (1983) False-positive EMIT indication of opiates and methadone in a doxylamine intoxication. J Clin Chem Clin Biochem 21/10: 599–600PubMedGoogle Scholar
  355. 10.
    H äver VM, Romson JL, Sadrzadeh SM (1991) Semiquantitation of cannabinoid immunoassays? A reexamination of the EMIT 20-ng/mL assay. J Anal Toxicol 15: 98–100Google Scholar
  356. 11.
    Hofbauer B, Kottenhahn B, Meyer L von (1999) Möglichkeiten und Grenzen von Drogenschnelltests. Z Allg Med 75: 470–475Google Scholar
  357. 12.
    Kottenhahn B, Hofbauer B, Meyer L von. (2000) Direct detection of drugs of abuse in whole hemolysed postmortem blood and qualitative measurement in whole blood and serum using the CEDIA DAU urine assays. Eingereicht zur PublikationGoogle Scholar
  358. 13.
    Maurer HH (1992) Systematic toxicological analysis of drugs and their metabolites by gas chromatographymass spectrometry. J Chromatogr 580: 3–41PubMedGoogle Scholar
  359. 14.
    Maurer HH, Kraemer T (1992) Toxicological detection of seligiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of Selegiline from abuse of methamphetamine or amphetamine. Arch Toxicol 66/9: 675–678PubMedGoogle Scholar
  360. 15.
    Meyer L von (1985) Zum enzymatisch-immunochemischen Nachweis des Haschischkonsums und seiner dünnschichtchromatographischen Absicherung. Rechtsmed 94: 219–225Google Scholar
  361. 16.
    Meyer L von, Hänseier E, Lardet G et al. (1997) European multicentre evaluation of the analytical Performance of the Abbott AxSYM abused drugs assays. Eur J Clin Chem Clin Biochem 35: 133–140Google Scholar
  362. 17.
    Pelders MG, Ros JJ (1996) Poppy seeds: differences in morphine and codeine content and variation in inter and intra-individual excretion. J Forensic Sci 41/29: 209–212PubMedGoogle Scholar
  363. 18.
    Ritter D, Cortese CM, Edwards LC et al. (1997) Interference with testing for lysergic acid diethylamide. Clin Chem 43: 635–637PubMedGoogle Scholar
  364. 19.
    Schwarzhoff R, Cody JT (1993) The effects of adulterating agents on FPIA analysis of urine for drugs of abuse. J Anal Toxicol 17/1: 14–17PubMedGoogle Scholar
  365. 20.
    Wennig R, Möller MR, Haguenoer JM et al. (1998) Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine. J Anal Toxicol 22: 148–155PubMedGoogle Scholar
  366. 21.
    Yoo Y, Chung H, Choi H (1994) Urinary methamphetamine concentration following fampropazone administration. J Anal Toxicol 18: 265–268PubMedGoogle Scholar
  367. 1.
    Dzubay TG (ed) (1977) X-ray fluorescence analysis of environmental samples. Ann Arbor Science Publishers, Ann ArborGoogle Scholar
  368. 2.
    Jenkin R, Gould RW, Gedcke D (1981) Quantitative Xray spectrometry. Dekker, New YorkGoogle Scholar
  369. 3.
    Tertian R, Claisse F (1982) Principle of quantitative Xray fluorescence analysis. Heyden, LondonGoogle Scholar
  370. 1.
    Belkas EP, Souliotis AG (1966) Analyst 91: 199Google Scholar
  371. 2.
    Bowen HJM (1964) Analyst 89: 658Google Scholar
  372. 3.
    Christell R, Sjöstrand B (1962) Acta Chem Scand 16: 2123Google Scholar
  373. 4.
    Comor D et al. (1962) Bull Soc Chim Fr 56Google Scholar
  374. 5.
    Derobert L, Michon R (1954) Ann Med Leg 34: 130PubMedGoogle Scholar
  375. 6.
    Griffen H, Barbaud J (1951) CR Hebd Seances Acad Sci 232: 1455–1457Google Scholar
  376. 7.
    Griffen H, Barbaud J (1951) Ann Pharm Fr 9: 545–551Google Scholar
  377. 8.
    Griffen H (1955) Ann Pharm Fr 13: 258Google Scholar
  378. 9.
    Hamaguchi H et al. (1964) Anal Chim Acta 30: 335Google Scholar
  379. 10.
    Henke G (1968) Ar Toxikol 27: 293Google Scholar
  380. 11.
    Howie RA, Molokhia MM, Smith H (1965) Anal Chem 37: 1059PubMedGoogle Scholar
  381. 12.
    Howie RA, Smith H (1967) J Forens Sci Soc 7: 90Google Scholar
  382. 13.
    Kaiser DG, Meinke WW (1963) Anal Chim Acta 29: 211Google Scholar
  383. 14.
    Kennedy JH (1966) Am J Med Sci 251: 75Google Scholar
  384. 15.
    Kirchmann R, Roderbourg J (1965) J Appl Radiat 16: 457Google Scholar
  385. 16.
    Kjellin KG (1964) Int J Appl Radiat 15: 461PubMedGoogle Scholar
  386. 17.
    Krishnan S, Erickson E (1966) F Forens Sci 11: 89Google Scholar
  387. 18.
    Leniham JMA (1960) Pure Appl Chem 1: 81Google Scholar
  388. 19.
    Leniham JMA, Smith H, Chalmers JG (1958) Nattalure 181: 1463Google Scholar
  389. 20.
    Livingstone H, Smith H (1965) Anal Chim Acta 29: 211Google Scholar
  390. 21.
    Mueller B (1953) Gerichtliche Medizin. Springer, Berlin Heidelberg, S 638Google Scholar
  391. 22.
    Rakovic M (1963) Atompraxis 9: 177Google Scholar
  392. 23.
    Savel B (1963) Ann Parm Fr 21: 21Google Scholar
  393. 24.
    Sjöstrand B (1964) Anal Chem 36: 814Google Scholar
  394. 25.
    Smith H (1959) Anal Chem 31: 165Google Scholar
  395. 26.
    Smith H (1961) J Forens Med 8: 165–171Google Scholar
  396. 27.
    Smith H (1962) Anal Chem34: 190Google Scholar
  397. 28.
    Smith H (1963) Anal Chem 35: 749Google Scholar
  398. 29.
    Smith H (1967) J Forens Sci Soc 7: 97Google Scholar
  399. 30.
    Specht W (1964) Rohner Acta Med Leg Soc 17: 27Google Scholar
  400. 31.
    Westermark T, Sjöstrand B (1960) J Appl Radiat Isotopes 9: 1Google Scholar
  401. 32.
    Wichitill J (1964) Diss. Technische Universität, Dresden, Schriftenreihe der DVP 97: 831Google Scholar
  402. 33.
    Wichitill J (1966) Forum der Kriminalistik: 42Google Scholar
  403. 1.
    Kijewski H (1993) Die forensische Bedeutung der Mineralstoffgehalte in menschlichen Kopfhaaren. Schmidt-Römhild, LübeckGoogle Scholar
  404. 2.
    Kauert G, Röhrich J (1996) Concentration of Δ9-Tetrahydrocannabinol, Cocaine and 6-Monoacetylmorphine in Hair of Drug Users. Int J Legal Med 108: 294–299PubMedGoogle Scholar
  405. 3.
    Kintz P, Mangin P (1995) What constitutes a positive result in hair analysis: proposal for the establishment of cut-off values. Forensic Sci Int 70: 3–11PubMedGoogle Scholar
  406. 4.
    Kintz P (1996) Drug Testing in Hair. CRC Press, Boca RatonGoogle Scholar
  407. 5.
    Moeller MR, Fey P, Wennig R (1993), Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GC/MS and its application to a methadone treatment program. Forensic Sci Int 63: 185–206PubMedGoogle Scholar
  408. 6.
    Müller RK, Thieme D. (2000) Recent developments in hair analysis. Sport und Buch Strauß, KölnGoogle Scholar
  409. 7.
    Pepin G, Gaillard Y (1997) Concordance between selfreported drug use and fmdings in hair about cocaine and heroin. Forensic Sci Int 84: 37–41PubMedGoogle Scholar
  410. 8.
    Pragst F, Rothe M, Spiegel K, Sporkert F (1998) Illegal and therapeutic drug concentrations in hair segments — A time table of drug exposure? Forensic Sci Rev 10: 81–111Google Scholar
  411. 9.
    Pötsch L, Skopp G, Eser HP, Möller MR (1996) Zum Suchtmittelnachweis in Kopfhaaren. I. Die Abschätzung und Bedeutung des individuellen Haarwachstumsfensters und des intradermalen Abschnittes anagener Haare bei der segmentweisen Haaranalyse. Rechtsmedizin 6: 156–160Google Scholar
  412. 10.
    Sachs H, Kintz P (1998) Testing for drugs in hair: Critical review of Chromatographie procedures since 1992. J Chromatogr B 713: 147–161Google Scholar
  413. 1.
    Aderjan RE, Herbold M (1998) Qualitätskontrolle für quantitative Analysen von Betäubungsmitteln im Blut. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit M 87. Wirtschaftsverlag NW, BremerhavenGoogle Scholar
  414. 2.
    Wu AHB, Hill DW, Crouch D et al. (1999) Minimal Standards for the Performance and Interpretation of toxicology tests in legal proceedings. J Forens Sci 44: 516–522Google Scholar
  415. 3.
    Anlage zu den Richtlinien der GTFCh zur Qualitätssicherung bei forensisch-toxikologischer Untersuchungen (2000) Anhang A: Anforderung an einzelne Analysenmethoden. I Analysen mit Gaschromatographie-Massenspektrometrie mit Elektronenstoßionisation. Toxichem & Krimtech 67: 13–128Google Scholar
  416. 4.
    Baselt RC, Cravey RH (1999) Disposition of toxic drugs and chemicals in man, 5th edn. Foster City/CAGoogle Scholar
  417. 5.
    Chaturvedi AK. (2000) The FAA’s postmortem forensic toxicology self-evaluated proficiency test program: The first seven years. J Forens Sci 45: 422–428Google Scholar
  418. 6.
    Pounders DJ, Jones GR (1990) Post-mortem drug redistribution — a toxicological nigthmare. J Forens Sci 45: 253–263Google Scholar
  419. 7.
    Uges DRA (1996) Therapeutic and toxic drug concentrations. TIAFT Bulletin 26/1 [Suppl]: 1–34Google Scholar
  420. 8.
    Uges DRA (1999) Toxic and therapeutic ranges(update). TIAFT Bulletin 29/1: 15–16Google Scholar
  421. 9.
    Druid H, Holmgreen P (1997) A compilation of fatal and control concentrations of drugs in postmortem femural blood. J Forens Sci 42: 79–87Google Scholar
  422. 10.
    Eichordnung vom 12. August 1988, Bundesgesetzblatt Teil I Nr 43 S 1657–1684 sowie Anlagenband zum Bundesgesetzblatt Teil I Nr 43 v. 26. Aug. 1988, S 67-79Google Scholar
  423. 11.
    Ellenhorn MJ: Ellenhorn’s medical toxicology. Diagnosis and treatment of human poisoning. Williams & WilkinsGoogle Scholar
  424. 12.
    Ergänzung der „Richtlinien der Bundesärztekammer zur Qualitätssicherung in medizinischen Laboratorien“ (1994) Dtsch Ärztebl 91: B175–B177Google Scholar
  425. 13.
    Fresenius R. (1844) Über die Stellung des Chemikers bei gerichtlich-chemischen Untersuchungen und über die Anforderungen, welche von Sciten des Richters an ihn gemacht werden können. Ann Chem Pharm XLIX: 275–286Google Scholar
  426. 14.
    Geldmacher-v Mallinckrodt M (1980) Ringversuch Blei. Toxichem 12: 9Google Scholar
  427. 15.
    Geldmacher-v Mallinckrodt M (1982) Mitteilungen der DFG-Kommission „Klinisch-toxikologische Analytik“. Ringversuch Thallium. Toxichem 22: 2–4Google Scholar
  428. 16.
    Gildemeister H, Käding U, Ziegler M (1990) 17 Jahre Qualitätsbestimmung der forensischen Ethanolbestimmung im Blut. 1. Gesamtdeutsches Symposium der GTFCh, Leipzig, 3.-5. Juli 1990, S 76–78Google Scholar
  429. 17.
    Goodman-Gilman A, Goodman LS, Rall TW, Murad R. (1985) The pharmacological basis of therapeutics, 7th edn. MacMillan, New YorkGoogle Scholar
  430. 18.
    Gottschall S, Käding U, Demme U (1986) Ringversuche zur externen Qualitätskontrolle in der toxikologischen Analytik. Toxichem 44: 9–10Google Scholar
  431. 19.
    Hausmann D, Möller MR, Otte D (1988) Medikamente, Drogen und Alkohol bei verkehrsunfallverletzten Fahrern. Bericht zum Forschungsprojekt 8004 der Bundesanstalt für Straßenwesen, Bereich Unfallforschung. Bergisch Gladbach, Bd 184Google Scholar
  432. 20.
    Harzer K (1980) Ergebnisse von Ringversuchen I–V. Toxichem 10: 9–10Google Scholar
  433. 21.
    Herbold M, Schmitt G (1998) Qualitätsansprüche an quantitative MS-Untersuchungen. Toxichem & Krimtech 65: 87–96Google Scholar
  434. 22.
    Hillberg T, Rodge S, Morland J (1999) Postmortem drug redistribution-human cases related to results in experimental animals. J Forens Sci 44: 1–9Google Scholar
  435. 23.
    Machata G (1970) Toxikologische Analyse. Ergebnis einer Umfrage. Beitr Gerichtl Med 27: 192–198PubMedGoogle Scholar
  436. 24.
    Machata G (1971) Toxikologische Analyse: Testversuche. Beitr Gerichtl Med 28: 367–368Google Scholar
  437. 25.
    Machata G (1972) Toxikologische Analyse: Testversuche Beitr Gerichtl Med 29: 427–428PubMedGoogle Scholar
  438. 26.
    Machata G (1973) Toxikologische Analyse: Testversuche (IV). Beitr Gerichtl Med 31: 340–341PubMedGoogle Scholar
  439. 27.
    Machata G (1974) Toxikologische Analyse: Testversuche (V). Beitr Gerichtl Med 32: 191–192PubMedGoogle Scholar
  440. 28.
    Machata G (1975) Toxikologische Analyse: Testversuche (V). Beitr Gerichtl Med 33: 228–229PubMedGoogle Scholar
  441. 29.
    Maurer HH (2000) Applications of GC-MS in clinical and forensic toxicology and doping control. In: Niessen WMA (ed) Current practice of GC-MS. Dekker, New York (in press)Google Scholar
  442. 30.
    Prouty RW, Anderson WH (1990) The forensic science implication of site and temporal influence on postmortem blood-drug concentrations. J Forensic Sci 35: 243–270PubMedGoogle Scholar
  443. 31.
    Richtlinien der Bundesärztekammer zur Qualitätssicherung in medizinischen Laboratorien (1988) Dtsch Ärztebl 85: A697–A712Google Scholar
  444. 32.
    Richtlinien für die Blutalkoholbestimmung für forensische Zwecke (http://www.uni-duesseldorf.de/WWW/ MedFak/rechtsm/aktmeld/start.html)Google Scholar
  445. 33.
    Richtlinien der GTFCh zur Qualitätssicherung bei forensisch-txikologischen Untersuchungen (1998) Toxichem & Krimtech 65: 18–24Google Scholar
  446. 34.
    Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52: 895–911PubMedGoogle Scholar
  447. 35.
    Society of Forensic Toxicologists (SOFT)/American Academy of Forensic Sciences (AAFS) (1999) Toxicology Section, Forensic Toxicology Laboratory Guidelines (http://www.soft-tox.org)Google Scholar
  448. 36.
    U.S. National Institue of Drug Abuse (1988) NIDA Guidelines. Fed Reg 53/6: 11970–11989Google Scholar
  449. 37.
    Vycudilik W, Stimpfl T (1996) The determination of Opioids in brain tissue — A possibility to estimate the span of the survival period. Proceedings of the 34th Conference of The International Association of Forensic Toxicologists, Interlaken, August 11-15, 1996Google Scholar
  450. 38.
    Zeuuw RA de, Müller RK, Finkle BS et al. (1994) Laboratory Guidelines for Toxicological Analysis, adopted at the TIAFT Triennial Meeting, Leipzig, Aug 16-20, 1993. Molinapress, Leipzig, pp 537-545Google Scholar
  451. 1.
    Ciasing D (Hrsg.) (1992) Doping — verbotene Arzneimittel im Sport. Gustav Fischer, StuttgartGoogle Scholar
  452. 2.
    Deutsche Reiterliche Vereinigung Leistungsprüfungsordnung LPO Stand 1998, § 67a Liste der verbotenen Substanzen. LPO 1998, FN-Verlag, WarendorfGoogle Scholar
  453. 3.
    Donike M, Rauth S (1996) Dopingkontrollen, Bundesinstitut für Sportwissenschaften (Hrsg). Strauß, KölnGoogle Scholar
  454. 4.
    Düe M (1998) Doping bei Pferden. Dtsch Tierärztl Wochenschr 105/3: 81–136Google Scholar
  455. 5.
    Federation Equestre Internationale (FEI) (1998) Veterinary regulations (Stand 1998) Art 1013, Prohibited substances, Lausanne 1998Google Scholar
  456. 6.
    Hettinger T, Hollmann W (2000) Sportmedizin: Grundlagen für Arbeit, Training und Präventivmedizin. Schattauer, StuttgartGoogle Scholar
  457. 7.
    International Olympic Committee (IOC) (1999) Press Statement on Nandrolone, Lausanne 1999Google Scholar
  458. 8.
    International Olympic Committee (IOC) (1995) Medical Code and Explanatory Document, Lausanne 4.6.1995Google Scholar
  459. 9.
    International Olympic Committee (IOC) and World Antidoping Agency (WADA) Olympic Movement Antidoping Code (OMAC) (1999) Appendix A: Prohibited classes of substances and prohibited methods, Lausanne 1. 9. 2001Google Scholar
  460. 10.
    Kindermann W, Urhausen A (1999) Plötzlicher Herztod beim Sport: was sich aktive Betreuer zu Herzen nehmen sollten. Bundesinstitut für Sportwissenschaften und Deutscher Sportbund — Bereich Leistungssport (Hrsg). Strauß, KölnGoogle Scholar
  461. 11.
    Kniess A, Mueller RK, Kratzsch J. (2000) Quantitation of human growth hormone, insulin-like growth factors I and II (IGF-I and II) and IGF binding protein-2 and-3 in athletes. In: Schänzer W, Geyer H, Gotzmann A, Marek-Engelke U (eds) Recent advances in doping analysis (7). Strauß, Köln, pp 365–369Google Scholar
  462. 12.
    Müller RK. (2000) Proposal of completion of the lists of examples to the classes of prohibited substances of the I.O.C. doping definition. Monitoring Group to the Anti Doping Convention of the Council of Europe, Strasbourg, Separatum T-DO, 10Google Scholar
  463. 13.
    Müller RK. (2001) Analytik zum Dopingnachweis. In: Ciasing D, Müller RK (Hrsg) Doping — Dopingkontrolle. Strauß, Köln, S 62–79Google Scholar
  464. 14.
    Müller RK, Grosse J, Thieme D et al. (1999) Introduction to the application of capillary chromatography of performance-enhancing drugs in doping control. J Chromatography A 843: 275–285Google Scholar
  465. 15.
    Mueller RK, Grosse J, Thieme D, Preiss R. (2000) Banned agents and related Compounds — how many? In: Schänzer W, Geyer H, Gotzmann A, Marek-Engelke U (eds) Recent advances in doping analysis (7). Strauß, Köln: pp 13–19Google Scholar
  466. 16.
    Mueller RK, Preiss R, Krueger M. (2000) Anabolic Steroids and enhanced aggressiveness. In: Schänzer W, Geyer H, Gotzmann A, Marek-Engelke U (eds) Recent advances in doping analysis (7). Strauß, Köln: pp 131–142Google Scholar
  467. 17.
    Mueller RK, Thieme D, Große J, Lang R (1996) Doping-Analyse. In: Borsdorf R et al. (Hrsg) Analytiker-Taschenbuch, Bd 15. Springer, Berlin Heidelberg New York Tokio, S 289–319Google Scholar
  468. 18.
    Prokop L (1983) Einführung in die Sportmedizin. Gustav Fischer, StuttgartGoogle Scholar
  469. 19.
    Sachs H, Kintz P (2000) Consensus of the Society of Hair Testing on hair testing for doping agents. Forens Sci Int 107: 3Google Scholar
  470. 20.
    Schänzer W (1996) Doping. Nachr Chem Tech Lab 44: 971–976Google Scholar
  471. 21.
    Staak M (1996) Eignung von Blut und/oder Urin zum Dopingnachweis. In: Büch MP (Hrsg) Blut und/oder Urin zur Dopingkontrolle. Hofmann, Schorndorf, S 187–203Google Scholar
  472. 22.
    Thieme D, Grosse J, Mueller RK, Sachs H. (2000) Analytical strategy for detecting doping agents in hair. In: Proceedings of the International Meeting of TIAFT (The International Association of Forensic Toxicologists), Albuquerque, New Mexico, Oct. 1998. Forens Sci Int 107: 335–345Google Scholar
  473. 23.
    Ungemach FR, Nürnberger MC (1999) Doping im Pferdesport. In: Dietz O, Huskamp B (Hrsg) Handbuch Pferdepraxis, 2. Aufl. vEnke, StuttgartGoogle Scholar
  474. 1.
    Achmadi UF (1994) Occupational exposure to mercury at the gold mining: a case study from Indonesia. In: Environmental mercury pollution and its health effects in Amazon river Basin. National Institute Minamata Disease and Ins. Biopyhsics of the University Federal do Rio de Janeiro. Rio de Janairo, pp 10–16Google Scholar
  475. 2.
    Ahlqwist M, Bengtsson C, Furunes B, Hollender L, Lapidus L (1988) Number of amalgam tooth fillings in relation to subjectively experienced Symptoms in a study of Swedish women. Community Dent Oral Epidemiol 16/4: 227–231PubMedGoogle Scholar
  476. 3.
    al Khayat A, Menon NS, Alidina MR (1997) Acute lead encephalopathy in early infancy — clinical presentation and outcome. Ann Trop Paediatr 17/1: 39–44PubMedGoogle Scholar
  477. 4.
    Alcser KH, Brix KA, Fine LJ, Kallenbach LR, Wolfe RA (1989) Occupational mercury exposure and male reproductive health. Am J Ind Med 15/5: 517–529PubMedGoogle Scholar
  478. 5.
    Alfrey AC (1983) Aluminium. Adv Clin Chem 23: 69–91PubMedGoogle Scholar
  479. 6.
    Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encepalopathy Syndrome — possible aluminum intoxication. New Engl J Med 294: 184–188PubMedGoogle Scholar
  480. 7.
    Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy Syndrome — possible aluminium intoxication. New Engl J Med 294: 184–188PubMedGoogle Scholar
  481. 8.
    Al-Saleem T (1976) Levels of mercury and pathological changes in patients with organomercury poisoning. Bulletin WHO 53 [Suppl]: 99–104Google Scholar
  482. 9.
    Angerer J, Schaller KH (1985) Analyses of hazardous substances in biological materials, vol 1. VCH, WeinheimGoogle Scholar
  483. 10.
    Anke M, Groppel B, Müller M, Kräuter U (1990) Aluminiummangelerscheinungen beim Tier. In: Anke M et al. (Hrsg) Mengen-und Spurenelemente, 10. Arbeitstagung 1990, Bd 1. Verlagsabteilung der Friedrich-Schiller-Universität, Jena, S 505–515Google Scholar
  484. 11.
    Aposhian V (1989) Biochemical toxicology of arsenic. Elsevier, AmsterdamGoogle Scholar
  485. 12.
    Apostoli P, Alessio L, Romeo L, Buchet JP, Leone R (1997) Metabolism of arsenic after acute occupational arsine intoxication. J Toxicol Environ Health 52/4: 331–342PubMedGoogle Scholar
  486. 13.
    Araki S, Sato H, Yokoyama K, Murata K. (2000) Subclinical neurophysiological effects of lead: A review on peripheral, central, and autonomic nervous system effects in lead workers. Am J Ind Med 37/2: 193–204PubMedGoogle Scholar
  487. 14.
    Bailey MJ, Fischer E, Winstanley R (1987) Fatal Ingestion of mercury chloride. TIAFT Bulletin 19/2: 19–20Google Scholar
  488. 15.
    Barchet R, Harzer K, Helmers E, Wippler K (1995) An Arsenic overdose in a child. TIFT Bulletin 25/1: 37–39Google Scholar
  489. 16.
    Barry PSI (1975) A comparison of concentrations of lead in human tissues. Br J Ind Med 32: 119-139Google Scholar
  490. 17.
    Barton BM, Gitlin MJ (1987) J Clin Psychopharmacol 7: 101PubMedGoogle Scholar
  491. 18.
    Baselt RC, Cravey RH (1995) Disposition of toxic drugs and chemicals in man, 4th edn. Chemical Toxicology Institute, Foster City/CAGoogle Scholar
  492. 19.
    Bayer MJ (1985) Recreational gasoline sniffmg: Acute gasoline intoxication and latent organolead poisoning: Case reports and literature review. J Emerg Med 3/5: 365–370PubMedGoogle Scholar
  493. 20.
    Becker K, Nollke P, Hermann-Kunz E et al. (1998) Die Aufnahme von Schadstoffen und Spurenelementen mit der Nahrung — Ergebnis einer Duplikatstudie. Aktuel Ernähr Med Klin Prax 23/3: 142–151Google Scholar
  494. 21.
    Behne D, Kyriakopoulos A (1997) Neue Selenoproteine: Verteilung, Funktion und Selenbedarf. In: Lombeck I (Hrsg) Spurenelemente: Bedarf, Vergiftungen, Wechselwirkungen und neuere Messmethoden. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 73–77Google Scholar
  495. 22.
    Behne D, Kyriakopoulos A, Scheid S, Gessner H (1991) Effects of chemical form and dosage on the incorporation of selenium into tissue proteins in rats. J Nutr 121/ 6: 806–814PubMedGoogle Scholar
  496. 23.
    Behne D, Weiss-Nowak C, Kalcklösch M et al. (1995) Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst 120: 823–825Google Scholar
  497. 24.
    Benramdane L, Accominotti M, Fanton L, Malicier D, Vallon JJ (1999) Arsenic speciation in human organs following fatal arsenic trioxide poisoning — A case report. Clin Chem 45/2: 301–306PubMedGoogle Scholar
  498. 25.
    Berlin M (1986) Mercury. In: Friberg L, Nordberg GF, Vouk VB (eds) Handbook on the toxicology of Metals, vol II, Specific metals, 2nd edn. Elsevier, Amsterdam, pp 387–445Google Scholar
  499. 26.
    Bhattacharya B, Banerjee S, Singhi S (1997) Acute mercury vapour poisoning in an infant. Ann Tropic Pediatr 17: 57–60Google Scholar
  500. 27.
    Bolt HM, Greim H, Marquardt H, Neumann HG, Oesch F, Ohnesorge FK (1990) Zur Toxizität von Zahnfüllungen aus Amalgam. Med Klin 85/5: 350–352Google Scholar
  501. 28.
    Borkowski T, Lech T, Sadlik J (1983) Acute tetraethyl lead intoxication per os. TIAFT Bulletin 17/2: 6–7Google Scholar
  502. 29.
    Böse S, Drasch G, Eife R, Laub MC (1993) Chronische Metallintoxikationen als Ursache neuropädiatrischer Erkrankungen. Pädiat Prax 45: 183–197Google Scholar
  503. 30.
    Boumann AA (1986) Determination of aluminium in human tissues by flameless atomic absorption spectroscopy and comparison of reference values. Ann Clin Biochem 23/1: 97–101Google Scholar
  504. 31.
    Branches FJP, Erickson T, Aks SE, Hryhorczuk DO (1993) The price of gold: mercury exposure in the Amazon Rain Forest. J Clin Toxicol 31: 295–306Google Scholar
  505. 32.
    Brody DJ, Pirkle JL, Kramer RA et al. (1994) Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA 272/4: 277–283PubMedGoogle Scholar
  506. 33.
    Buchet JP, Lauwerys R, Roels H, Bernard A (1990) Renal effects of cadmium body bürden of the general population. Lancet 336: 699–702PubMedGoogle Scholar
  507. 34.
    Bundesgesundheitsamt (Hrsg) (1988a) Monographie: Amalgame, gamma-2-haltig (Teil I). Bundesanzeiger 46: 1019–1042Google Scholar
  508. 35.
    Bundesgesundheitsamt (Hrsg) (1988b) Monographie: Amalgame, gamma-2-haltig (Teil II) Bundesanzeiger 46: 4779–47982Google Scholar
  509. 36.
    Bundesgesundheitsamt (Hrsg) (1991) Bericht der Zentralen Erfassungs-und Bewertungsstelle für Umweltchemikalien ZEBS. Bundesgesundheitsbl 34: 226–332Google Scholar
  510. 37.
    Burg R von, Greenwood MR (1991) Mercury. In: Merian E (ed) Metals and their Compounds in the environment. VCH, Weinheim, pp 1045–1088Google Scholar
  511. 38.
    Burow M, Stoeppler M (1987) Ingestion/excretion experiments for arsenic in fish. In: Brätter P, Schramel P (eds) Trace elements, analytical chemistry in medicine and biology, vol 4. de Gruyter, BerlinGoogle Scholar
  512. 39.
    Campbell JP, Alvarez JA (1989) Acute arsenic intoxication. Am Farn Physician 40/6: 93–97Google Scholar
  513. 40.
    CDC, Centers for Disease Control (1991) Preventing lead poisoning in young children. US Dept. of Health and Human Services, CDC, AtlantaGoogle Scholar
  514. 41.
    Chan JC, Jacob M, Brown S, Savory J, Wills MR (1988) Aluminium methabolism in rats: effects of vitamin D, dihydrotachysterol, 1,25-dihydrovitamin D and phosphate binders. Nephron 48/1: 61–64PubMedGoogle Scholar
  515. 42.
    Chan LTF, Gago SK (1984) Arsenic poisoning. TIAFT Bulletin 17/3: 15–16Google Scholar
  516. 43.
    Chao J; Kikano GE (1993) Lead poisoning in children. Am Farn Physician 47: 113–120Google Scholar
  517. 44.
    Cherian MG, Hursh JB, Clarkson TW, Allen J (1978) Radioactive mercury distribution in biological fluids and excretion in human subjects after inhalation of mercury vapor. Arch Environ Health 33/3: 109–114PubMedGoogle Scholar
  518. 45.
    Choi BH, Lapham LW, Amin-Zaki L, Saleem T (1978) Abnormal neuronal migration, deranged cerebral cortical Organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol 37/6: 719–733PubMedGoogle Scholar
  519. 46.
    Christensen JM, Kristiansen J (1994) Lead. In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 425–440Google Scholar
  520. 47.
    Clark LC (1985) The epidemiology of selenium and Cancer. Fed Proc 44/9: 2584–2589PubMedGoogle Scholar
  521. 48.
    Clarkson TW, Hursh JB, Sager PR, Syversen TLM. (1988) Mercury. In: Clarkson TW, Friberg L, Nordberg GF, Sager P (eds) Biological monitoring of toxic metals. Plenum Press, New York, pp 199–246Google Scholar
  522. 49.
    Compton JAF (1987) Military chemical and biological agents. Chemical and toxicological properties. Telford, Caldwell/NJ, pp 17–43Google Scholar
  523. 50.
    Cooney GH, Bell A, McBride W, Carter C (1989) Low-level exposures to lead: the Sydney lead study. Dev Med Child Neurol 31/5: 640–649PubMedGoogle Scholar
  524. 51.
    Cooper GS, Sigwart CD (1980) Neurophysiological effects of lead. In: Singhai RL, Thomas JA (eds) Lead toxicity. Urban & Schwarzenberg, Baltimore, pp 401–424Google Scholar
  525. 52.
    Cullen NM, Wolf LR, St-Clair D (1995) Pediatric arsenic ingestion. Am J Emerg Med 13/4: 432–435PubMedGoogle Scholar
  526. 53.
    DAB 10 (1991) Deutsches Arzneibuch, Loseblattsammlung, Bd 1-3, 10. Ausgabe. Deutscher Apothekerverlag, StuttgartGoogle Scholar
  527. 54.
    DAB 6, Deutsches Arzneibuch, 6. Ausgabe, 1926Google Scholar
  528. 55.
    Davidson PW, Myers GJ, Cox C et al. (1998) Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA 280/8: 701–707PubMedGoogle Scholar
  529. 56.
    Day JP, Barker J, Evans LJ et al. (1991) Aluminium absorption studied by 2 6A1 tracer. Lancet 337: 1345PubMedGoogle Scholar
  530. 57.
    de Lacerda L, Salomons W (1998) Mercury from gold and silver mining: a chemical time bomb? Springer, Berlin Heidelberg New York TokioGoogle Scholar
  531. 58.
    Denk R, Holzmann H, Lange HJ, Greve D (1969) Über Arsenspätschäden bei obduzierten Moselwinzern. Med Welt 11: 557–567PubMedGoogle Scholar
  532. 59.
    Desenclos JC; Wilder MH, Coppenger GW et al. (1992) Thallium poisoning: An outbreak in Florida 1988. South Med J 85: 1203–1206PubMedGoogle Scholar
  533. 60.
    Deutsche Forschungsgemeinschaft (Hrsg) (1999) MAK und BAT-Werte-Liste 1999. Wiley-VCH, WeinheimGoogle Scholar
  534. 61.
    D’haese PC, Van de Vyver FL, Lamberts LV, De Broe ME (1987) Aluminium — An uremic toxin. Adv Exp Med Biol 233: 89–96Google Scholar
  535. 62.
    Dietrich KN, Berger OG, Succop PA et al. (1993) The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neuro toxicol Teratol 15/1: 37–44Google Scholar
  536. 63.
    Dietrich KN, Succop PA, Bornschein RL et al. (1990) Lead exposure and neurobehavioral development in later infancy. Environ Health Perspect 89: 13–19PubMedCentralPubMedGoogle Scholar
  537. 64.
    Drasch G (1982) Kadmium-Belastung im südbayerischen Raum. MMW 124: 1129–1132Google Scholar
  538. 65.
    Drasch G (1982) Lead bürden in prehistorical, historical and modern human bones. Sci Tot Environm 24: 199–231Google Scholar
  539. 66.
    Drasch G (1994) Mercury. In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 479–494Google Scholar
  540. 67.
    Drasch G, Aigner S, Roider G, Staiger F, Lipowsky G. (1998) Mercury in human Colostrum and early breast milk. Its dependence on dental amalgam and other factors. J Trace Elements Med Biol 12: 23–27Google Scholar
  541. 68.
    Drasch G, Böhm J, Baur C (1987) Lead in human bones. Investigations on an occupationally non-exposed population in Southern Bavaria (F.R.G.) I. Adults. Sci Tot Environm 64: 303–315Google Scholar
  542. 69.
    Drasch G, Hauck G (1977) Verlaufskontrolle der Intensivtherapie von Thalliumintoxikationen. Arch Toxicol 38: 209–215PubMedGoogle Scholar
  543. 70.
    Drasch G, Kretschmer E (1988a) Cadmium — A model for the risk evaluation of an occupationally non-burdened population. Environmental toxin series, vol 2. Springer, Berlin Heidelberg New York, pp 135–143Google Scholar
  544. 71.
    Drasch G, Kretschmer E (1988 b) Distribution of cadmium within the kidney. Environmental toxin series, vol 2. Springer, Berlin Heidelberg New York, pp 146–156Google Scholar
  545. 72.
    Drasch G, Mailänder S, Schlosser G, Roider G. (2000) Content of non-mercury associated selenium in human tissues. Biol Trace Elem Res 77: accept for publGoogle Scholar
  546. 73.
    Drasch G, Ott J (1988) Lead in human bones. Investigations on an occupationally non-exposed population in Southern Bavaria (F.R.G.) II. Children Sci Tot Environm 68: 61–69Google Scholar
  547. 74.
    Drasch G, Roider G, Böse-O’Reilly S, Feenstra O, Sampl H (2000) Rückgang der Bleibelastung der Bevölkerung im Umkreis einer Bleihütte in Arnoldstein/Kärnten durch erfolgreiche Sanierungsmaßnahmen. Umweltmed Forsch Prax 5/3Google Scholar
  548. 75.
    Drasch G, Scharl K, Roider G et al. (1997) Ausssagekraft des DMPS-Tests auf Quecksilber. Umweltmed Forsch Prax 2: 2–10Google Scholar
  549. 76.
    Drasch G, Schupp I, Höfl H, Reinke R, Roider G (1994) Mercury bürden of human fetal and infant tissues. Eur J Pediatr 153: 607–610PubMedGoogle Scholar
  550. 77.
    Drasch G, Schupp I, Riedl G, Günther G (1992) Einfluss von Amalgamfüllungen auf die Quecksilberkonzentration in menschlichen Organen. Dtsch Zahnärztl Z 47: 490–496Google Scholar
  551. 78.
    Drasch G, Wanghofer E, Roider G (1997) Are blood, urine, hair, and muscle valid biomonitors for the internal bürden of men with the heavy metals mercury, lead and cadmium? Trace Elements Electrolytes 14: 116–123Google Scholar
  552. 79.
    Drasch, G, Probst R, Roider G (1991) Aluminium in human bones. Investigations on an occupationally non-exposed population in southern Bavaria (FRG) — Adults. In: Momcilovic B (ed) Trace elements in man and animals. Zagreb: IMI Institute for Medical Research and Occupational Health, University of Zagreb, pp 23–6-23-8Google Scholar
  553. 80.
    Drexler H, Schaller K (1998) The mercury concentration in breast milk resulting from amalgam fillings and dietary habits. Environ Res 77/2: 124–129PubMedGoogle Scholar
  554. 81.
    Drobner C, Röhrig B, Anke M, Thomas G (1997) Selenium intake of adults in Germany depending on sex, time, living area and type of diet. In: Fischer PW, L’abbe MR, Cockell KA, Gibson RS (eds) TEMA 9. Proceedings of the Ninth International Symposium on Trace Elements in Man and Animals. NRC Research Press, Ottawa, Ontario, pp 158–159Google Scholar
  555. 82.
    Druet P, Druet E, Potdevin F, Sapin C (1978) Immune type glomerulonephritis induced by HgCl2 in the Brown Norway rat. Ann Immunol Paris 129 C/6: 777–792PubMedGoogle Scholar
  556. 83.
    Dumestre-Toulet V, Azparren J, Ballasteros S. (2000) Family poisoning with thallium. TIAFT Bull 30/2: 14–16Google Scholar
  557. 84.
    Dunn JD, Clarkson TW, Magos L (1978) Ethanol-increased exhalation of mercury in mice. Br J Ind Med 35/3: 241–244PubMedCentralPubMedGoogle Scholar
  558. 85.
    Elinder CG, Gerhardsson, Oberdoerster G (1988) Absorption. In: Clarkson TW, Friberg L, Nordberg GF, Sager P (eds) Biological monitoring of metals. Plenum Press, New YorkGoogle Scholar
  559. 86.
    Elinder CG, Kjellström T, Lind B et al. (1983) Cadmium exposure from smoking cigarettes. Variations with time and country where purchased. Environm Res 32: 220–227Google Scholar
  560. 87.
    Ellenhorn MJ (1997) Medical toxicology, diagnosis and treatment of human poisoning. Williams & Wilkins, BaltimoreGoogle Scholar
  561. 88.
    Enestrom S, Hultman P (1995) Does amalgam affect the immune System? A controversial issue. Int Arch Allergy Immunol 106/3: 180–203PubMedGoogle Scholar
  562. 89.
    EPA Envirnmental Protection Agency (ed) (1986) Air quality criteria for lead. EPA-600/8-028 U.S.EPA, vol I — IV. Environmental Criteria and assessment Office, Research Triangle Park, N.C.Google Scholar
  563. 90.
    Ericson A, Kallen B (1989) Pregnancy outcome in women working as dentists, dental assistants or dental technicians. Int Arch Occup-Environ Health 61/5: 329–333PubMedGoogle Scholar
  564. 91.
    Erway LC (1984) Genetic and developmental implications for trace metal metabolism from mutant and inbred strains of animals. In: Rennert O, Chan W-Y (eds) Metabolism of trace metals in man, vol I. CRC Press, Boca Raton/FL, p 34Google Scholar
  565. 92.
    Europäisches Arzneibuch 1997, deutsche Ausgabe. Deutscher Apotheker-Verlag, StuttgartGoogle Scholar
  566. 93.
    Eweres U, Krause C, Schulz C, Wilhelm M (1999) Reference values and human biological monitoring values for environmental toxins. Int Arch Occup Environ Health 72: 255–260Google Scholar
  567. 94.
    Ewers U (1988) Environmental exposure to thallium. Sci tot Envoron 71/3: 285–292Google Scholar
  568. 95.
    Ewers U (1990) Untersuchungen zur Cadmiumbelastung der Bevölkerung in der Bundesrepublik Deutschland. Schadstoffe und Umwelt 4. Erich Schmidt, BerlinGoogle Scholar
  569. 96.
    Ewers U, Brockhaus A (1987) Die biologische Überwachung der Schadstoffbelastung des Menschen und ihre Bedeutung bei der Beurteilung umwelttoxikologischer Einflüsse. Öff Gesundh Wes 49: 639–647Google Scholar
  570. 97.
    Ewers U, Schlipköter H (1991) Intake, distribution, and exeretion of metals and metal Compounds in humans and animals. In: Merian E (ed) Metals and their Compounds in the environment. VCH, Weinheim, pp 571–583Google Scholar
  571. 98.
    Farago E, Horvath E (1987) Fatal, suicidal sodium selenite poisoning. TIAFT Bull 19/3: 30Google Scholar
  572. 99.
    Feer E (1931) Die Feersche Krankheit. In: von Pfaundler M, Schloßmann A (Hrsg) Handbuch der Kinderheilkunde, Bd 3. Vogel-Verlag, Leipzig, S 528–538Google Scholar
  573. 100.
    Fernandez MA, Sanz P, Palomar M, Serra J, Gadea E (1996) Fatal chemical pneumonitis due to cadmium fumes. Occup Med (London) 45/5: 372–374Google Scholar
  574. 101.
    Fishbein L (1991) Selenium. In: Merian E (ed) Metals and their Compounds in the environment. VCH, Weinheim, pp 1153–1190Google Scholar
  575. 102.
    Florentine MJ, Sanfilippo DJ (1991) Elemental mercury poisoning. Clin Pharm 10: 213–221PubMedGoogle Scholar
  576. 103.
    Forchhammer K, Böck A (1991) Biologie und Biochemie des Elements Selen. Naturwissenschaften 78/1: 497–504PubMedGoogle Scholar
  577. 104.
    Forth W (1987) Aluminium-Intoxikation durch Antacida? Dtsch Ärztebl 1987/7: 278–279Google Scholar
  578. 105.
    Forth W (1988) Toxikologische Bewertung systemischer Effekte von Antacida. Z Gastroenterologie 26 [Suppl 1]: 20–26Google Scholar
  579. 106.
    Forth W, Henschler D, Rummel W (1996) Allgemeine und spezielle Pharmakologie und Toxikologie, 7. Aufl. Urban & Fischer, MünchenGoogle Scholar
  580. 107.
    Forth W, Schäfer S (1987) Absorption of di-and trivalent iron. Drug Res 37: 96–100Google Scholar
  581. 108.
    Fowler BA, Weissberg JB (1974) Arsine poisoning. N Engl J Med 291/2: 1171–1174PubMedGoogle Scholar
  582. 109.
    Franck U, Herbarth O, Langer O, Stark HJ, Treide A. (1999) Lead levels in deciduous teeth in relation to tooth type and tissue as well as to maternal behavior and selected individual environmental parameters of children. Environ Toxicol 14/15: 439–454Google Scholar
  583. 110.
    Friberg L (1984) Cadmium and the kidney. Environ Health Perspect 54: 1–11PubMedCentralPubMedGoogle Scholar
  584. 111.
    Friberg L, Elinder C-G, Kjellström T, Nordberg G (1985a) Cadmium and health: A toxicological and epidemiological appraisal, vol I: Exposure, dose and metabolism. CRC Press, Boca Raton/FLGoogle Scholar
  585. 112.
    Friberg L, Elinder C-G, Kjellström T, Nordberg G. (1985b) Cadmium and health: A toxicological and epidemiological appraisal, vol II: Effects and response. CRC Press, Boca Raton/FLGoogle Scholar
  586. 113.
    Friberg L, Kjellström T, Nordberg GF (1986) Cadmium. In: Friberg L, Nordberg GF, Vouk VB (eds) Handbook on the toxicology of metals, vol II. Elsevier, Amsterdam, pp 130–184Google Scholar
  587. 114.
    Galvan-Arzate S, Santamaria A (1998) Thallium toxicity. Toxicolog Letters 99: 1–13Google Scholar
  588. 115.
    Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environ Health Perspect 65: 363–441PubMedCentralPubMedGoogle Scholar
  589. 116.
    Gasmi A, Garnier R, Galliot Guilley M et al. (1997) Acute selenium poisoning. Vet Hum Toxicol 39: 304–308PubMedGoogle Scholar
  590. 117.
    Ge K, Yang G (1993) The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr Suppl 57/2: 259S–263SGoogle Scholar
  591. 118.
    Geldmacher-von Mallinckrodt M (1975) Forensische Toxikologie. In: Mueller B (Hrsg) Gerichtliche Medizin, Teil 2, 2. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  592. 119.
    Gerhardsson L, Brune D, Nordberg GF, Wester PO. (1986) Selenium and other trace elements in lung tissue in smelter workers: Relationship to the occurence of lung cancer. Acta Pharmacol Toxicol Copenh 59/7 [Suppl]: 256–259PubMedGoogle Scholar
  593. 120.
    Ghariani M, Adrien ML, Raucoules M, Bayle J, Jacomet Y, Grimaud D (1991) Intoxication suraigue a l’arsenic. Ann Fr Anesth Reanim 10/3: 304–307PubMedGoogle Scholar
  594. 121.
    Gosselin B, Mathieu D, Desprez-Nolf M, Cosson A, Goudemand J, Haguenoer JM, Wattel F (1982) Intoxications aigues par l’hydrogene arsenie. 4 observations. Nouv Presse Med 11/6: 439–442PubMedGoogle Scholar
  595. 122.
    Götz D, Baudisch H, Koppel C (1993) Post mortem changes in cadmium blood concentration in patients with cardiovascular disease. Proceedings of the 8th International Symposium on Trace Elements in Man and Animals, DresdenGoogle Scholar
  596. 123.
    Goyens P, Goldstein J, Nsombola B, Vis H, Dumont JE. (1987) Selenium deficiency as a possible factor in the pathogenesis of myxedematous endemic cretism. Acta Endocrinol Copenh 114/4: 497–502PubMedGoogle Scholar
  597. 124.
    Goyer RA (1990) Transplacental transport of lead. Environ Health Perspect 89: 101–115PubMedCentralPubMedGoogle Scholar
  598. 125.
    Goyer RA (1991) Toxic effects of metals. In: Amdur MO, Doull J, Klaassen CD (eds) Toxicology. 4th edn. Pergamon Press, New York, pp 623–680Google Scholar
  599. 126.
    Graben N, Doss M, Klöppel HA (1978) Störung des Porphyrinstoffwechsels bei der Thalliumvergiftung. Med Klein 73: 1114–1116Google Scholar
  600. 127.
    Graeme KA, Pollack CV jr (1998) Heavy metal toxicity. Part I: arsenic and mercury. J Emerg Med 16/1: 45–56PubMedGoogle Scholar
  601. 128.
    Gräfe G (1979) Anorganische Gifte und Arzneimittel. In: Graf E, Preuß R (Hrsg) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte, Bd I, 2. Hälfte, 3. Aufl. Vandenhoeck & Ruprecht, Göttingen, S 966Google Scholar
  602. 129.
    Grandjean P, Olsen NB (1984) Lead. In: Vercruysse A (ed) Hazardous metals in human toxicology. Elsevier, Amsterdam, p 166Google Scholar
  603. 130.
    Grandjean P, White RF, Nielsen A et al. (1999) Methylmercury neurotoxicity in amazonian children downstream from gold mining. Environ Health Perspect 107: 587–591PubMedCentralPubMedGoogle Scholar
  604. 131.
    Grandjean P (1984) Organolead exposures and intoxications. In: Grandjean P (ed) Biological effects of organolead compounds. CRC Press, Boca Raton/FL, pp 227–242Google Scholar
  605. 132.
    Gray JR, Khalil A, Prior JC (1989) Acute arsenic toxicity — an opaque poison. Can Assoc Radiol J 40/4: 226–227PubMedGoogle Scholar
  606. 133.
    Greenberg C, Davies S, McGowan T, Schorer A, Drage C (1979) Acute respiratory failure following severe arsenic poisoning. Chest 76/5: 596–598PubMedGoogle Scholar
  607. 134.
    Grogan DP, Bucholz RW (1981) Acute lead intoxication from a bullet in an intervertebral disc space. A case report. J Bone Joint Surg Am 63/7: 1180–1182Google Scholar
  608. 135.
    Gross M, Oertel M, Köhrle J (1995) Differencial selenium-dependent expression of type I 5’-deiodinase and glutathione peroxidase in the porcine epithelial cell line LLC-PKI. Biochem J 306: 851–856PubMedGoogle Scholar
  609. 136.
    Grunfeld O, Hinostroza G (1964) Thallium poisoning. Arch Int Med 114: 132–138Google Scholar
  610. 137.
    Gulson BL et al. (1998) Blood lead’ urine lead relationships in adults and children. Environ Res 78/2: 152–160PubMedGoogle Scholar
  611. 138.
    Halbach S (1995) Combined estimation of mercury species released from amalgam. J Dent Res 74/4: 1103–1109PubMedGoogle Scholar
  612. 139.
    Heider J, Böck A (1993) Selenium metabolism in micro-organisms. Adv Microbiol Physiol 35: 71–109Google Scholar
  613. 140.
    Heintze U, Edwardsson S, Derand T, Birkhed D (1983) Methylation of mercury from dental amalgam and mercuric chloride by oral Streptococci in vitro. Scand J dent Res 91/2: 150–152PubMedGoogle Scholar
  614. 141.
    Hennekes R (1983) Netzhautfunktionsschädigung bei akuter Thalliumintoxikation. Klein Monatsbl Augenheilkd 182/4: 334–336Google Scholar
  615. 142.
    Henning HV (1989) Die Toxizität des Aluminiums. Klin Wochenschr 67: 1221–1228PubMedGoogle Scholar
  616. 143.
    Henningsson C, Hoffmann S, McGonigle L, Winter JS (1993) Acute mercury poisoning (acrodynia) mimicking pheochromocytoma in an adolescent. J Pediatr 122: 252–253PubMedGoogle Scholar
  617. 144.
    Henschler D (1999) Arsenwasserstoff. In: Gesundheitsschädliche Arbeitsstoffe (Hrsg) Toxikologisch-arbeitsmedizinische Begründung von MAK-Werten (Loseblattsammlung), 28. Lieferung. VCH. WeinheimGoogle Scholar
  618. 145.
    Henschler D, Lehnert G (Hrsg) Biologische Arbeitsstoff-Toleranz-Werte (BAT-Werte) Arbeitsmedizinischtoxikologische Begründungen (Loseblattsammlung). VCH, WeinheimGoogle Scholar
  619. 146.
    Herber RFM (1994) Cadmium. In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 283–297Google Scholar
  620. 147.
    Hernandez AF, Schiaffino S, Ballesteros JL, Gil F, Pia A, Villanueva E (1998) Lack of clinical Symptoms in an acute arsenic poisoning: an unusual case. Vat Hum Toxicol 40/6: 344–345Google Scholar
  621. 148.
    Heydorn K (1970) Environmental Variation of arsenic levels in human blood determined by neutron activation analysis. Clin Chem Acta 28: 349–357Google Scholar
  622. 149.
    Hindmarsh JT, Mc Curdy RF (1986) Clinical and environmental aspects of arsenic toxicity. CRC Crit Rev Clin Lab Sci 23: 315–347Google Scholar
  623. 150.
    Högberg J, Alexander J (1986) Selenium. In: Friberg L, Nordberg GF, Vouk VB (eds) Handbook on the toxicology of metals. vol 2, 2nd edn. Elsevier, Amsterdam, pp 482–520Google Scholar
  624. 151.
    Höring E, Radtke KU, Gaisberg U von (1991) Akute Bleivergiftung. Dtsch Med Wochenschr 116/5: 175–178PubMedGoogle Scholar
  625. 152.
    Hotz P, Boillat MA (1991) Intoxication aigue a l’arsine et a la phosphine. Rev Med Suisse Romande 111/2: 169–173PubMedGoogle Scholar
  626. 153.
    Houeto P, Sandouk P, Baud FJ, Levillain P (1994) Elemental mercury vapour toxicity: treatment and levels in plasma and urine. Hum Exp Toxicol 13/1: 848–852PubMedGoogle Scholar
  627. 154.
    Hsu LF, Lee HS, Chia SE, Sin Fai Lam KN (1999) Acute mercury vapour poisoning in a shipyard worker. A case report. Ann Acad Med Singapore 28: 294–298PubMedGoogle Scholar
  628. 155.
    Huang SY et al. (1998) Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia. Br J Haematol 103: 1092–1095PubMedGoogle Scholar
  629. 156.
    Hursh JB, Clarkson TW, Cherian MG, Vostal JV, Mallie RV (1976) Clearance of Mercury (197Hg, 203Hg) vapor inhaled by human subjects. Arch Environ Health 31/6: 302–309PubMedGoogle Scholar
  630. 157.
    Hursh JB, Clarkson TW, Miles EF, Goldsmith LA (1989) Percutaneous absorption of mercury vapor by man. Arch Environ Health 44/2: 120–127PubMedGoogle Scholar
  631. 158.
    Hursh JB, Greenwood MR, Clarkson TW, Allen J, Demuth S (1980) The effect of ethanol on the fate of mercury vapor inhaled by man. J Pharmacol Exp Ther 214/3: 520–527PubMedGoogle Scholar
  632. 159.
    Hursh JB, Sichak SP, Clarkson TW (1988) In vitro oxidation of mercury by the blood. Pharmacol Toxicol 63/4: 266–273PubMedGoogle Scholar
  633. 160.
    Iffland R (1994) Arsenic In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 238–253Google Scholar
  634. 161.
    Inoe N (1999) Crimes by Thallium. 18th Annual Meeting of JAFT, Fukuoka, Japan, ref. TIAFT Bull 30/2: 17Google Scholar
  635. 162.
    Issekutz B von, Vegh F von (1926) Arch Ex Path Pharmakol 114: 206Google Scholar
  636. 163.
    Jensen AA (1984) Metabolism and toxieokinetics. In: Grandjean P (ed) Biological effects of organolead Compounds. CRC Press, Boca Raton/FL, pp 97–115Google Scholar
  637. 164.
    John BE, Boatright D (1999) Lead toxicity from gunshot wound. South Med J 92/2: 223–224PubMedGoogle Scholar
  638. 165.
    Johnson KG, Evanger A, Van Meter W (1978) Elemental mercury poisoning manifest by acrodynia and neuropenia. Vet Hum Tox 20: 404–409Google Scholar
  639. 166.
    Jolliffe DM, Budd AJ, Gwilt DJ (1991) Massive acute arsenic poisoning. Anesthesia 46/4: 288–290Google Scholar
  640. 167.
    Jones DE, Ledingham KW (1982) Arsenic in Napoleon’s wallpaper. Nature 299: 626–627PubMedGoogle Scholar
  641. 168.
    Joselow MM, Goldwater LJ (1967) Absorption and excretion of mercury in man. XII. Relationship between urinary mercury and proteinuria. Arch Environ Health 15/2: 155–159PubMedGoogle Scholar
  642. 169.
    Julshamn K, Andersen KJ, Svendsen E, Ringdal O, Egholm M (1989) Trace elements intake in the Faroe Islands. III. Element concentrations in human organs in populations from Bergen (Norway) and the Faroe Islands. Sci Total Environ 84: 25–33PubMedGoogle Scholar
  643. 170.
    Kaiser G, Tölg G (1980) Mercury. In: Hutzinger O (ed) Handbook of environmental chemistry, vol 3, part A. Anthropogenic compounds. Springer, Berlin Heidelberg New York, pp 1–58Google Scholar
  644. 171.
    Kehoe RA (1976) Pharmacology and toxicology of heavy metals: lead. Pharmacol Therapy 1: 161–188Google Scholar
  645. 172.
    Kehoe RA, Cholak J, Story RV (1940) A spectrochemical study of the normal ranges of concentration of certain trace metals in biological materials. J Nutr 19: 579–592Google Scholar
  646. 173.
    Keller R, Thimme W, Dissmann W, Buschmann HJ, Dross K, Daugs J (1971) Thalliumvergiftung mit Verbrauchskoagulopathie. Schweiz Med Wochenschr 101/1: 511–515PubMedGoogle Scholar
  647. 174.
    Keiner M (1994) Thallium. In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 601–610Google Scholar
  648. 175.
    Kershaw TG, Clarkson TW, Dhahir PH (1980) The relationship between blood levels and dose of methylmercury in man. Arch Environ Health 35/1: 28–36PubMedGoogle Scholar
  649. 176.
    Kijewski H (1993) Die forensische Bedeutung der Mineralgehalte in menschlichen Kopfhaaren. Schmidt-Römhild, LübeckGoogle Scholar
  650. 177.
    Kjellström T (1979) Exposure and accumulation of cadmium in populations from Japan, the United States and Sweden. Environm Health Perspect 28: 169–197Google Scholar
  651. 178.
    Kjellström T (1986a) Renal Effects. In: Friberg L, Elinder CG, Kjellström T, Nordber G (eds) Cadmium and health: A toxicological and epidemiological appraisal, vol II. CRC Press, Boca Raton/FL, pp 21–110Google Scholar
  652. 179.
    Kjellström T (1986b) Effects on bone, on vitamin D and calcium metabolism. In: Friberg L, Elinder CG, Kjellström T, Nordber G (eds) Cadmium and health: A toxicological and epidemiological appraisal, vol II. CRC Press, Boca Raton/FL, pp 110–158Google Scholar
  653. 180.
    Kjellström T (1986c) Itai-Itai disease In: Friberg L, Elinder CG, Kjellström T, Nordber G (eds) Cadmium and health: A toxicological and epidemiological appraisal, vol II. CRC Press, Boca Raton/FL, pp 257–290Google Scholar
  654. 181.
    Kleber J, Ganzert M, Zilker Th (1995) Quecksilberkonzentration im Urin nach DMPS-Gabe: Korrelation zur Anzahl der Amalgamfüllungen. In: Friberg LT, Schrauzer GN: Status quo and perspectives of amalgam and other dental materials. Thieme, Stuttgart, pp 61–69Google Scholar
  655. 182.
    Klein GL (1991) The aluminium content of parenteral Solutions: Current Status. Nutrition Reviews 49/3: 74–79PubMedGoogle Scholar
  656. 183.
    Klein M, Namer R, Herput E, Corbin R (1979) Earthenware Containers as a source of fatal lead poisoning. New Engl J Med 283: 669–672Google Scholar
  657. 184.
    Kloke A, Eikmann T (1991) Nutzungs-und schutzbezogene Orientierungsdaten für (Schad-)Stoffe in Böden (Eikmann-Kloke-Werte). VDLUFA, Sonderdruck aus Heft 1/1991Google Scholar
  658. 185.
    Köhrle J (1995) Selen-und Jodversorgung — Endokrinologische Zusammenhänge. In: Kruse-Jarres JD (Hrsg) VII. Stuttgarter Mineralstoff-Symposium, Kongressband. Mack, Schönaich, S 61–105Google Scholar
  659. 186.
    Kommission „Human-Biomonitoring“ des Umweltbundesamtes. (1996) Stoffmonographie Blei — Referenzund Human-Biomonitoring-Werte (HBM). Bundesgesundhbl 39: 236–241Google Scholar
  660. 187.
    Kommission „Human-Biomonitoring“ des Umweltbundesamtes. (1998) Stoffmonographie Cadmium — Referenz-und Human-Biomonitoring-Werte (HBM). Bundesgesundhbl 41: 218–226Google Scholar
  661. 188.
    Kommission „Human-Biomonitoring“ des Umweltbundesamtes. (1999) Stoffmonographie Quecksilber — Referenz-und Human-Biomonitoring-Werte (HBM). Bundesgesundhbl 42: 522–532Google Scholar
  662. 189.
    Koo WW, Kaplan LA, Krug-Wispe SK (1988) Aluminum contamination of infant formulas. J Parenteral Enterai Nutr 12/2: 170–173Google Scholar
  663. 190.
    Kopp R (1985) Werkstoffe unter klinischen Aspekten. In: Eichner K (Hrsg) Zahnärztliche Werkstoffe und ihre Verarbeitung, Bd 2, 5. Aufl. Hüthig, HeidelbergGoogle Scholar
  664. 191.
    Koppel C, Baudisch H, Beyer KH, Klöppel I, Schneider V (1986) Fatal poisoning with selenium dioxide. J Toxicol Clin Toxicol 24/1: 21–35PubMedGoogle Scholar
  665. 192.
    Krause C et al. (1989) Umwelt-Survey. Bd I: Studienbeschreibung und Humanbiologisches Monitoring. Deskription der Spurenelementgehalte in Blut, Urin und Haar der Bevölkerung in der Bundesrepublik Deutschland 1985/86. Bundesgesundheitsamt, Berlin, WaBoLu Hefte 5/89Google Scholar
  666. 193.
    Krause C et al. (1991) Umwelt-Survey. Bd IIIb: Wohninnenraum: Trinkwasser. Bundesgesundheitsamt, Berlin WaBoLu Hefte 3/91Google Scholar
  667. 194.
    Krause C et al. (1996) Umweltsurvey 1990/92. Bd la: Studienbeschreibung und Human-Biomonitoring. Deskription der Spurenelementgehalte in Blut und Urin der Bevölkerung in der Bundesrepublik Deutschland. Umweltbundesamt (Hrsg), BerlinGoogle Scholar
  668. 195.
    Krause C, Thron HL, Wagner HM, Flesch-Janys D, Schümann M (1987) Ergebnisse aus Feldstudien über die Belastung der Bevölkerung mit Schwer metallen durch industrielle Quellen. Schriftenreihe Verein WaBoLu 74, Fischer, Stuttgart, S 105–111Google Scholar
  669. 196.
    Kremers L, Halbach S, Willruth H et al. (1999) Effect of rubber dam on mercury exposure during amalgam removal. Eur J Oral Sci 107/3: 202–207PubMedGoogle Scholar
  670. 197.
    Lambeth L (1988) Mercury soaps and skin lightening creams. Directorate of Environmental and Consumer Services, LondonGoogle Scholar
  671. 198.
    Lauwerys R, Bernard A, Roels HA, Buchet JP, Viau C (1984) Characterization of cadmium proteinuria in man and rat. Environm Health Perspect 54: 147–152Google Scholar
  672. 199.
    Lauwerys R, Roels H, Bucher JP, Bernard A Stanescu D (1979) Investigations on the lung and kidney functions in workers exposed to cadmium. Environ Health Perspect 28: 137–145PubMedCentralPubMedGoogle Scholar
  673. 200.
    Leslie ACD, Smith H (1978) Napoleon Bonaparte’s Exposure to Arsenic During 1816. Arch Toxicol 41: 163–167PubMedGoogle Scholar
  674. 201.
    Levin M, Jacobs J, Polos PG (1988) Acute mercury poisoning and mercurial pneumonitis from gold ore purification. Chest 94/3: 554–556PubMedGoogle Scholar
  675. 202.
    Lewin L (1928) Gifte und Vergiftungen. 6. Aufl. 1992. Haug, HeidelbergGoogle Scholar
  676. 203.
    Liesegang D (1987) Schwermetall-Emissionen. In: Lahmann E, Jander K (Hrsg) Schwermetalle in der Umwelt. Schriftenreihe Verein WaBoLu 74, Gustav Fischer, Stuttgart, pp 3–16Google Scholar
  677. 204.
    Lim HE, Shim JJ, Lee SY, Lee SH, Kang SY, Jo Jy (1998) Mercury inhalation poisoning and acute lung injury. Korean J Int Med 13: 127–130Google Scholar
  678. 205.
    Lippmann M (1990) Lead and human health: Background and recent findings. Environm Res 51: 1–24Google Scholar
  679. 206.
    Lockitch G (1989) Selenium: Clinical significance and analytical concepts. Crit Rev Clin Lab Sci 27/6: 483–541PubMedGoogle Scholar
  680. 207.
    Lombeck I, Menzel H, Frosch D (1989) Acute selenium poisoning of a 2-year old child. Eur J Pediatr 146: 308–312Google Scholar
  681. 208.
    Lovell MA, Farmer JG (1985) Arsenic speciation in urine from humans intoxicated by inorganic arsenic compounds. Hum Toxicol 4/2: 203–214PubMedGoogle Scholar
  682. 209.
    Lugo G, Cassady G, Palmisano P (1969) Acute maternal arsenic intoxication with neonatal death. Am J Dis Child 117/3: 328–330PubMedGoogle Scholar
  683. 210.
    Magee RJ, James BD (1994) Selenium. In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 551–562Google Scholar
  684. 211.
    Magos L, et al. (1976) Tissue levels of mercury in autopsy specimens of liver and kidney. Bulletin WHO 53 [Suppl]: 93–97Google Scholar
  685. 212.
    Magos L, Webb M (1980) The interaction of selenium with cadmium and mercury. CRC Crit Rev Toxicol 8: 1–42Google Scholar
  686. 213.
    Mahieu P, Buchet JP, Roels HA, Lauwerys R (1991) The metabolism of arsenic in humans acutely intoxicated by As2 O3. Its significance for the duration of BAL therapy. Clin Toxicol 18/9: 1067–1075Google Scholar
  687. 214.
    Malm O et al (1995b) An assessment of Hg pollution in different gold mining areas, Amazon, Brazil. Sci Tot Environ 175: 141–150Google Scholar
  688. 215.
    Mani J, Chaudhary N, Kanjalkar M, Shah PU (1998) Cerebellar ataxia due to lead eneephalopathy in an adult. J Neurol Neurosurg Psychiatry 65/5: 797PubMedGoogle Scholar
  689. 216.
    Markiewicz J, Kobylecka K (1991) Occupational poisoning by thallium. TIAFT Bull 21: 22–23Google Scholar
  690. 217.
    Markiewicz J, Kobylecka K (1992) A suicidal case of poisoning with a large dose of arsenic trioxide. TIAFT Bulletin 22/4: 26–28Google Scholar
  691. 218.
    Marsh DO, Clarkson TW, Cox C, Myers GJ, Amin-Zaki L, Al-Tikriti S (1987) Fetal methylmercury poisoning. Relationship between concentration in single Strands of maternal hair and child effects. Arch Neurol 44/1: 1017–1022PubMedGoogle Scholar
  692. 219.
    Massey EW, Wold D, Heyman A (1984) Arsenic: homicidal intoxication. South Med J 77/7: 848–851PubMedGoogle Scholar
  693. 220.
    Matoba R, Kimura H, Uchima E et al. (1986) An autopsy case of acute selenium (selenious acid) poisoning and selenium levels in human tissues. Forensic Sci Int 31/2: 87–92PubMedGoogle Scholar
  694. 221.
    Mayer-Popken O, Denkhaus W, Konietzko H (1986) Lead content of fetal tissues after maternal intoxication. Arch Toxicol 58/3: 203–204PubMedGoogle Scholar
  695. 222.
    McFarland RB, Reigel H (1978) Chronic mercury poisoning from a single brief exposure. J Occup Med 20/8: 532–534PubMedGoogle Scholar
  696. 223.
    McMillan TM, Jacobson RR, Gross M (1997) Neuropsychology of thallium poisoning. J Neurol Neurosurg Psychiatry 63/2: 247–250PubMedGoogle Scholar
  697. 224.
    Meggs WK, Glodfrank LR, Shid RD (1994) Thallium poisoning from maliciously contaminated food. J Toxicol Clin Toxicol 32: 723–730PubMedGoogle Scholar
  698. 225.
    Merian E (ed) (1991) Metals and their compounds in the environment. VCH, WeinheimGoogle Scholar
  699. 226.
    Metallgesellschaft AG (Hrsg) (1991) Metallstatistik, 78. Jahrg., Frankfurt a.M.Google Scholar
  700. 227.
    Miller GD, Massaro TF, Massaro EJ (1990) Interactions between lead and essential elements: a review. Neurotoxicology 11: 99–120PubMedGoogle Scholar
  701. 228.
    Milliner DS et al. (1985) Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin replacement solutions. New Engl J Med 312: 165–167PubMedGoogle Scholar
  702. 229.
    Moeschlin S (1986) Klinik und Therapie der Vergiftungen. Thieme, Stuttgart, S 126Google Scholar
  703. 230.
    Moore D, House I (1993) Thallium poisoning: Diagnosis may be elusive but alopecia is the clue. Br Med J 306: 1527–1529Google Scholar
  704. 231.
    Moore MR, Meredith PA, Goldberg A (1980) Lead and heme biosynthesis. In: Singhai RL, Thomas JA (eds) Lead toxicity. Urban & Schwarzenberg, Baltimore, pp 79–118Google Scholar
  705. 232.
    Mühlendahl von KE (1991) Die Feersche Krankheit. Monatsschr Kinderheilk 139/4: 224–227Google Scholar
  706. 233.
    Müller J, Weigert P (1990) Bleigehalt in und auf Lebensmitteln. Bundesgesundheitsamt (Hrsg), ZEBS Hefte 2Google Scholar
  707. ai]234.
    Müller L (1991) Die toxikologische Bewertung. Eine solide Grundlage für den vorsorgenden Gesundheitsschutz? Überlegungen zum Vorsorgecharakter von Richtwerten für (Schwer-)Metall-Kontaminationen auf Kinderspielplätzen. Öff Gesundh Wes 53: 736–745Google Scholar
  708. 235.
    Müller M, Anke M, Illing-G (1998) Aluminium in foodstuffs. Food Chem 61/4: 419–428Google Scholar
  709. 236.
    Muramatsu Y, Parr RM (1988) Concentrations of some trace elements in hair, liver and kidney from autopsy subjects — relationship between hair and internal organs. Sci Tot Environm 76: 29–40Google Scholar
  710. 237.
    National Board of Health and Weifare (ed) (1987) SOS, Mercury/Amalgam — health risks. Report for the LEK Committee, StockholmGoogle Scholar
  711. 238.
    Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN (1990) The long-term effects of exposure to low doses of lead in childhood. N Engl J Med 322: 83–88PubMedGoogle Scholar
  712. 239.
    Neve J (1991) Methods in determination of selenium status. J Trace Elem Electrolytes Health Dis 5: 1–17PubMedGoogle Scholar
  713. 240.
    Newton D, Fry FA (1978) The retention and distribution of radioactive mercuric oxide following accidental inhalation. Ann Occup Hyg21/1: 21–32PubMedGoogle Scholar
  714. 241.
    Nordentoft T, Andersen EB, Mogensen PH (1998) Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning. Neurotoxicology 19/3: 421–426PubMedGoogle Scholar
  715. 242.
    Nowotzki-Grimm S, Grimm P (1997) Selen: Ein essenzielles Spurenelement findet Eingang in die Medizin. Pharm Z 10/142: 11–23Google Scholar
  716. 243.
    Nriagu M (1989) The history of leaded gasoline. 7th Int. Conference on Heavy Metals in the Environment, Genf, Proceedings, vol 2. CEP Consultants, Edinburgh, pp 361–365Google Scholar
  717. 244.
    Nylander M, Friberg L, Lind B (1987) Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed Dent J 11/5: 179–187PubMedGoogle Scholar
  718. 245.
    O’Mahony D, Denton J, Templar J et al. (1995) Bone aluminium content in Alzheimer’s disease. Dementia 6/2: 69–72PubMedGoogle Scholar
  719. 246.
    Ohnesorge K (1992) Grundlagen zur humantoxikologischen Beurteilung von Blei-, Cadmium-und Quecksilberverbindungen. Pflanzliche Arzneimittel in der Diskussion, Tagungsbericht. Atrium, BonnGoogle Scholar
  720. 247.
    Okuda B, Iwamoto Y, Tachibana H, Sugita M (1997) Parkinsonism after cadmium poisoning. Clin Neurol Neurosurg 99/4: 263–265PubMedGoogle Scholar
  721. 248.
    Olson OE (1986) Selenium toxicity in animals with emphasis on man. J Am Coli Toxicol 5: 45–69Google Scholar
  722. 249.
    Orlowski C, Piotrowski JK, Kubow M (1996) The levels of cadmium, zinc and copper in the renal cortex and liver of the inhabitants of the copper basin. Int J Occup Med Einviron Health 9/3: 255–263Google Scholar
  723. 250.
    Orlowski-JP, Mercer-RD (1980) Urine mercury levels in Kawasaki disease Pediatrics 66/4: 633–636Google Scholar
  724. 251.
    Oster O (1992) Zum Selenstatus in der Bundesrepublik Deutschland. Universitäts-Verlag Jena, JenaGoogle Scholar
  725. 252.
    Oster O (1996) Selen — ein essenzielles Spurenelement. Die Situation der Selenversorgung in der Bundesrepublik Deutschland. Medwelt 47: 12–22Google Scholar
  726. 253.
    Oster O, Prellwitz W (1989) The daily dietary selenium intake of West German adults. Biol Trace Elem Res 20/1-2: 1–14PubMedGoogle Scholar
  727. 254.
    Oster O, Prellwitz W (1990) Selenium and cardiovascular disease. Biol Trace Elem Res 24/2: 91–103PubMedGoogle Scholar
  728. 255.
    Oster O, Schmiedel G, Prellwitz E (1988) The organ distribution of selenium in German adults. Biol Trace Element Res 15: 23–45Google Scholar
  729. 256.
    Pawlowicz Z, Zachara BA, Trafikowska U et al. (1991) Blood selenium concentration and glutathione peroxidase activities in patients with breast Cancer and with advanced gastrointestinal cancer. J Trace Elem Electrolyt Health Dis 5: 275–277Google Scholar
  730. 257.
    Pentel P, Fletcher D, Jentzen J (1985) Fatal acute selenium toxicity. J Forens Sci 30/2: 556–562Google Scholar
  731. 258.
    Perazella MA (1996) Lead and the kidney: nephropathy, hypertension, and gout. Conn Med 60/9: 521–526PubMedGoogle Scholar
  732. 259.
    Pfab R, Muckter H, Roider G, Zilker T (1996) Clinical course of severe poisoning with thiomersal. J Toxicol Clin Toxicol 34/4: 453–460PubMedGoogle Scholar
  733. 260.
    Poklis A, Saady JJ (1990) Arsenic poisoning: acute or chronic? Suicide or murder? Am J Forensic Med Pathol 11/3: 226–232PubMedGoogle Scholar
  734. 261.
    Poor G, Mituszova M (1989) Saturnine gout. Baillieres Clin Rheumatol 3: 51–61PubMedGoogle Scholar
  735. 262.
    Pothel C, Brosseau A (1976) Acute arsine poisoning: report of two cases in the Montreal region. J Can Soc For Sci 9: 87–93Google Scholar
  736. 263.
    Pötsch L et al. (1996a) Zum Einbau organischer Substanzen in anagene Haare — Ein biochemisches Konzept. Vortrag bei: Jahrestagung der Dtsch Ges Rechtsmedizin, ZürichGoogle Scholar
  737. 264.
    Pötsch L, Skopp G, Eser HP, Möller MR (1996b) Zum Suchtmittelnachweis in Kopfhaaren. I. Die Abschätzung und Bedeutung des individuellen Haarwachstumsfensters und des intradermalen Abschnittes anagener Haare bei der segmentweisen Haaranalyse. Rechtsmedizin 6: 156–160Google Scholar
  738. 265.
    Pragst F, Rothe M, Spiegel K, Sporkert F (1998) Illegal and therapeutic drug concentrations in hair segments — A time table of drug exposure? Forens Sci Rev 10/2: 81–111Google Scholar
  739. 266.
    Quagliaro DA, Geraci VA, Dwan RE, Kent RS, Olson WP (1988) Aluminium in albumin for injection. J Parenter Sci Technol 42/6: 187–190PubMedGoogle Scholar
  740. 267.
    Rabinowitz MB, Wetherill GW, Kopple JD (1976) Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 58: 260–270PubMedCentralPubMedGoogle Scholar
  741. 268.
    Rae CE, Bell CN, Elliott CE, Shannon M (1991) Ten cases of acute lead intoxication among bridge workers in Luisiana. DICP 25/9: 932–937PubMedGoogle Scholar
  742. 269.
    Rahman H, al-Khayat A, Menon N (1986) Lead poisoning in infancy — unusual causes in the U.A.E. Ann Trop Paediatr 6/3: 213–217PubMedGoogle Scholar
  743. 270.
    Ramirez-Compos J, Ramos-Peek J, Martinez-Barros M et al. (1998) Neuropatia periferica por intoxicacion aguda con arsenico. Gac Med Mex 134/2: 241–246Google Scholar
  744. 271.
    Rat von Sachverständigen für Umweltfragen (1990) Sondergutachten „Altlasten“. Deutscher Bundestag, Drucksache 11/6191Google Scholar
  745. 272.
    Rauschke J (1967) Thallium. In: Ponsold A (Hrsg) Lehrbuch der Gerichtlichen Medizin. Thieme, Stuttgart, S 444–453Google Scholar
  746. 273.
    Reddy CC, Massaro EJ (1983) Biochemistry of selenium: A brief overview. Fundam Appl Toxicol 3/5: 431–436PubMedGoogle Scholar
  747. 274.
    Rehling CL (1967) Poison residues in human tissues. In: Stolman A (ed) Progress in chemical toxicology, vol 3. Academic Press, New York, pp 363–386Google Scholar
  748. 275.
    Richelmi P, Bono F, Guardia L, Ferrini B, Manzo L (1980) Salivary levels of thallium in acute human poisoning. Arch Toxicol 43: 321–325PubMedGoogle Scholar
  749. 276.
    Richlmayer-Lais AM, Kirchgessner M (1981) Zur Essentialität von Blei für das tierische Wachstum. Z Tierphysiol Tierernährg 46: 1–8Google Scholar
  750. 277.
    Roby DS, Fein AM, Bennett RH, Morgan LS, Zatuchni J, Lippmann ML (1984) Cardiopulmonary effects of acute thallium poisoning. Chest 85/2: 236–240PubMedGoogle Scholar
  751. 278.
    Roider G, Drasch G (1999) Concentration of aluminium in human tissues — investigations on an occupationally non-exposed population in Southern Bavaria (Germany). Trace Element Electrolyt 16: 77–86Google Scholar
  752. 279.
    Roider G, Drasch G, Eisenmenger W. (2000) Tod nach intravenöser Infusion einer Aluminium-haltigen Blasenspüllösung. Vortrag bei: 9. Frühjahrstagung der Deutschen Gesellschaft für Rechtsmedizin — Region Süd, NürnbergGoogle Scholar
  753. 280.
    Roman-Franco AA, Turiello M, Albini B, Ossi E, Milgrom F, Andres GA (1978) Anti-basement membrane antibodies and antigen-antibody complexes in rabbits injected with mercuric chloride. Clin Immunol Immunopathol 9/4: 464–481PubMedGoogle Scholar
  754. 281.
    Roses OE et al. (1991) Mass poisoning by sodium arsenite. J Toxicol Clin Toxicol 29/2: 209–213PubMedGoogle Scholar
  755. 282.
    Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: Biochemical role as a component of glutathione peroxidase. Science 179/73: 588–590PubMedGoogle Scholar
  756. 283.
    Rowland IR, Grasso P, Davies MJ (1975) The methylation of mercuric chloride by human intestinal bacteria. Experimentia 31/9: 1064–1065Google Scholar
  757. 284.
    Ruff HA; Bijur PE (1989) The effects of low to moderate lead levels on neurobehavioral functioning in children: toward a conceptual model. J Dev Behav Pediatr 10: 103–109PubMedGoogle Scholar
  758. 285.
    Saager R (1984) Mercury. In: Metallic rawmaterials dictionary. Bank von Tobel-Verlag, ZürichGoogle Scholar
  759. 286.
    Salib E (1998) Alzheimers disease and the aluminium connection: A literature review. Int J Phsychiatry Clin Pract 2: 181–188Google Scholar
  760. 287.
    Salomons W, Förstner U (1984) Metals in the hydrocycle. Springer, Berlin Heidelberg New YorkGoogle Scholar
  761. 288.
    Salvatore D, Bartha T, Harney JW, Larsen PR (1996) Molecular biological and biochemical characterization of the human type 2 selenodeiodase. Endocrinology 137/8: 3308–3315PubMedGoogle Scholar
  762. 289.
    Sassa S (1978) Toxic effects of lead with particular reference to porphyrin and heme metabolism. Handb Exp Pharm 44: 333–371Google Scholar
  763. 290.
    Savory J, Sedor FA, Wills MR (1984) Arsenic. In: Vercruysse A (ed) Hazardous metals in human toxicology. Elsevier, Amsterdam, pp 225–240Google Scholar
  764. 291.
    Savory J, Wills MR (1991) Aluminum. In: Merian E (ed) Metals and their Compounds in the environment. VCH, Weinheim, pp 715–741Google Scholar
  765. 292.
    Schaller K-H (1994) Aluminium. In: Sciler HG, Sigel A, Sigel H (eds) Handbook on metals in clinical and analytical chemistry. Dekker, New York, pp 217–226Google Scholar
  766. 293.
    Schaller KH, Manke G, Raithel HJ, Buhlmeyer G, Schmidt M, Valentin H (1980) Investigations of thallium-exposed workers in cement factories. Int Arch Occup Environ Health 47/3: 223–231PubMedGoogle Scholar
  767. 294.
    Schellmann B, Raithel HJ, Schaller KH (1986) Acute fatal selenium poisoning — Toxicological and occupational medical aspects. Arch Toxicol 59: 61–63PubMedGoogle Scholar
  768. 295.
    Schiele R, Schaller KH, Welte D (1989) Mobilisation von Quecksilber-Speicherungen im Organismus mittels DMPS (Dimaval). Arbeitsmed Sozialmed Präventivmed 24: 249–251Google Scholar
  769. 296.
    Schmidt D, Bach M, Gerling J (1997) A case of localized retinal damage in thallium poisoning. Int Ophthalmol 21/3: 143–147PubMedGoogle Scholar
  770. 297.
    Schmidt G (1954) Arsenbefunde in Leichenaschen. Dtsch Z Ges Gerichtl Med 43: 245–251Google Scholar
  771. 298.
    Schneider V, Klug E (1976) Selbsttötung durch Einnahme von Arsentrichlorid. Z Rechtsmed 78/1: 83–90PubMedGoogle Scholar
  772. 299.
    Schoolmeester WL, White DR (1980) Arsenic poisoning. South Med J 73/2: 198–208PubMedGoogle Scholar
  773. 300.
    Schrauzer GN (1993) Selen — Natürlicher Schutzstoff bei Quecksilberbelastungen. In: Becker W (Hrsg) Ganzheitliche Zahnheilkunde in der Praxis. Spitta, Balingen, S 3–28Google Scholar
  774. 301.
    Schwablein-Sprafke U (1985) Multiple Basaliome als Spätfolge einer akuten iatrogenen Arsenvergiftung im Kindesalter. Dermatol Monatsschr 171/7: 443–448PubMedGoogle Scholar
  775. 302.
    Schwartz K, Foltz CM (1957) Selenium is an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc 79: 3292–3293Google Scholar
  776. 303.
    Schwerd W (1969) Bleibefunde bei tödlichen Bleivergiftungen. Arch Toxicol 18: 177–186Google Scholar
  777. 304.
    Schwörer I, Kaul A, Stolpmann HJ, Hunger J (1983) Bleieinlagerungen im Knochen — Röntgenaufnahme als Nachweismethode? ROFO 138: 84–94PubMedGoogle Scholar
  778. 305.
    Sciler HG, Sigel A, Sigel H (eds) (1994) Handbook on metals in clinical and analytical chemistry. Dekker, New YorkGoogle Scholar
  779. 306.
    Selbst SM, Henretig FM, Pearce J (1985) Lead encephalopathy. a case report and review of management. Clin Pediatr Phila 24/5: 280–282PubMedGoogle Scholar
  780. 307.
    Sherlock J, Hislop J, Newton D, Topping G, Whittle K (1984) Elevation of mercury in human blood from controlled chronic ingestion of methylmercury in fish. Hum Toxicol 3/2: 117–131PubMedGoogle Scholar
  781. 308.
    Sherrard DJ, Andress DL (1989) Aluminum-related osteodystrophy. Adv Intern Med 34: 307–324PubMedGoogle Scholar
  782. 309.
    Sigerman A (1984) Exposure to toxic metals: Biological effects and their monitoring. In: Vercruysse A (ed) Hazardous metals in human toxicology, part B. Elsevier, Amsterdam, pp 17–93Google Scholar
  783. 310.
    Sikorski R, Juszkiewicz T, Paszkowski T, Szprengier-Juszkiewicz T (1987) Women in dental surgeries: reproductive hazards in occupational exposure to metallic mercury. Int Arch Occup Environ Health 59: 551–557PubMedGoogle Scholar
  784. 311.
    Simons TJ (1993) Lead-calcium interactions in cellular lead toxicity. Neurotoxicology 14/2-3: 77–85PubMedGoogle Scholar
  785. 312.
    Sioris LJ, Guthrie K, Pentel PR (1980) Acute selenium poisoning. Vet Hum Toxicol 22: 364–372Google Scholar
  786. 313.
    Sjøgren B, Elinder CG, Lidums V, Chang G (1988) Uptake and urinary excretion of aluminum among weiders. Int Arch Occup Environ Health 60/2: 77–79PubMedGoogle Scholar
  787. 314.
    Smith DH, Doherty RA (1964) Thallitoxicosis: report of three cases in Massachusetts. Pediatrics 34: 480–490PubMedGoogle Scholar
  788. 315.
    Specht W, Katte W (1954) Giftverdacht? Kriminalistik-Verlag, zit. nach Geldmacher-von Mallinckrodt M (1975) Forensische Toxikologie. In: Mueller B (Hrsg) Gerichtliche Medizin, Teil 2, 2. Aufl. Springer, Berlin, Heidelberg New York, S 717Google Scholar
  789. 316.
    Stadtman TC (1990) Selenium biochemistry. Annu Rev Biochem 59: 111–127PubMedGoogle Scholar
  790. 317.
    Statistisches Bundesamt (Hrsg) (1993) Statistisches Jahrbuch 1993 für das Ausland. Metzler Poeschel, Stuttgart, S 262Google Scholar
  791. 318.
    Stoeppler M (1991) Cadmium. In: Merian E (ed) Metals and their Compounds in the environment. VCH, Weinheim, pp 803–852Google Scholar
  792. 319.
    Subramanian KS, Meranger JC, Burnett RT (1985) Kidney and liver levels of some major, minor and trace elements in two Ontario communities. Sci Total Environ 42: 223–235PubMedGoogle Scholar
  793. 320.
    Sun X, Tian X, Tomsig JL, Suszkiw JB (1999) Analysis of differential effects of Pb2+ on protein kinase C isozymes. Toxicol Appl Pharmacol 156/1: 40–45PubMedGoogle Scholar
  794. 321.
    Sunde RA (1990) Molecular biology of selenoproteins. Annu Rev Nutr 10: 451–474PubMedGoogle Scholar
  795. 322.
    Takeuchi T, Eto K, Oyanag S, Miyajima H (1978) Ultrastructural changes of human sural nerves in the neuropathy induced by intrauterine methylmercury poisoning (so-called fetal Minamata disease). Virchows Arch B Cell Pathol 27/2: 137–154PubMedGoogle Scholar
  796. 323.
    Teitelbaum DT, Kier LC (1969) Arsine poisoning. Arch Eniron Health 19: 133–143Google Scholar
  797. 324.
    Tipton IH, Cook MJ (1963) Trace elements in human tissue — Part II — Adult subjects from the United States. Health Phys 9: 103–145PubMedGoogle Scholar
  798. 325.
    Tiran B, Karpf E, Tiran A (1995) Age dependency of selenium and cadmium content in human liver, kidney and thyroid. Arch Environ Health 50: 242–246PubMedGoogle Scholar
  799. 326.
    Tötsch W (1990) Cadmium — uses and possibilities of substitution. Toxicol Environm Chem 27: 123–130Google Scholar
  800. 327.
    Tromme I, Van Neste D, Dobbelaere F et al. (1998) Skin signs in the diagnosis of thallium poisoning. Br J Dermatol 138/2: 321–325PubMedGoogle Scholar
  801. 328.
    Umweltbundesamt (Hrsg) (1981) Cadmium-Bericht. UBA Texte 1/81, BerlinGoogle Scholar
  802. 329.
    Umweltbundesamt (Hrsg) (1992) Daten zur Umwelt 1990/91. Erich Schmidt, BerlinGoogle Scholar
  803. 330.
    Umweltbundesamt (Hrsg) (1994) Daten zur Umwelt 1992/93. Erich Schmidt, BerlinGoogle Scholar
  804. 331.
    Vahter M (ed) (1982) Assessment of human exposure to lead and cadmium through biological monitoring. Report prepared for the UN WHO. National Swedish Institute of Environmental Medicine and Karolinska Institute, StockholmGoogle Scholar
  805. 332.
    Vahter M, Berglund M, Slorach S et al. (1991) Methods for the integrated exposure monitoring of lead and cadmium. Environm Res 56: 78–89Google Scholar
  806. 333.
    Valentine JL, Kang HK, Spivey G (1979) Arsenic level in human blood, urine and hair in response to exposure via drinking water. Environ Res 20: 24–32PubMedGoogle Scholar
  807. 334.
    Van de Vyver FL, Visser WJ, D’Haese PC et al. (1989) Risk of aluminium intoxication in long-term acetate Redy dialysis. Nephrol Dial Transplant 4/6: 555–562PubMedGoogle Scholar
  808. 335.
    Van der Voet GB, De Wolff F A (1984) A method of studying the intestinal absorption of aluminium in the rat. Arch Toxicol 55: 168–172PubMedGoogle Scholar
  809. 336.
    Vance MV, Curry SC, Bradley JM et al. (1990) Acute lead poisoning in nursing home and Psychiatric patients from the ingestion of lead-based ceramic glazes. Arch Intern Med 150: 2085–2092PubMedGoogle Scholar
  810. 337.
    Vercruysse A (1984) Hazardous metals in human toxicology, part B. Elsevier, AmsterdamGoogle Scholar
  811. 338.
    Verity MA (1990) Comparative observations on inorganic and organic lead neurotoxicity. Environ Health Perspect 89: 43–48PubMedCentralPubMedGoogle Scholar
  812. 339.
    Villanueva E, Hernandez-Cueto C, Lachica E (1990) Poisoning by thallium: a study of five cases. Drug Safety 5: 384–389PubMedGoogle Scholar
  813. 340.
    Vimy MJ, Lorscheider FL (1985) Serial measurements of intra-oral air mercury: estimation of daily dose from dental amalgam. J Dent Res 64/8: 1072–1075PubMedGoogle Scholar
  814. 341.
    Vimy MJ, Luft AJ, Lorscheider FL (1986) Estimation of mercury body bürden from dental amalgam: computer Stimulation of a metabolic compartmental model. J Dent Res 65/12: 1415–1419PubMedGoogle Scholar
  815. 342.
    Wang ST, Pizzolato S, Demshar HP (1991) Aluminum levels in normal human serum and urine as determined by zeeman atomic absorption spectrometry. J Anal Toxicol 15: 66–70PubMedGoogle Scholar
  816. 343.
    Warren JA (1982) A fatal poisoning involving mercury containing fungicide. TIAFT Bulletin 16/3: 16–17Google Scholar
  817. 344.
    Weast RC, Astle MJ (1983) Handbook of chemistry and physics, 4th edn. CRC Press, Boca Raton/FLGoogle Scholar
  818. 345.
    Wedeen RP, D’Haese P, Van-de-Vyver FL et al. (1986) Lead nephropathy. Am J Kidney Dis 8/5: 380–383PubMedGoogle Scholar
  819. 346.
    Weinig E, Schmidt G (1962) Über den Konzentrationsabfall des Thalliums im Harn bei subletalen Vergiftungen am Menschen. Beitr Gerichtl Med 22: 331–343Google Scholar
  820. 347.
    Weinig E, Zink P (1967) Über die quantitative massenspekrometrische Bestimmung des normalen Thallium-Gehaltes im menschlichen Organismus. Arch Toxicol 22: 255–274Google Scholar
  821. 348.
    Welter A, Michaux M, Blondeel A (1982) Lignes de Mees dans un cas d’intoxication aigua a l’arsenic. Dermatologica 165/5: 482–483PubMedGoogle Scholar
  822. 349.
    WHO (1976) Environmental Health Criteria 71: Pentachlorophenol. GenfGoogle Scholar
  823. 350.
    WHO (1977) Environmental Health Criteria 3: Lead. GenfGoogle Scholar
  824. 351.
    WHO (1987) Environmental Health Criteria 58: Selenium. GenfGoogle Scholar
  825. 352.
    WHO (1988) Environmental Health Criteria 85: Aluminium. GenfGoogle Scholar
  826. 353.
    WHO (1989) Environmental Health Criteria 86: Mercury — Environmental Aspects. GenfGoogle Scholar
  827. 354.
    WHO (1990) Environmental Health Criteria 101: Methylmercury. GenfGoogle Scholar
  828. 355.
    WHO (1991) Environmental Health Criteria 118: Inorganic Mercury. GenfGoogle Scholar
  829. 356.
    WHO (1991) Environmental Health Criteria 118: Inorganic Mercury. GenfGoogle Scholar
  830. 357.
    WHO (ed) (1972) Evaluation of certain food additives and the contaminants mercury, lead and cadmium. 16th Report of the Joint FAO/WHO expert committee on food additives. WHO Technical Report Series 505, GenfGoogle Scholar
  831. 358.
    WHO (ed) (1989) Toxicological evaluation of certain food additives and contaminants. 33rd Report of the Joint FAO/WHO expert committee on food additives. WHO Technical Report Series 776, GenfGoogle Scholar
  832. 359.
    Widy W (1959) Die Pigmentansammlungen in den Haarwurzeln bei Thalliumvergiftung. Hautarzt 10:216–221PubMedGoogle Scholar
  833. 360.
    Wigg NR, Vimpani GV, McMichael AJ et al. (1988) Port Pirie Cohort study: childhood blood lead and neuropsychological development at age two years. J Epidemiol Community Health 42/3: 213–219PubMedGoogle Scholar
  834. 361.
    Wilhelm M, Höhr D, Abel J, Ohnesorge F (1989) Renal aluminium excretion. Biol Trace Elem Res 21: 241–245PubMedGoogle Scholar
  835. 362.
    Wilhelm M, Jäger D, Ohnesorge F (1990) Aluminium toxicokinetics. Pharmakol Toxicol 66: 4–9Google Scholar
  836. 363.
    Wilhelm M, Lombeck I, Kouros B, Ohnesorge FK (1994) Dietary intakes os arsenic, cadmium, lead and mercury by German children measured by the duplicate method. Zbl Hyg 195/3: 203–209Google Scholar
  837. 364.
    Wilhelm M, Sprenger K, Vossas U, Ohnesorge F. (1987) Aluminum load in chronic intermittent plasma exchange. Clin Toxicol. 25/3: 209–220Google Scholar
  838. 365.
    Wong SS, Tan KC, Goh CL (1998) Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol 38: 179–185PubMedGoogle Scholar
  839. 366.
    Yeates KO, Mortensen ME (1994) Acute and chronic neurophysiological consequences of mercury vapor poisoning in two early adolescents. J Clin Exp Neuropsych 16: 209–222Google Scholar
  840. 367.
    Yeh J-Y, Beilstein MA, Andrews JS, Whanger PD. (1995) Tissue distribution and influence of selenium Status on levels of selenoprotein W. FASEB J 9/5: 392–396Google Scholar
  841. 368.
    Yoshida M, Satoh H, Igarashi M, Akashi K, Yamamura Y, Yoshida K (1997) Acute mercury poisoning by intentional ingestion of mercuric chloride. Tohoku J Exp Med 182/4: 347–352PubMedGoogle Scholar
  842. 369.
    Yoshinaga J et al. (1990) Interrelationship between the concentrations of some elements in the organs of Japanese with special reference to selenium-heavy metal realtionsship. Sci Total Environ 91: 127–140PubMedGoogle Scholar
  843. 370.
    Young VR, Nahapetian A, Janghorbani M (1982) Selenium bioavailability with reference to human nutrition. Am J Clin Nutr 35: 1076–1087PubMedGoogle Scholar
  844. 371.
    Yukawa M, Suzuki-Yasumoto M, Amano K, Terai M. (1980) Distribution of trace elements in human body determined by neutron activation analysis. Arch Environ Health 35: 36–44PubMedGoogle Scholar
  845. 372.
    Zumkley H, Bertram HP, Brandt M, Roedig M, Spieker S, Kisters K (1987) Aluminiumkonzentration in Knochen und Gehirn nach Antacidagabe. Fortschr Med [Suppl] 19: 15–18Google Scholar
  846. 1.
    Berg S (1984) Grundriss der Rechtsmedizin. Müller & Steineicke, MünchenGoogle Scholar
  847. 2.
    Breitenecker L (1938) Über die Ausscheidungsgeschwindigkeit des CO. Beitr Gerichtl Med 14: 98–137Google Scholar
  848. 3.
    Breitenecker L (1940) Kohlenoxyd. In: Von Neureiter, Pietrusky, Schutt (Hrsg) Handwörterbuch der gerichtlichen Medizin und naturwissenschaftlichen Kriminalistik. Springer, Berlin, S 401Google Scholar
  849. 4.
    Chen S, Wu SM, Kou HS, Wu HL (1994) Electron-capture gas Chromatographie determination of Cyanide, iodide, nitrite and thioeyanate anions. J Anal Tox 18: 81–85Google Scholar
  850. 5.
    Choc MG, Caughey WS (1981) Evidence from infrared and 13C-NMR spectra for discrete rapidly interconverting conformers at ten carbon monoxid binding sites of hemoglobine A and Zürich. Biol Chem 256: 1831–1838Google Scholar
  851. 6.
    Cook M, Simon PA, Hoffmann RE (1995) Unintenional carbon monoxide poisoning in Colorado, 1986 through 1991. Am J Public Health 85: 988–990PubMedGoogle Scholar
  852. 7.
    Deutsche Forschungsgemeinschaft (DFG) MAK-und BAT-Werte-Liste 1999, Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, Mitteilung 35. Wiley-VCH, WeinheimGoogle Scholar
  853. 8.
    Egekeze JO, Oehme FW (1979) Direct Potentiometrie method for the determination of cyanide in biological materials. J Anal Tox 3: 119–124Google Scholar
  854. 9.
    Falke KJ, Rossaint R, Pison U, Zapol WW (1991) Inhaled nitric oxide selectively reduces hypertension in severe ARDS. Am Rev Resp Dis 143: A248Google Scholar
  855. 10.
    Feldstein M, Klendshoj NC (1954) The determination of Cyanide in biologic fluids by microdiffusion analysis. J Lab Clin Med 44: 166–170PubMedGoogle Scholar
  856. 11.
    Feldstein M, Klendshoj NC (1958) The determination of volatile substances by microdiffusion analysis. J For Sci 2: 39–58Google Scholar
  857. 12.
    Forth W, Henschler D, Runge W, Stork K (Hrsg) (1996) Pharmakologie und Toxikologie. Spektrum, HeidelbergGoogle Scholar
  858. 13.
    Goldsmith JR, Landaw SA (1968) Carbon monoxide and human health. Science 162: 1352–1359PubMedGoogle Scholar
  859. 14.
    Hallermann W, Pribilla O (1959) Tödliche Vergiftungen mit Phosphorwasserstoff. Arch Toxikol 17: 219–242Google Scholar
  860. 15.
    Hardy KR, Thom SR (1994) Pathophysiology and treatment of carbon monoxide poisoning. J Toxicol Clin Toxicol 32: 613–629PubMedGoogle Scholar
  861. 16.
    Heilmeyer L (1933) Medizinische Spektrophotometrie. Fischer, JenaGoogle Scholar
  862. 17.
    Henningfield E, Stitzer ML, Griffith RR (1980) Exspired carbon monoxide accumulation and elimination as a function of number of cigarettes smoked. Addict Behav 5: 265–272PubMedGoogle Scholar
  863. 18.
    Henze O (1995) Die Kohlenmonoxidelimination aus dem Blut von Rauchern als Modell für die Eliminationskinetik sehr niedriger Kohlenmonoxidkonzentrationen im Blut. (Inaugural-)Dissertation, GöttingenGoogle Scholar
  864. 19.
    Hoffmann J (1997) Automatisierte Messung von Carboxyhämoglobin-Konzentrationen in Blutstropfen mittels Fourier-Transformations-Infrarot-Mikroskopie (FTIR-M). (Inaugural-)Dissertation, GöttingenGoogle Scholar
  865. 20.
    Hoffmeister A (1997) Trocknungs-und Feuchtigkeitseinflüsse auf die Kohlenmonoxidkonzentration in Blutproben und deren Konzentrationsbestimmung mittels der Fourier-Transform-Infrarot-Spektrometrie. (Inaugural-) Dissertation, GöttingenGoogle Scholar
  866. 22.
    Hofmann M (1995) FTIR-spektroskopische Untersuchung der Stabilität des COHb-Komplexes. (Inaugural-) Dissertation, GöttingenGoogle Scholar
  867. 23.
    Holzbrecher M, Ellenberger HA (1985) An evaluation and modification of a microdiffusion method for the emergency determination of blood cyanide. J Anal Tox 9: 251–253Google Scholar
  868. 24.
    Hüfner G (1902) Über das Gesetz der Verteilung des Blutfarbstoffs zwischen Kohlenoxid und Sauerstoff. Arch exper Pathol Pharmakol 48: 87–99Google Scholar
  869. 25.
    Iffland R, Madea B, Balling P (1988) Diagnose Kohlenmonoxidvergiftung. Arch Kriminol 182: 100–106PubMedGoogle Scholar
  870. 26.
    Iffland R, Sticht G (1972) Gaschromatographisches Verfahren zur Bestimmung des Kohlenmonoxidgehaltes im Blut. Arch Toxikol 29: 325–330PubMedGoogle Scholar
  871. 27.
    Kampmann H, Kijewski H (1992) Unklare Todesfälle am Arbeitsplatz. In: Berg S (Hrsg) Unerwartete Todesfälle. Springer, Berlin Heidelberg New YorkGoogle Scholar
  872. 28.
    Kijewski H, Seefeld KP, Pöhlmann KP (1985) Eine neue Technik zur Bestimmung von Carboxyhämoglobin in flüssigem und trockenem Blut durch Fourier-Transform-Infrarotspektroskopie. Z Rechtsmed 95: 67–74PubMedGoogle Scholar
  873. 29.
    Kijewski H, Hofmann M, Henze O, Hoffmann J, Hoffmeister A, Frisch S, Briese BH. (2000) Möglichkeiten und Grenzen des Einsatzes der Fourier-Transform-Infrarot (FTIR)-Spektrophotometrie zur Kohlenoxid-Hämoglobin-( COHb)-Bestimmung. Rechtsmedizinische Forschungsergebnisse. Schmidt-Römhild, Lübeck, S 365–395Google Scholar
  874. 30.
    Klöppel A, Weiler G (1986) Fäulnisbedingte Konzentrationsänderungen und zeitliche Nachweisbarkeit von Kohlenmonoxid in Leichenblutproben. Rechtsmed 97:105–109Google Scholar
  875. 31.
    Lewin L (1920) Die Gifte in der Weltgeschichte. Springer, Berlin, Lizenzausgabe Parkland 2000Google Scholar
  876. 32.
    Lochte T (1932) Über die Kronenbildung des auffallenden Bluttropfens und ihre Beziehungen zu sekundären Blutspritzern. Dtsch Z Gerichtl Med 22: 387–396Google Scholar
  877. 33.
    Ludewig R (1999) Akute Vergiftungen. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  878. 34.
    Marley WG (1935) Gas Journal (London) 209: 314Google Scholar
  879. 35.
    Marquardt H, Schäfer S (Hrsg) (1997) Toxikologie. Spektrum, HeidelbergGoogle Scholar
  880. 36.
    May J (1941) Beziehungen zwischen Kohlenoxidkonzentration der Luft und Kohlenoxydhämoglobingehalt des Blutes. Arch Gewerbepathol 10: 97Google Scholar
  881. 37.
    McAnalley BH, Lowry WT, Oliver RD, Garriott JC (1979) Determination of inorganic sulfide and cyanide in blood using specific ion electrodes: application to the investigation of hydrogen sulfide and cyanide poisoning. J Anal Tox 3: 111–114Google Scholar
  882. 38.
    Mutschier E (1997) Arzneimittelwirkungen. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  883. 39.
    Nicolet Analytical Instruments (1986) FT-IR Theory. Nicolet Instruments Corporation, MadisonGoogle Scholar
  884. 40.
    Oberdisse E, Hackenthal E, Kuschinsky K (1999) Pharmakologie und Toxikologie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  885. 41.
    Pankow D (1981) Toxikologie des Kohlenmonoxids. VEB Volk und Gesundheit, BerlinGoogle Scholar
  886. 42.
    Sammek R, Züchner K (1998) Verzögerter Kohlendioxid-Konzentrationsausgleich in einem „Rooming-In-Bett“. In: Saternus KS, Karimow S (Hrsg) Säuglingssterblichkeit. Rechtsmedizinische Forschungsergebnisse, Bd 18. Schmidt-Römhild, Lübeck, S 127–133Google Scholar
  887. 43.
    Schlag G, Redl H (Hrsg) (1994) Shock, sepsis and organ failure — nitric oxide. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  888. 44.
    Schütz H, Machbert G (1988) Deutsche Forschungsgemeinschaft (DFG) Photometrische Bestimmung von Carboxy-Hämoglobin (COHb) im Blut. VCH, WeinheimGoogle Scholar
  889. 45.
    Schwarzacher W (1922) Die Anwendung der spektrophotometrischen Blutuntersuchung in der gerichtlichen Medizin. Dtsch Z Ges Gerichtl Med 1: 411–422Google Scholar
  890. 46.
    Schwerd W (1962) Der rote Blutfarbstoff und seine wichtigsten Derivate. Schmidt-Römhild, LübeckGoogle Scholar
  891. 47.
    Schwerd W, Schwemmer H (1957) Der Einfluss der Alterung von Blutproben auf das Ergebnis der spektrophotometrischen Kohlenoxydbestimmung. Arch Toxikol 16: 393–400PubMedGoogle Scholar
  892. 48.
    Sjöstrand T (1952) The formation of carbon monoxide by the decomposition of haemoglobin in vivo. Acta Physiol Scand 26: 338–344PubMedGoogle Scholar
  893. 49.
    Spencer J, Johansson A (1989) CO and Suicide. Aust Nz J Psych 23: 312–313Google Scholar
  894. 50.
    Thieme, Mattig (1992) Kohlenmonoxid-Hämoglobin-Konzentrationen bei Intoxikationen im Stadium der Raumluftsättigung. Z Rechtsmed 2: 59–62Google Scholar
  895. 51.
    Woodman G, Wintoniuk DM, Taylor RG, Clarke SG (1987) Time course of endexspired carbon monoxide concentration is important in studies of cigarette smoking. Clin Sci 73: 553–555PubMedGoogle Scholar
  896. 1.
    Aderjan R, Hofmann S, Schmidt G, Skopp G (1995) Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection. J Anal Toxicol 19: 163–168PubMedGoogle Scholar
  897. 2.
    Aderjan R, Skopp G (1998) Formation and clearance of active and inactive metabolites of opiates in humans. Ther Drug Monit 20: 561–569PubMedGoogle Scholar
  898. 3.
    Balabanowa S, Schneider E (1990) Detection of drugs in sweat. Beitr Gerichtl Med 48: 45–49Google Scholar
  899. 4.
    Baumgartner AM, Jones PF, Baumgartner WA, Black CT. (1979) Radioimmunoassay of hair for determining opiate-abuse histories. J Nucl Med 20: 748–752PubMedGoogle Scholar
  900. 5.
    Bogusz MJ, Maier RD, Driessen S (1997) Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionisation-mass spectrometry-liquid chromatography in body fluids of heroin victims. J Anal Toxicol 21: 346–355PubMedGoogle Scholar
  901. 6.
    Burchel B, Ebner T, Bairds et al. (1994) Use of cloned and expressed human liver UDP-glucuronosyltransferases for the analysis of drug glucuronide formation and assessment of drug toxicity. Environ Health Perspect 102 [Suppl 9]: 19–23Google Scholar
  902. 7.
    ElSohly HN, ElSohly MA, Stanford DF (1990) Poppy seed ingestion and opiates in urinalysis: a closer look. J Anal Toxicol 14: 308–310PubMedGoogle Scholar
  903. 8.
    Fogerson R, Schoendorfer D, Fay J, Spiehler V (1997) Qualitative detection of opiates in sweat by EIA and GC/MS. J Anal Toxicol 21: 451–458PubMedGoogle Scholar
  904. 9.
    Goldberger BA, Cone EJ, Grant TM et al. (1994) Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol 18: 22–28PubMedGoogle Scholar
  905. 10.
    Gorodetzky CW, Kullberg MP (1974) Validity of Screening methods for drugs of abuse in biological fluids II. Heroin in plasma and saliva. Clin Pharmacol Ther 15: 579–587PubMedGoogle Scholar
  906. 11.
    Häckel R, Häckel P (1993) The application of saliva, Perspiration and tear fluid for diagnostic purposes. Ann Clin Biochem 50: 903–910Google Scholar
  907. 12.
    Häckel R, Häckel P (1996) Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem 34:171–191Google Scholar
  908. 13.
    Huwyler J, Drewe, J, Klusemann C, Fricker G (1996) Evidence for glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Clin Pharmacol 118: 1879–1885Google Scholar
  909. 14.
    Inturissi CE, Max MB, Foley KM et al. (1984) The pharmacokinetics of heroin in patients with chronic pain. New Eng J Med 310: 213–218Google Scholar
  910. 15.
    Ishiyama I, Nagai T, Komuro E, Momose T, Akimori N (1979) The significance of drug analysis of Perspiration in respect to rapid Screening of drug abuse. Z Rechtmed 82: 251–256Google Scholar
  911. 16.
    Jenkins AJ, Oyler JM, Cone EJ (1995) Comparison of heroin and cocaine concentrations in saliva with concentration in blood and plasma. J Anal Toxicol 19: 359–374PubMedGoogle Scholar
  912. 17.
    Kauert G, Röhrich J (1996) Concentrations of delta-9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers. Int J Legal Med 108: 294–299PubMedGoogle Scholar
  913. 18.
    Keats AS (1985) The effects of drugs on respiration in man. Ann Rev Pharmacol 25: 41–65Google Scholar
  914. 19.
    Kintz P, Bündele P, Brenneisen R, Ludes B (1998) Dose concentration relationships in hair from subjects in a controlled heroin-maintenance program. J Anal Toxicol 22: 231–236PubMedGoogle Scholar
  915. 20.
    Klinder K (1998) Stoffwechsel und Pharmakokinetik des Dihydrocodeins als Therapeutikum und Drogenersatzstoff beim Menschen. Dissertation, Universität HeidelbergGoogle Scholar
  916. 21.
    Klingmann A, Skopp G, Pedal I, Pötsch L, Aderjan R. (2000) Verteilung von Morphin-und Morphinglucuroniden in Körpergewebe und-flüssigkeiten — Postmortale Befunde bei kurzer Überlebenszeit. Arch Kriminol 206: 38–49PubMedGoogle Scholar
  917. 22.
    Koren G, Klein J (1992) Post-mortem redistribution of morphine in the heart blood of rats. Ther Drug Monit 14: 461–463PubMedGoogle Scholar
  918. 23.
    Letrent SP, Polli JW, Humphreys JE et al. (1999) P-Glycoprotein-mediated transport of morphine in brain capillary cells. Biochem. Pharmacol 58: 951–957PubMedGoogle Scholar
  919. 24.
    Logan BK, Smirnow D (1996). Postmortem distribution and redistribution of morphine in man. J Forens Sci 41: 37–46Google Scholar
  920. 25.
    Lötsch J, Kobal G, Stockmann A, Brune K, Geisslinger G (1997) Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology 87: 1348–1358PubMedGoogle Scholar
  921. 26.
    Martin WR (1983) Pharmacology of opioids. Pharmacol Reviews 35/4: 283–323Google Scholar
  922. 27.
    Melzack R (1991) Morphium und schwere chronische Schmerzen. Spektrum, Heidelberg, Sonderdruck, S 2–10Google Scholar
  923. 28.
    Minn A, Ghersi-Egea JF, Perrin R, Leiniger B, Siest G. (1991) Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Research Reviews 16: 65–82PubMedGoogle Scholar
  924. 29.
    Moriya F, Hashimoto Y (1997) Distribution of free and conjugated morphine in body fluids in a fatal heroin overdose: Is conjugated morphine stable in postmortem specimens. J Forens Sci 42: 736–740Google Scholar
  925. 30.
    Oberst FW (1942) Morphin im Schweiss. J Pharm Exp Ther 74: 37Google Scholar
  926. 31.
    Osborne R, Joel S, Slevin ML (1986) Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Brit Med J 292: 1548–1549Google Scholar
  927. 32.
    Osborne RJ, Joel SP, Trew D, and Slevin ML (1988) Analgesic activity of morphine-6-glucuronide. Lancet I (8589): 828Google Scholar
  928. 33.
    Osborne RJ, Joel SP, Slevin ML (1990) Morphine and metabolite behaviour after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 47: 12–19PubMedGoogle Scholar
  929. 34.
    Pasternak GW, Childers SH, Snyder SR (1980) Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science 208: 514–516PubMedGoogle Scholar
  930. 35.
    Pragst F, Spiegel F, Leuschner U, Hager A (1999) Detection of 6-acetylmorphine in vitreous humor and cerebrospinal fluid — comparision with urinary analysis for proving heroin administration in opiate fatalities. J Anal Toxicol 23: 168–172PubMedGoogle Scholar
  931. 36.
    Püschel K, Thomasch P, Arnold W (1983) Opiate levels in hair. Forensic Sci Int 21: 181–186PubMedGoogle Scholar
  932. 37.
    Schulz M, Schmoldt A (1994) Zusammenstellung therapeutischer und toxischer Plasmakonzentrationsbereiche von Arzneistoffen. Anästhesist 43: 835–844Google Scholar
  933. 38.
    Selavaka CM (1991) Poppy seed ingestion as a contribution factor to opiate positive urinlysis results. J Forens Sci 36: 685–696Google Scholar
  934. 39.
    Skopp G, Ganßmann B, Cone EJ, Aderjan R (1996) Plasma concentrations of morphine and morphine glucuronides after intranasal and intramuscular heroin. J Anal Toxicol 21: 105–111Google Scholar
  935. 40.
    Skopp G, Lutz R, Ganßmann B, Mattern R, Aderjan R. (1996) Post mortem distribution of morphine and morphine glucuronides in heroin overdose. Int J Legal Med 109: 118–124PubMedGoogle Scholar
  936. 41.
    Skopp G, Pötsch L, Ganßmann B, Aderjan R, Mattern R (1998) A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood. J Anal Toxicol 22: 261–264PubMedGoogle Scholar
  937. 42.
    Skopp G, Pötsch L (1999) Perspiration vs. saliva — basic coneepts concerning their use in roadside drug testing. Int J Legal Med 112: 213–221PubMedGoogle Scholar
  938. 43.
    Skopp G, Pötsch L, Klinder K et al. (1999) Saliva testing after single low dose and chronic high dosage administration of dihydrocodeine. Int J legal Med, in pressGoogle Scholar
  939. 44.
    Vermiere A, Remon JP, Rosseel MT et al. (1998) Eur J Clin Pharmacol 53: 331–336Google Scholar
  940. 45.
    Wanke K, Täschner KL (1979) Straftaten unter Einfluss von Drogen. Z Rechtsmed 83: 209–220PubMedGoogle Scholar
  941. 46.
    Zusammenfassend: Trevor A, Castagnoli N Jr, Singer T (1989) Pharmacology and toxicology of MPTP: A neurotoxic by-product of illicit designer drug chemistry. In: Redda KK, Walker CA, Barnett G (eds) Cocaine, marijuana, designer drugs: Chemistry, Pharmacology and Behaviour. CRC Press, Boca Raton/FL, pp 201–207Google Scholar
  942. Cami J (1989) Methylphenyltetrahydropyridine neurotoxicity: From clandestine drug synthesis to a model for parkinsons disease. Ibid pp 201–209Google Scholar
  943. 1.
    Augsburger M, Rivier L (1997) Drugs and alcihol among suspected impaired drivers in canton de Vaud (Switzerland). Forensic Sci Int 85: 95–104PubMedGoogle Scholar
  944. 2.
    Barnett G, Chiang CN, Perez-Reyes M, Owens SM. (1982) Kinetic study of smoking marijuana. J Pharmacokin Biopharm 10/5: 495–506Google Scholar
  945. 3.
    v. Bibra (1855) Die Narkotischen Genussmittel und der Mensch. Verlag von Wilhelm Schmidt, Nürnberg, SS 269, 272Google Scholar
  946. 4.
    Bundesgesetzblatt (1996) Teil I Nr. 21. Bonn, 15. April 1996Google Scholar
  947. 5.
    Brauchle P, Weinmann W, Pollak S (1997) Drogen-und Medikamentenbeeinflussung von Verkehrsteilnehmern im Raum Südbaden am Beispiel des Jahres 1995. Blutalkohol 34: 385–395Google Scholar
  948. 6.
    Ergebnisbericht der gemeinsamen Arbeitsgruppe für Grenzwertfragen und Qualitätskontrolle (1998). Blutalkohol 35: 372–380Google Scholar
  949. 7.
    Forth W, Henschler D, Rummel W, Starke K (Hrsg). (1992) Allgemeine und Spezielle Pharmakologie und Toxikologie, 6. Aufl. Wissenschaftsverlag, Mannheim, S 249Google Scholar
  950. 8.
    Friedrich-Koch A, Iten PX (1994) Die Verminderung der Fahrtüchtigkeit durch Drogen und Medikamente. Institut für Rechtsmedizin der Universität ZürichGoogle Scholar
  951. 9.
    Giebelmann R (1997) Kulturgeschichtliches zum Haschisch. T+K 64/2: 54Google Scholar
  952. 10.
    Glass M, Felder CC (1998) Endogenous and synthetic cannabinoids and their reeeptors. Neurotransmissions 14/3: 3–11Google Scholar
  953. 11.
    Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol: 16Google Scholar
  954. 12.
    Jahrbuch Sucht ‘99 (1998) Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg) Neuland-Verlagsgesellschaft, GeesthachtGoogle Scholar
  955. 13.
    Kauert G, Röhrich J (1996) Concentrations of Delta-9-tetrahydrocannabinol, cocaine and 6-monoacetylmorphine in hair of drug abusers. Int J Legal Med 108: 294–299PubMedGoogle Scholar
  956. 14.
    Kelly P, Jones RT (1992) Metabolism of THC in frequent and infrequent Marijuana Users. J Anal Toxicol 16: 228–235PubMedGoogle Scholar
  957. 15.
    Kleiber D, Kovar K-A (1998) Auswirkungen des Cannabiskonsums — eine Expertise zu pharmakologischen und psychosozialen Konsequenzen. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  958. 16.
    Kovar K-A (1992) Cannabis — was ist das? Zur Pharmakologie und Wirkungsweise. Dtsch Apothek Z 132/43: 2302–2305Google Scholar
  959. 17.
    Krüger HP, Schulz E, Magerl H (1996) Medikamentenund Drogennachweis bei verkehrsunauffälligen Fahrern. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit, Heft M 60Google Scholar
  960. 18.
    Möller MR (1994) Drogen-und Medikamentennachweis bei verkehrsauffälligen Kraftfahrern. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit, Wirtschaftsverlag Bremerhaven, Heft M 29Google Scholar
  961. 19.
    Mußhoff F, Daldrup T (Hrsg) (1995) Cannabis im Straßenverkehr, Bundesanstalt für Straßenwesen Mensch und Sicherheit. Wirtschaftsverlag NW, Heft M 47Google Scholar
  962. 20.
    Ohlsson A, Lindgren JE, Wahlen A et al. (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28: 409–416PubMedGoogle Scholar
  963. 21.
    Preuß FR (Hrsg) (1979) Gadamers Lehrbuch der chemischen Toxikologie, Bd 1. Vandenhoeck & Ruprecht, Göttingen, S 218Google Scholar
  964. 22.
    Priemer F, Gappmaier A, Ruby M et al. (1999) Pupillenverhalten unter akutem THC-Einfluss, Blutalkohol 36:84–98Google Scholar
  965. 23.
    Rätsch C (1998) Enzyklopädie der psychoaktiven Pflanzen. AT Verlag, AarauGoogle Scholar
  966. 24.
    Röhrich J, Schmidt K, Kauert G (1997) Drogennachweis im Speichel mit dem Immunoassay Triage. Blutalkohol 34: 102–114Google Scholar
  967. 25.
    Schmidt P, Scheer N, Berghaus G (1995) Cannabiskonsum und Fahrtauglichkeit. Kriminalistik 49/4: 241–246Google Scholar
  968. 26.
    Scholer A (1999) Nicht-instrumentelle Immunoassays in der Suchtmittelanalytik, T+K 66/1: 27–44Google Scholar
  969. 27.
    Schulz E, Vollrath M, Klimesch C, Szegedi A (1997) Fahruntüchtigkeit durch Cannabis, Amphetamine und Cocain. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit. Wirtschaftsverlag Bremerhaven, Heft M 81Google Scholar
  970. 28.
    Schulz EO, Wasilewski J (1967) Betäubungsmittelgesetz: „Nicht geringe Menge“ das Vielfache einer Konsumeinheit. Kriminalistik 1/1979: 11-15. Nach Isbell et al, Effects of delta-9-Tetrahydrocannabinol in man. Psychopharmakologia 11: 184–88Google Scholar
  971. 29.
    Skopp G, Pötsch L, Zimmer G, Mattern R (1997) Zur Interpretation von Drogenbefunden auf der Haut. Blutalkohol 34: 427–434Google Scholar
  972. 30.
    Täschner K-L (1979) Das Cannabis-Problem. Akademische Verlagsgesellschaft, WiesbadenGoogle Scholar
  973. 31.
    Turner CE, ElSohly MA, Boergen EG (1980) Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Natural Product 43: 169–234Google Scholar
  974. 32.
    Volmer L, Bieniek D, Körte F (1986) Review of analytical methods for identification of cannabis products. Regulat Toxicol Pharmacol 6: 348–358Google Scholar
  975. 33.
    de Zeeuw R, Wijsbek J (1972) Cannabinoids with a propyl side chain in cannabis. Occur Chromatograph Behavior Sci 175: 778–779Google Scholar
  976. 1.
    Baselt RC, Cravey RH: Disposition of toxic drugs and chemicals in man, 4th edn. Cocaine, Chemical Toxicology Institute, Foster City/CA, pp 186–190Google Scholar
  977. 2.
    Cone, EJ (1995) Pharmacokinetics and pharmacodynamics of cocaine. J Anal Tox 19/6: 459–478Google Scholar
  978. 3.
    Cook CE, Jeffcoat AR, Perez-Reyes M (1985) Pharmacokinetic studies of cocaine in man. In: Barnett G, Chiang CN eds Pharmacokinetics and pharmacodynamics of psychoactive drugs — A research monograph, chapt 3. Biomedical Publications, Foster City/CA, pp 48–74Google Scholar
  979. 4.
    Denison ME, Paredes A, Booth JB (1997) Alcohol and cocaine interactions and aggressive behaviors. Rec Devel Alcoholism 13: 283–303Google Scholar
  980. 5.
    Fandiño AS, Tönnes SW, Kauert GF (1999) Methode zum Nachweis inhalativen Cocainkonsums anhand des thermischen Zersetzungsproduktes Anhydroecgoninmethylester. In: Pragst F, Aderjan R HRsg GTFCH-Symposium — Nachweis berauschender Mittel im Straßenverkehr — Forensische Aspekte der toxischen Präparation von Lebensmitteln. Helm, Heppenheim, S 44–49Google Scholar
  981. 6.
    Farre M, Torre R de la, Gonzales ML et al. (1997) Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exper Ther 283/1: 164–176Google Scholar
  982. 7.
    Farre M, Torre R de la, Llorente M et al. (1993) Alcohol and cocaine interactions in human. J Pharmacol Exper Ther 266/3: 1364–1373Google Scholar
  983. 8.
    Fish F, Wilson WDC (1969) Excretion of cocaine and its metabolites in man. J Pharm Pharmac 21: 135S–138SGoogle Scholar
  984. 9.
    Goodman Gilman A, Rall TW, Nies AS, Taylor P (1994) The pharmacological basis of therapeutics, 8th edn. Pergamon, New YorkGoogle Scholar
  985. 10.
    Herber B, Spahn-Langguth H, Röhrich J et al. (1997) Distribution of i.p. and nasal cocaine into the CNS of rats: Increased tissue-to-blood ratio after application on the nasal mucosa. Naunyn Schmiedeberg’s Arch Pharmacol 355 [Suppl]: R8Google Scholar
  986. 11.
    Holmstedt B, Lindgren J, Rivier L, Plowman T (1979) Cocaine in blood of coca chewers. J Ethnopharm 1: 69–78Google Scholar
  987. 12.
    Inaba T (1989) Cocaine: pharmacokinetics and biotransformation in man. Can J Phys Pharmacol 67/9: 1154–1157Google Scholar
  988. 13.
    Jeffcoat AR, Perez-Reyes M, Hill JM (1989) Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting) or smoking. Drug Met Disp 17: 153–159Google Scholar
  989. 14.
    Miller NS (1990) The pharmacology of alcohol and drugs of abuse and addiction. Pharmacology of cocaine. Springer, Berlin Heidelberg New York Tokio, pp 153–172Google Scholar
  990. 15.
    Mittleman M (1999) Circulation 99: 2737–2741, cited in: Wunsch H (1999) Cocaine use transiently increases heart-attack risk. Lancet 353: 1943Google Scholar
  991. 16.
    Nayak PK, Misra AL, Mule SJ (1976) Physiological disposition and biotransformation of [3H]-cocaine in acutely and chronically treated rats. J Pharmacol Exp Ther 196: 556–569PubMedGoogle Scholar
  992. 17.
    Perez-Reyes M Jeffcoate AR, Myers M et al. (1994) Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. Psychopharmacol 116/4: 428–432Google Scholar
  993. 18.
    Van Dyke C, Jatlow P, Ungerer J (1978) Oral cocaine: plasma concentrations and central effects. Science 200: 211–213PubMedGoogle Scholar
  994. 19.
    Zernig G, O’Laughlin IA, Fibiger HC (1997) Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens. Eur J Pharmacol 337/1: 1–10PubMedGoogle Scholar
  995. 1.
    Henry AJ, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-Methylenedioxymethamphetamine („ecstasy“). Lancet 340: 384–387PubMedGoogle Scholar
  996. 2.
    Karch V, Stevens BG, Ho C-HH (1999) Methamphetamine-related deaths in San Francisco: Demographic, pathologic and toxicologic profiles. J Forens Sci 44/2: 359–368Google Scholar
  997. 3.
    Logan BK, Fligner CL, Haddix T (1998) Cause and manner of death in fatalities involving methamphetamine. J Forens Sci 43/1: 28–34Google Scholar
  998. 4.
    Lora-Tamayo C, Tena T, Rodriguez A (1997) Amphetamine derivate related deaths. Forensic Sci Int 85: 149–157PubMedGoogle Scholar
  999. 5.
    Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52: 12 ff.Google Scholar
  1000. 1.
    Bergemann D, Geier A, Meyer L von (1999) Determination of lysergic acid diethylamide in body fluids by high-performance liquid chromatography and fluorescence detection — A more sensitive method suitable for routine use. J Forensic Sci 44/2: 372–374PubMedGoogle Scholar
  1001. 2.
    Cai J, Henion J (1996) Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry. J Analyt Toxicol 20: 27–37Google Scholar
  1002. 3.
    Foltz RL, Foltz RB (1988) Lysergic acid diethylamide (LSD) in advances in analytical toxicology, edn R Baselt. PSG, Littleton/MAGoogle Scholar
  1003. 4.
    Gillin JC, Kaplan J, Stillman R (1976) The psychedelic model of schizophrenia: The case of N,N-Dimethyltryptamine. Am J Psychiatry 133/2: 203–208PubMedGoogle Scholar
  1004. 5.
    Hofmann A, Heim R, Brack A, Kobel H, Frey A, Ott H, Petrzilka T, Troxler F (1959) Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen. Helv. Chim. Acta 42 (162) 1557–1572Google Scholar
  1005. 6.
    Hollister LE (1990) New class of hallucinogens: GABA enhancing agents. Drug Develop Res 21: 253–256Google Scholar
  1006. 7.
    Jansen KLR (1995) Using ketamine to induce neardeath experience: Mechanism of action and therapeutic potential. Jahrbuch für Ethnomedizin und Bewusstseinsforschung 4: 55–79Google Scholar
  1007. 8.
    Keup W (1995) Die Aga-Kröte und ihr Sekret: Inhaltsstoffe und Missbrauch. Pharmazeut Z 140/42: 9–14Google Scholar
  1008. 9.
    Lim HK, Andrenyak D, Francom P, Foltz RL (1988) Quantification of LSD and N-Desmethyl-LSD in urine by GC/MS. Anal Chem 60: 1420–1425PubMedGoogle Scholar
  1009. 10.
    Müller GFR, Eugster CH (1965) Muscimol, ein pharmakodynamisch wirksamer Stoff aus Amanita muscaria. Helv Chem Acta 48: 910–926Google Scholar
  1010. 11.
    Popik P, Glick SD, Ibogaine A (1996) Putatively anti-addictive alkaloid. Drugs Future 21/11: 1109-1115; Popik P, Skolnick P (1999) „The alkaloids“, vol 52, edn GA Cordell. Academic Press, San Diego, pp 197–231Google Scholar
  1011. 12.
    Schienger R (1993) 50 Jahre LSD. Dtsch Apoth Z 133/ 32: 26–28Google Scholar
  1012. 13.
    Shulgin AT (1981) „Bufotenine“. J Psychoact Drugs 13/ 4: 389Google Scholar
  1013. 14.
    Shulgin A, Shulgin A (1991) PIHKAL. Transform Press, Berkeley/CAGoogle Scholar
  1014. 15.
    Shulgin A, Shulgin A (1997) TIHKAL. The continuation. Transform Press, Berkeley/CAGoogle Scholar
  1015. 16.
    White SA, Kidd AS, Webb KS (1999) The determination of Lysergide (LSD) in urine by high-performance liquid chromatography-isotope dilution mass spectrometry (IDMS). J Forensic Sci 44/2: 375–379PubMedGoogle Scholar
  1016. 1.
    Aderjan R, Buhr H, Schmidt G (1979) Investigation of cardiac glycoside levels in human post-mortem blood and tissues, determined by a special radioimmunoassay procedure. Arch Toxicol 42: 107PubMedGoogle Scholar
  1017. 2.
    Aderjan R, Mattern R (1980) Zur Wertigkeit postmortaler Digoxin-Konzentrationen im Blut. Z Rechtsmed 86: 12Google Scholar
  1018. 3.
    Aderjan R (1982) Tödliche Vergiftungen mit Herzglykosiden. Habilitationsschrift, Universität HeidelbergGoogle Scholar
  1019. 4.
    Aderjan R (1983) Digitoxin-Konzentrationen in postmortal entnommenen Blut und Gewebeproben des Menschen nach therapeutischer Dosierung. In: Digitalistherapie heute. Gillmann R, Storstein L (Hrsg). Verlag für angewandte Wissenschaften, München, S 49Google Scholar
  1020. 5.
    Bentur Y, Tsipiniuk A, Taitelman U (1999) Post-mortem digoxin-like immunoreactive substances (DLIS) in patients not treated with digoxin. Human Exp Toxicol 18: 67Google Scholar
  1021. 6.
    Brown BT, Stafford A, Wright SE (1962) Chemical structure and pharmacological activity of some derivatives of digoxigenin and digitoxigenin. Brit J Pharmacol 18: 311PubMedGoogle Scholar
  1022. 7.
    Butler VP Jr, Schmidt DH, Smith TW et al. (1977) Effects of sheep digoxin-specific antibodies and their Fab-fragments on digoxin pharmacokinetics in dogs. J Clin Invest 59: 345PubMedCentralPubMedGoogle Scholar
  1023. 8.
    Cavet ME, West M, Simmons NL (1996) Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br J Pharmacol 118: 1389PubMedGoogle Scholar
  1024. 9.
    Clausen T (1996) The Na+,K+ pump in skeletal muscle: quantitation, regulation and functional significance. Acta Physiol Scand 156: 227PubMedGoogle Scholar
  1025. 10.
    Clarke Blut zu Serum quotientGoogle Scholar
  1026. 11.
    Digitalis Investigation Group (1996) Rationale, design, implementation, and baseline characteristics of patients in DIG trial: a large simple long-term trial to evaluate the effect of digitalis on mortality in heart failure. Controll Clin Trial 17: 77Google Scholar
  1027. 12.
    Doris PA (1994) Regulation of Na,K-ATPase dependent ouabain-like material. Proc Soc Exp Biol Med 205: 202PubMedGoogle Scholar
  1028. 13.
    Doris PA; Bagrov AY (1998) Endogenous sodium pump inhibitors and blood pressure regulation: an update on recent progress. Proc Soc Exp Biol Med 218: 156PubMedGoogle Scholar
  1029. 14.
    Duvoir M, Pollet L, Desoille H, Gaulthier H (1938) Deux cas d’intoxications par la digitaline, etude cardiographique. Soc Med Hop de Paris 54: 139Google Scholar
  1030. 15.
    Fisher IL (1962) A case of digitalis poisoning (suspect of murder). Acta Med Leg Soc (Liege) 15: 85Google Scholar
  1031. 16.
    Foss PRB, Benezra SA (1980) Digoxin. In: K Florey (ed) Analytical profiles of drug substances, vol 9. Academic Press, San DiegoGoogle Scholar
  1032. 17.
    Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM (1999) Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 99: 4Google Scholar
  1033. 18.
    Fühner M (1929) Rectale Strophanthin-Vergiftung. Dtsch Med Wochenschr 1408Google Scholar
  1034. 19.
    Gaultier M, Fourrner E, Efthymiou ML et al. (1968) L’intoxication digitalique aigue (70 observatios) Soc Med Hop Paris 119: 247Google Scholar
  1035. 20.
    Grange SGM (1983) Commissioner Report of the Royal Commission of Inquiry into certain deaths at the hospital for sick children and related matters. Supreme court of OntarioGoogle Scholar
  1036. 21.
    Greef K (1977) Zur Pharmakokinetik des g-Strophanthins. Dtsch Med Wochenschr 102: 135Google Scholar
  1037. 22.
    Gruber KA (1982) Endogenous drug-like substances: implications and approaches to their study. Perspec Biol Med 26: 51Google Scholar
  1038. 23.
    Haan D, Kreuzer H (1973) Anhang I. Klinische Methoden: Bestimmung der Vollwirkdosis, Abklingquote, Erhaltungsdosis und der Resorptionsquote. In: Beiträge zur Kardiologie und Angiologie 24, Probleme der Prüfung herzwirksamer Glykoside. Steinkopff, Darmstadt, S 165Google Scholar
  1039. 24.
    Haberland G (1973) Struktur und biologische Wirkung von Digitalisstoffen. In: Probleme der klinischen Prüfung herzwirksamer Glykoside. Steinkopff, Darmstadt, S 1Google Scholar
  1040. 25.
    Hastreiter AR, Kim PW Horst RL vd (1983) Accidental digoxin overdose in an infant-post mortem tissue concentrations. J Forensic Sci 28: 482PubMedGoogle Scholar
  1041. 26.
    Heidenreich O, Osswald H (1981) Effects of cardiac glycosides on the kidneys. In: Greef K (ed) Cardiac glycosides, part I (experimental pharmacology). Springer, Berlin Heidelberg New York, p 533Google Scholar
  1042. 27.
    Hess T, Scholtysik G, Riesen W (1978) The prevention and reversal of digoxin intoxication with specific antibodies. Am Heart J 96: 486PubMedGoogle Scholar
  1043. 28.
    Jakovljevic IM (1974) Digitoxin. In: Florey K (ed) Analytical profiles of drug substances, vol 3. Academic Press, San DiegoGoogle Scholar
  1044. 29.
    Jortani SA, Valdes R (1997) Digoxin and its related endogenous factors. Crit Rev Clin Lab Sci 34: 225PubMedGoogle Scholar
  1045. 30.
    Klinder K, Ganßmann B, Aderjan R (1999) unveröffentlichte ErgebnisseGoogle Scholar
  1046. 31.
    Köhnhorn C. (1876) Digitalisvergiftung. Vj Gerichtl Med 24: 278Google Scholar
  1047. 32.
    Koppe R (1875) Untersuchungen über die pharmakologischen Wirkungen des Digitoxins, Digitalins und Digitaleins. Arch Exp Path Pharmak 3: 374Google Scholar
  1048. 33.
    Lannoy IA de, Silverman M (1992) The MDR1 gene produet, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem Biophys Res Commun 189: 551PubMedGoogle Scholar
  1049. 34.
    Lely AH, Enter CHJ van (1970) Large scale digitoxin intoxication. Brit Med J 3: 737PubMedGoogle Scholar
  1050. 35.
    Lowenstein JM (1965) A method for measuring plasma level of digitalis glycosides. Circulation 31: 228PubMedGoogle Scholar
  1051. 36.
    Lowenstein JM, Corrill EM (1966) An improved method for measuring plasma and tissue digitalis glycosides. J Lab Clin Med 67: 1048PubMedGoogle Scholar
  1052. 37.
    Lukas DS (1971) Some aspects of the distribution and disposition of digitoxin in man. Ann N YAcad Sci 179: 338Google Scholar
  1053. 38.
    Mayer U, Wagenaar E, Beijnen JH et al. (1996) Substantial exeretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdrla P-glycoprotein. Br J Pharmacol 119: 1038–1044PubMedGoogle Scholar
  1054. 39.
    Okita GT, Talso PJ, Curry JH, Smith FD, Geiling EMK. (1955) Metabolie fate of radioactive digitoxin in human subjects. J Pharmacol Exp Ther 115: 371PubMedGoogle Scholar
  1055. 40.
    Phillips CDF, Bradford JR. (1876) On the action of certain drugs on the circulation and the secretion of he kidney. J Physiol 8: 117Google Scholar
  1056. 41.
    Potter M (1963) L’intoxication digitalique massive. Rev Prat 1291Google Scholar
  1057. 42.
    Potter M, Perrot L, Vedrinne J, Restoy R (1964) L’intoxication digitalique massive. Masson edit, ParisGoogle Scholar
  1058. 43.
    Reuning RH, Shepard TA, Morrison BE (1985) Formation of 20R-dihydrodigoxin from digoxin in humans. Drug Metab Dispos 13: 51PubMedGoogle Scholar
  1059. 44.
    Ritz S, Harding P, Martz H, Schütz W, Kaatsch HJ (1992) Measurement of digitalis glycoside levels in ocular tissues. A way to improve post mortem diagnosis of lethal digitalis poisoning. Int J Leg Med 105: 149Google Scholar
  1060. 45.
    Robertson LW, Chandrasekaran A, Reuning PH et al (1986) Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum. Appl Environ Microbiol 51:1300PubMedCentralPubMedGoogle Scholar
  1061. 46.
    Rose AM, Valdes R jr (1994) understanding of the sodium pump and its relevance to disease. Clin Chem 40: 1674PubMedGoogle Scholar
  1062. 47.
    Rule G, McLaughlin LG, Henion J (1993) A quest for oleandrin in decayed tissue. Anal Chem 65: 875 AGoogle Scholar
  1063. 48.
    Ryung-Soon K, Labella FS (1981) Endogenous ligands and modulators of the digitalis receptor: some candidates. Pharm Ther 14: 391Google Scholar
  1064. 49.
    Schinkel AH, Wagenaar E, Deemter L van, Mol CA, Borst P (1995) Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96: 1698PubMedCentralPubMedGoogle Scholar
  1065. 50.
    Schinkel AH (1997) The physiological function of drugtransporting P-glycoproteins. Sem Cancer Biol 8: 1Google Scholar
  1066. 51.
    Scumaik GM (1988) Oleander poisoning: treatment with digoxin-specific Fab antibody fragment. Ann Emerg Med 20: 732Google Scholar
  1067. 52.
    Selesky M, Spiehler VR, Cravey RH, Elliot HW (1976) Digoxin concentrations in fatal cases. J Forensic Sci 22:409Google Scholar
  1068. 53.
    Shaik IM, Lau BWE, Siegfried A et al. (1991) Isolation of digoxin-like immunoreactive factors from mammalian adrenal cortex. Biol Chem 266: 13672Google Scholar
  1069. 54.
    Smith TW, Haber E, Yeatman L, Butler VP Jr (1976) Reversal of advanced digoxin intoxication with Fab-fragments of digoxin-specific antibodies. N Engl J Med 294: 797PubMedGoogle Scholar
  1070. 55.
    Steentoft A (1973) Fatal digitalis poisoning. Acta Pharmacol Toxicol 32: 353Google Scholar
  1071. 56.
    Sweadner KJ (1991) Overview: subunit diversity in the Na,K-ATPase. In: Kaplan JH, De Weer P (eds) The sodium pump, strueture, mechanism, and regulation. Rockefeller University press, New York, pp 63–67Google Scholar
  1072. 57.
    Tardieu A, Roussin FZ. (1864) Relation medico-legale de l’affaire Couty de la Pommerais. Ann Hyg Publ Med Leg 22: 80Google Scholar
  1073. 58.
    Thomas F (1964) Milestones in forensic medicine: the Belgian contribution. Med Sci Law 4: 155PubMedGoogle Scholar
  1074. 59.
    Thomas L, La Barre J, Renaux J, Draux E (1979) A therapeutic catastrophe, entailing 16 exhumations following the administration of oestradiol benzoate to prostatic cancer patients. Med Sci Law 19: 8–19PubMedGoogle Scholar
  1075. 60.
    Tracqui A, Kintz P, Ludes B, Mangin P (1997) High-performance liquid chromatography-ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma. J Chromatogr B Biomed Sci Appl 692: 101PubMedGoogle Scholar
  1076. 61.
    Vöhringer HF, Rietbrock N (1974) Metabolism and excretion of digitoxin in man. Clin Pharmacol Ther 16:14Google Scholar
  1077. 62.
    Vöhringer HF (1981) Pharmakokinetik von Digoxin im Vergleich zu Digitoxin bei Niereninsuffizienz. In: Kochsiek K, Rietbrock N (Hrsg) Digitalistherapie bei Niereninsuffizienz. Urban & Schwarzenberg, München, S 21Google Scholar
  1078. 63.
    Vorpahl TE, Coe JI (1978) Correlations of ante-mortem and post-mortem digoxin levels. J Forensic Sci Soc 23: 329Google Scholar
  1079. 64.
    Watkins PB (1997) The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv Drug Del Rev 27: 161Google Scholar
  1080. 65.
    Wolf AD (1991) Digoxin specific antibody fragments. Clin Tox Rev 13: 1Google Scholar
  1081. 66.
    Wood WG, Farber P, Kurowski V (1990) A case of divergent digitoxin values under treatment of a patient with acute digitoxin overdose with digitalis antibody fragments. Klin Wochenschr 68: 324PubMedGoogle Scholar
  1082. 67.
    Zilker T, Bihlmayr J, Felgenhauer N, Clarman M v. (1991) Comparison of cases of digitalis intoxications before and after introduction of anti digoxin FAB fragments (ADFABF) into therapy. In: Proceedings of the Meeting of the European Association of Poison Control Centres, Lyon, FranceGoogle Scholar
  1083. 1.
    Ackenheil M (1989) Clozapine-pharmacokinetic investigations and biochemical effects in man. Psychopharmacology 99: S32–S37PubMedGoogle Scholar
  1084. 2.
    Ahrens B, Schütz H, Seno H, Weiler G (1994) Screening, identification and determination of the two new hypnotics Zolpidem and Zopiclone. Arzneim Forsch/Drug Res 44:799–802Google Scholar
  1085. 3.
    Aravagiri M, Marder SR, Wirshing D, Wirshing WC. (1998) Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in Schizophrenie patients: simultaneous determination by a high Performance liquid chromatography with electrochemical detection. Pharmacopsychiatry 31/3: 102–109PubMedGoogle Scholar
  1086. 4.
    Auterhoff H, Knabe J, Höltje H-D (1999) Lehrbuch der Pharmazeutischen Chemie, 14. Aufl. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1087. 5.
    Badian M, Brettel HF, Malerczyk V, Ostrowski J, Sittig W (1987) Untersuchungen zur Kombination von Alkohol und Piracetam. Blutalkohol 24: 333–340PubMedGoogle Scholar
  1088. 6.
    Balant-Gorgia AE, Gex-Fabry M, Genet C, Balant LP. (1999) Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors. Ther Drug Monit 21/1: 105–115PubMedGoogle Scholar
  1089. 7.
    Baselt RC, Cravey RH (1995) Disposition of toxic drugs and chemicals in man, 4th edn. Chemical Toxicology Institute, Foster City/CAGoogle Scholar
  1090. 8.
    Benfield P, Heel RC, Lewis SP (1986) Fluoxetine: a review of its pharmacodynamic and pharmacokinetie properties, and therapeutic efficaey in depressive illness. Drugs 32: 481–508PubMedGoogle Scholar
  1091. 9.
    Beyer K-H (1990) Biotransformation der Arzneimittel, 2. Aufl. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  1092. 10.
    Boniface PJ, Russell SG (1996) Two cases of fatal zopiclone overdose. J Anal Tox 20: 131–133Google Scholar
  1093. 11.
    Bost RO, Kemp PM (1992) A possible association between fluoxetine use and suicide. J Anal Toxicol 16:142–145PubMedGoogle Scholar
  1094. 12.
    Brown RP, Kocsis JH (1984) Sudden death and antipsychotic drugs. Hosp Commun Psychiatr 35: 486–491Google Scholar
  1095. 13.
    Catalano G, Catalano MC, Taylor W (1997) Acute risperidone overdose. Clin Neuropharmacol 20/1: 82–85PubMedGoogle Scholar
  1096. 14.
    Dain JG, Nicoletti J, Ballard-F (1997) Biotransformation of clozapine in humans. Drug Metab Dispos 25/5: 603–609PubMedGoogle Scholar
  1097. 15.
    Daldrup T, Michalke P, Boehme W (1982) A Screening test for pharmaceuticals, drugs and insecticides with reversed phase liquid chromatography — retention data of 560 compounds. Chromatogr Newsletter 10: 1–7Google Scholar
  1098. 16.
    Duenas-Laita A, Castro-Villamor MA, Martin-Escudero JC, Perez-Castrillon JL (1999) New clinical manifestations of acute risperidone poisoning [letter]. J Toxicol Clin-Toxicol 37/7: 893–895PubMedGoogle Scholar
  1099. 17.
    Fachinformation Risperdal. (2000) Bundesverband der Pharmazeutischen Industrie, AulendorfGoogle Scholar
  1100. 18.
    Forth W, Henschler D, Rummel W (Hrsg) (1990) Allgemeine und spezielle Pharmakologie und Toxikologie. BI Wissenschaftsverlag & Brockhaus MannheimGoogle Scholar
  1101. 19.
    Forth W, Henschler D, Rummel W, Starke K (1996) Allgemeine und spezielle Pharmakologie und Toxikologie, 7. Aufl. Spektrum, HeidelbergGoogle Scholar
  1102. 20.
    Friedrich G, Logemann E, Werp J (1986) Toxikologie und postmortale Biochemie. In: Forster B (Hrsg) Praxis der Rechtsmedizin. Thieme, Stuttgart, S 673–833Google Scholar
  1103. 21.
    Gaillard Y, Pepin G (1997) Moclobemide fatalities: report of two cases and analytical determinations by GCMS and HPLC-PDA after solid-phase extraction. Forensic Sci Int 87: 239–248PubMedGoogle Scholar
  1104. 22.
    Gailliot J, Heusse D, Hougton GW, Marc-Aurele J, Dreyfus JF (1982) Pharmacokinetics and metabolism of Zopiclone. Int Pharmacopsychiatr 17 [Suppl. 2]: 76–91; Pharmacology 27 [Suppl. 2]: 76-91Google Scholar
  1105. 23.
    Ganssmann B, Skopp G, Aderjan R, Mattern R (1998) Tödliche Vergiftung mit Clozapin und Perazin — Eine Falldarstellung. Arch Kriminol 201: 11–20PubMedGoogle Scholar
  1106. 24.
    Geldmacher-von Mallinckrodt M (1975) Forensische Toxikologie. In: Mueller B (Hrsg) Gerichtliche Medizin, Bd II Springer, Berlin Heidelberg New York, S 691–965)Google Scholar
  1107. 25.
    Gibitz HJ, Schütz H (Hrsg) (1995) Einfache toxikologische Laboratoriumsuntersuchungen bei akuten Vergiftungen. VCH, WeinheimGoogle Scholar
  1108. 26.
    Gock SB, Wong SHY, Nuwayhid N et al. (1999) Acute Zolpidem overdose — Report of two cases. J Anal Toxicol 23: 559–562PubMedGoogle Scholar
  1109. 27.
    Goenechea VS, Rucker G, Brzezinka H et al. (1988) Untersuchungen zur Biotransformation von Meclozin im menschlichen Körper. J Clin Chem Clin Biochem 26:105–115PubMedGoogle Scholar
  1110. 28.
    Graf E, Preuß FR (Hrsg) (1979) Gadamers Lehrbuch der chemischen Toxikologie und Anleitung zur Ausmittelung der Gifte, Band 1/2. Vandenhoeck & Ruprecht, GöttingenGoogle Scholar
  1111. 29.
    Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gillmann A (1998) Goodman & Gillamn’s Pharmakologische Grundlagen der Arzneimitteltherapie, 9. Aufl. McGraw-Hill, Frankfurt a. M.Google Scholar
  1112. 30.
    Harry P (1997) Intoxications aigues par les nouveaux psychotropes. [Acute poisoning by new psychotropic drugs]. Rev Prat 47: 731–735PubMedGoogle Scholar
  1113. 31.
    Hollister LE, Kosek JC (1965) Sudden death during treatment with phenothiazine derivates. J Am Med Asso 21: 1035–1038Google Scholar
  1114. 32.
    Institut für Arzneimittelwesen der DDR (Hrsg) (1989) Arzneimittelverzeichnis 1988 Teil I, 22. Aufl. Verlag Volk & Gesundheit, BerlinGoogle Scholar
  1115. 33.
    Iten PX (1994) Fahren unter Drogen-oder Medikamenteneinfluss. Forensische Interpretation und Begutachtung. Institut für Rechtsmedizin, ZürichGoogle Scholar
  1116. 34.
    Iwersen S, Schmoldt A (1996) Three suicide attempts with moclobemide. J Toxicol Clin Toxicol 34: 223–225PubMedGoogle Scholar
  1117. 35.
    Jann MW (1988) Buspirone: An update on a unique anxiolytic. Pharmacotherapy 8/2: 100–116PubMedGoogle Scholar
  1118. 36.
    Jauch R, Griesser E, Oesterhelt G et al. (1990) Biotransformation of moclobemide in humans. Acta Psychiatr Scand [Suppl] 360: 87–90Google Scholar
  1119. 37.
    Keller T, Miki A, Binda S, Dirnhofer R (1997) Fatal overdose of clozapine. Forensic Sci Int 86: 119–125PubMedGoogle Scholar
  1120. 38.
    Kintz P, Tracqui A, Parent X, Hanser E, Mangin P (1994) Fatal Sulpiride intoxication. TIAFT Bull. 24/4: 37–39Google Scholar
  1121. 39.
    Kopala LC, Day C, Dillman B, Gardner D (1998) A case of risperidone overdose in early schizophrenia: a review of potential complications. J Psychiatr Neurosci 23/5: 305–308Google Scholar
  1122. 40.
    Koppel C, Ibe K, Tenczer J (1987) Clinical symptomatology of diphenhydramine overdose: an evaluation of 136 cases in 1982 to 1985. J Toxicol Clin Toxicol 25: 53–70PubMedGoogle Scholar
  1123. 41.
    Koppel C, Tenczer J, Ibe K (1987) Poisoning with overthe-counter doxylamine preparations: an evaluation of 109 cases. Hum Toxicol 6: 355–359PubMedGoogle Scholar
  1124. 42.
    Krenzelok EP, Anderson GM, Mirick M (1982) Massive diphenhydramine overdose resulting in death. Ann Emerg Med 11: 212–213PubMedGoogle Scholar
  1125. 43.
    Kudo Y, Suzuki Y, Nakamura et al. (1988) Tolerance and pharmaeokinetics of Zolpidem in healthy volounteers using double-blind manner. Psychopharm 96 [Suppl]: 353Google Scholar
  1126. 44.
    Kumar-A (1997) Sudden unexplained death in a psychiatric patient — a case report: the role of phenothiazines and physical restraint. Med Sci Law 37: 170–175PubMedGoogle Scholar
  1127. 45.
    Kunsman GW, Rodriguez R, Rodriguez P (1999) Fluvoxamine distribution in postmortem cases. Am J Forensic Med Pathol 20/1: 78–83PubMedGoogle Scholar
  1128. 46.
    Laposata EA, Hale P Jr, Poklis (1988) A Evaluation of sudden death in Psychiatric patients with special reference to phenothiazine therapy: forensic pathology. J Forensic Sci 33: 432–440PubMedGoogle Scholar
  1129. 47.
    Lee HS, Tan CH, Au LS, Khoo YM (1997) Serum and urine risperidone concentrations in an acute overdose [letter]. J Clin Psychopharmacol 17/4: 325–326PubMedGoogle Scholar
  1130. 48.
    Leestma JE, Koenig KL (1968) Sudden death and phenothiazines. Arch Gen Psych 18: 137–148Google Scholar
  1131. 49.
    Levine B, Jenkins, A Chute D, Smialek LE (1999) Perphenazine distribution in a postmortem case. J Anal Toxicol 23: 127–129PubMedGoogle Scholar
  1132. 50.
    Lichtenwalner M, Tully R (1997) A fatality involving Zolpidem. J Anal Toxicol 21: 567–569PubMedGoogle Scholar
  1133. 51.
    Marquardt H, Schäfer SG (Hrsg) (1994) Lehrbuch der Toxikologie. BI Wissenschaftsverlag, MannheimGoogle Scholar
  1134. 52.
    Meeker JE, Herrmann PW, Som CW, Reynolds PC (1992) Clozapine tissue concentrations following an apparant suicidal overdose of Clozaril. J Anal Toxicol 16: 54–56PubMedGoogle Scholar
  1135. 53.
    Moffat AC, Jackson JV, Moss MS, Widdop B (eds). (1986) Clarke’s isolation and identification of drugs. Pharmaceutical Press, LondonGoogle Scholar
  1136. 54.
    Müller K (Hrsg) (1991) Toxicological analysis. Verlag Gesundheit, BerlinGoogle Scholar
  1137. 55.
    Musshoff F, Grellner W, Madea B (1999) Toxikologische Befunde bei einem Suicid mit Doxepin und Paroxetin. Arch Kriminol 204: 28–32PubMedGoogle Scholar
  1138. 56.
    Mutschier E, Schäfer-Korting M (1996) Arzneimittelwirkungen Lehrbuch der Pharmakologie und Toxikologie, 7. Aufl. Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1139. 57.
    Nagasaki T, Ohkubo T, Sugawara K et al. (1999) Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia. J Pharm Biomed Anal 19: 3–4Google Scholar
  1140. 58.
    Negwer M (1994) Organic-chemical drugs and their synonyms. Akademie-Verlag, BerlinGoogle Scholar
  1141. 59.
    Pall M, Bested KM, Eriksen ND (1997) Forgiftning med en reversibel og selektiv monoaminooxydasehaemmer. [Poisoning with a reversible and selective monoaminooxidase inhibitor]. Ugeskr Laeger 159: 4859–4860PubMedGoogle Scholar
  1142. 60.
    Peele R, Von Loetzen IS (1973) Phenothiazine deaths: a critical review. Am J Psychiatry 130: 306–309PubMedGoogle Scholar
  1143. 61.
    Penning R (1997) Rechtsmedizin systematisch. Uni-Med, BremenGoogle Scholar
  1144. 62.
    Pentz R, Strubelt O, Gehlhoff C (1979) Therapeutische, toxische und letale Arzneimittelkonzentrationen im menschlichen Plasma. Dtsch Ärzteblatt 76: 2815–2820Google Scholar
  1145. 63.
    Pfeifer S, Borchert HH (1975-1983) Biotransformation von Arzneimitteln, Bd 1–5. VEB Volk & Gesundheit, BerlinGoogle Scholar
  1146. 64.
    Pfleger K, Maurer HH, Weber A (1999) Mass spectral and GC data of drug